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Abstract 
Developing a model of patient values in medical decision making: A qualitative 
inquiry into insulin initiation in type 2 diabetes 
Background: Shared decision making (SDM) is a medical decision making model 
where at least two parties (for example, patient and doctor) share information and values 
in order to build consensus on the preferred treatment to implement. Patient values are 
the most mentioned element in definitions of SDM. However, there is no agreed 
definition of patient values in both SDM and the larger field of medical decision 
making. Therefore, this study aimed to develop a model of patient values using insulin 
initiation in type 2 diabetes as an exemplar.  
Methods: The study design was a qualitative study based on an interpretive descriptive 
approach. Data was collected from both healthcare professionals (HCPs) and patients. 
The conceptual frameworks used were the Ottawa Decision Support Framework and 
Schwartz’s theory of values. Purposive sampling was used to recruit HCPs involved in 
insulin initiation and patients who were deciding about insulin. Participants were 
recruited from the three main healthcare settings in Malaysia (public health clinics, 
public university-based primary care clinics, and private clinics). An interview topic 
guide was developed based on the conceptual frameworks and expert opinion. In-depth 
interviews and focus group discussions were conducted between January 2011 and June 
2012. Interviews were stopped when data saturation was achieved. The interviews were 
transcribed verbatim and managed with Nvivo9 software. Data was analysed using 
thematic analysis and Strauss’ method of coding. A process of open, selective and axial 
coding was used to develop the model of patient values.  
Results: Forty-one HCPs were interviewed (30-66 years old; females, n=31). The 
sample was diverse in terms of professional background (general practitioners, medical 
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officers, family medicine specialists, government policy makers, diabetes nurse 
educators, endocrinologists and pharmacists), healthcare settings (public, private) and 
ethnicity (Malays, Chinese, Indians, other ethnicities). Twenty-one patients were 
interviewed (28-67 years old; males, n=12) from diverse healthcare settings and ethnic 
backgrounds. 
Based on HCP interviews, barriers and facilitators to insulin initiation included patient 
barriers (e.g. injection-related barriers, insulin-related barriers, social factors, emotional 
barriers), HCP barriers (e.g. lack of HCP motivation and confidence, lack of training, 
conflicting advice between HCPs), and system-related barriers. These factors provided 
the psychosocial and cultural context in which patient values were explored. 
Based on patient interviews, the types of patient values during insulin initiation were 
identified. Three categories of values emerged: (1) positive and negative insulin-specific 
beliefs, (2) personal life goals (e.g. health, career, finance) and philosophies (e.g. 
avoiding suffering, fatalism, not being a burden), and (3) socio-cultural values (e.g. 
religious teachings, cultural practices) and family background.  A model of patient 
values was then developed based on the three categories. 
Conclusions: When supporting patients in decision making, HCPs need to address 
more than just treatment-specific beliefs. A deeper understanding of patients’ life 
priorities and socio-cultural background are essential, as these also influence decisions 
about treatments. The proposed model of patient values helps to clarify the definition of 
patient values in SDM and can be used to systematically explore patient values during 
consultations.   
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Abstrak 
Membangunkan satu model nilai-nilai pesakit untuk membuat keputusan 
perubatan:  Siasatan kualitatif ke dalam keputusan memulakan insulin dalam 
diabetes jenis 2 
Latarbelakang: Shared Decision Making (SDM) adalah model membuat keputusan 
perubatan di mana sekurang-kurangnya dua pihak (pesakit dan doktor) berkongsi 
maklumat dan  nilai-nilai dalam usaha untuk membina konsensus mengenai rawatan 
pilihan. Nilai-nilai pesakit adalah elemen yang paling disebut dalam takrif SDM. Walau 
bagaimanapun, tidak ada definisi yang jelas mengenai nilai-nilai pesakit dalam SDM 
dan bidang "medical decision making". Oleh itu, kajian ini bertujuan untuk 
membangunkan satu model nilai-nilai pesakit menggunakan permulaan insulin dalam 
diabetes jenis 2 sebagai contoh.  
Kaedah kajian: Kajian ini menggunakan siasatan induktif bersifat kualitatif 
berdasarkan kaedah “interpretive descriptive”. Data dikumpulkan dari kedua-dua 
professional penjagaan kesihatan (PPK) dan pesakit. Rangka kerja konsep yang 
digunakan adalah Ottawa Decision Support Framework (PPK) dan Schwartz et al’s 
Theory of Human Values (pesakit). Persampelan bertujuan telah digunakan untuk 
memilih PK yang terlibat dalam permulaan insulin dan pesakit yang membuat 
keputusan mengenai insulin. Data dikumpulkan melalui temu bual secara mendalam dan 
perbincangan kumpulan fokus di antara Januari 2011 hingga Jun 2012. Data dianalisis 
menggunakan analisis tema (PPK) dan kaedah pengekodan Strauss (pesakit).  
Keputusan: 41 PPK ditemubual (usia 30-66 tahun; perempuan, n = 31). Sampel adalah 
berbeza dari segi latar belakang profesional (doktor am/ pegawai perubatan, pakar 
perubatan keluarga, pembuat polisi kerajaan, jururawat pendidik diabetes, ahli 
endokrinologi dan ahli farmasi), sektor kesihatan (awam, swasta) dan kumpulan etnik 
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(Melayu, Cina, India, etnik lain). 21 orang pesakit telah ditemubual (usia 28-67 tahun; 
lelaki, n = 12) dari pelbagai latar belakang etnik dan sektor kesihatan (hospital universiti 
berasaskan klinik penjagaan utama, n = 7; klinik kesihatan awam, n = 8; klinik swasta, n 
= 6). 10 orang pesakit berminat untuk memulakan insulin, 8 tidak berminat, seorang 
belum membuat keputusan, dan 2 orang pesakit telah ditemubual selepas memulakan 
insulin.  
Pelbagai halangan dan fasilitator untuk permulaan insulin telah dikenal pasti. Halangan 
terdiri daripada halangan pesakit (contohnya halangan yang berkaitan dengan suntikan, 
halangan yang berkaitan dengan insulin, faktor-faktor sosial, halangan emosi peribadi), 
halangan PK (contohnya kekurangan motivasi HCP dan keyakinan, kekurangan latihan, 
nasihat bercanggah antara PK), dan halangan berkaitan dengan sistem .  
Seterusnya, nilai-nilai pesakit semasa permulaan insulin telah dikaji. Pesakit mengenal 
pasti pelbagai kepercayaan tentang insulin yang positif atau negatif. Pesakit menyatakan 
bagaimana matlamat kehidupan peribadi (seperti kesihatan, kerjaya, kewangan) dan 
falsafah (contohnya mengelak penderitaan, fatalisme, tidak membebankan orang lain) 
mempengaruhi keputusan mereka. Akhir sekali, pesakit menggambarkan bagaimana 
nilai-nilai sosio-budaya (contohnya ajaran-ajaran agama, amalan budaya) dan latar 
belakang keluarga berkaitan dengan keputusan mereka tentang insulin. Akhirnya, model 
nilai-nilai pesakit telah dibangunkan berdasarkan tiga kategori nilai-nilai pesakit.  
Kesimpulan: Apabila menyokong pesakit dalam membuat keputusan, doktor perlu 
menerokai lebih daripada sekadar kepercayaan tentang rawatan. Pemahaman yang lebih 
mendalam tentang matlamat hidup pesakit dan latar belakang sosio budaya adalah 
penting kerana ini juga mempengaruhi keputusan mengenai rawatan. Model nilai-nilai 
pesakit yang dicadangkan membantu menjelaskan definisi nilai-nilai pesakit dalam 
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SDM dan boleh digunakan oleh PK untuk meneroka secara sistematik nilai-nilai pesakit 
dalam perundingan. 
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Chapter 1: Introduction 
The focus of this thesis is on exploring the role of patient values in shared decision 
making (SDM), using insulin initiation in patients with type 2 diabetes as an exemplar. 
The papers compiled in this thesis were published from data collected as part of the 
Decision Making in Insulin Therapy (DMIT) Project (see Appendix A for an overview 
of the project’s aims, methods and research team). This 3-year project aimed to develop 
a patient decision aid (PDA) for use during insulin initiation and was conducted in 
Malaysia, an ethnically diverse country located in South East Asia. Some data from this 
thesis was used to inform the values elicitation section of the PDA and also the 
accompanying Trainer’s Guide.  
This chapter introduces the concept of SDM, which forms the overarching paradigm in 
which patient values are investigated. SDM is a component of medical decision making, 
whereby medical decision making includes the various types of decisions that are made 
in the various disciplines (e.g. health economics, decision psychology, and health policy 
and systems research) and levels (individual consultations, local practice settings and 
policies, and global health). SDM is a model of medical decision making which is 
multi-disciplinary (e.g. decision psychology, medical ethics, evidence-based practice) 
and is practiced at the level of individual patient-doctor consultations.  
Next, reasons are given for the focus on the concept of patient values within SDM and 
why insulin initiation serves as a good exemplar in which to explore patient values. 
Lastly, Malaysia’s unique multi-cultural society and dual-sector healthcare system is 
described for the benefit of readers who are unfamiliar with Malaysia. As an 
introduction to SDM in Malaysia, a situational analysis on the current state of patient 
involvement in SDM is included after this chapter (refer to Chapter 2).  
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1.1 Introduction to shared decision making  
Bensing (2000) wrote that the two main paradigms of modern medicine can be 
identified as “patient-centred medicine” and “evidence-based medicine (EBM)”. 
Despite EBM appearing later in medical literature in 1992, as compared to the 1970's 
for patient-centeredness,  the total number of papers discussing EBM is almost three 
times as much as the number of papers discussing “patient-centred medicine” (Bensing, 
2000).  
EBM appeals strongly to healthcare professionals (HCPs) because this approach enables 
them to combine both individual expertise with best external evidence and the output is 
the best health decision option for their patients (Bensing, 2000). However, EBM is 
criticised as being too disease-centered owing to a biomedical approach and its reliance 
on randomised controlled trials (RCTs) as the gold standard for decision making 
(Bensing, 2000). On the other hand, patient-centered medicine uses a biopsychosocial 
model that focused on the needs and preferences of the patient, but was criticised for not 
having any theory or evidence to guide understanding of what these needs and 
preferences might be (Bensing, 2000). Efforts to address these criticisms include 
incorporation of patient values as a component of EBM alongside best evidence and 
clinical experience (Sackett, Straus, Richardson, Rosenberg, & Haynes, 2000). 
SDM is a medical practice model which aims to incorporate both evidence and patient 
values in medical decisions. The term ‘shared decision making’ is used fluidly and the 
model is still being refined. A systematic review of 161 articles which contained a 
conceptual definition of shared decision making, identified six key sources, whereby 
these six articles were cited by more than 5% of the other papers (Makoul & Clayman, 
2006).  
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The review showed that over three decades, SDM grew from a conceptual model into a 
model with standards and concrete practices. Makoul et al (2006) developed an 
integrative model of SDM based on the six key sources (Table 1.2). Their framework 
lists the essential elements (which must be present for SDM to occur), ideal elements 
(which may enhance SDM, but are not necessary) and the general qualities of SDM 
(relatively general characteristics describing SDM). More recent developments in SDM 
include closer international collaborations such as establishing international standards 
for patient decision aids (PDAs) (International Patient Decision Aids Collaboration, 
2006, 2012) and developing simplified SDM practice models and tools (Elwyn et al., 
2012). 
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Table 1.1: The development of the SDM model (1982-2003) 
Year Authors Source 
document 
Main points Key 
development 
1982 14 member 
presidential 
committee  
United States 
(1982). 
President’s 
Commission for 
the Study of 
Ethical Problems 
in Medicine and 
Biomedical and 
Behavioral 
Research. U S 
Code Annot U S 
Title 42 Sect. 
300v as added 
1978. 
 Focus of the report was 
on informed consent in 
the patient-doctor 
relationship 
 First time the term 
shared decision 
making mentioned 
 Defined SDM as the 
ethical relationship 
between doctor and 
patient  
 The commission called 
for more research on 
formalizing shared 
decision making 
First time 
SDM was 
mentioned 
1997 Charles, 
Gafni, et 
al. 
Charles, Gafni, et 
al. (1997). 
Shared Decision-
Making in the 
Medical 
Encounter: What 
Does it Mean? 
(Or it Takes at 
Least Two to 
Tango). Soc. Sci. 
Med. 44(5), 681-
692. 
 Defined SDM as a 
medical practice model 
by comparing it 
against paternalism, 
the informed model 
and doctor-as-agent. 
 Defined shared 
decision making as 
involving four criteria:  
 At least two 
participants- doctor 
and patient must be 
involved 
 Both parties (doctors 
and patients) take steps 
to participate in the 
process of treatment 
decision-making  
 Information sharing is 
a prerequisite to SDM  
 That an agreement is 
reached on the 
treatment to be 
implemented 
Identified four 
key criteria for 
defining SDM 
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Table 1.1, continued 
1999 Charles, 
Gafni, et 
al. 
Charles, Gafni, et 
al. (1999). 
Decision-making 
in the physician-
patient encounter: 
revisiting the 
shared treatment 
decision-making 
model. Soc Sci 
Med 49(5),  651-
661. 
 Emphasized  the 
process of SDM 
 Identified three stages 
in the consultation  
 Information exchange 
(flow, direction, type 
of information, 
amount) 
 Deliberation (Both 
physician and patient, 
including significant 
others, are involved in 
making the decision) 
 Deciding on treatment 
to implement (Both 
physician and patient 
make the decision) 
Identified the 
processes 
involved in 
SDM 
1999 Towle and 
Godolphin 
Towle, & 
Godolphin. 
(1999). 
Framework for 
teaching and 
learning informed 
shared decision 
making. BMJ 
319(7212), 766-
771. 
 Defined the skills 
needed for practice of 
SDM 
 Listed eight doctor 
competencies and 
seven patient 
competencies needed 
for informed shared 
decision making. 
Identified the 
HCP and 
patient skills 
(competence
s) needed for 
SDM  
1999 Coulter et 
al 
Coulter, Entwistle, 
et al. (1999). 
"Sharing decisions 
with patients: is 
the information 
good enough?" 
BMJ 318(7179), 
318-322. 
 Emphasized the need 
to bridge conceptual 
and actual practice of 
SDM 
 Advocated patient 
decision aids as a tool 
for practical 
implementation of 
SDM 
Emphasize 
the need to 
develop 
practical 
ways to 
implement 
SDM 
2003 Elwyn et al Elwyn, Edwards, 
et al. (2003). 
Shared decision 
making: 
developing the 
OPTION scale for 
measuring patient 
involvement. Qual 
& safety in 
healthcare 12(2), 
93-99. 
 Created the 12-item 
OPTION scale for 
measuring SDM 
Develop a 
measure for 
SDM 
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Table 1.2 An integrated model of SDM  
Essential elements 
1. Define/explain problem  
2. Present options  
3. Discuss pros/cons 
(benefits/risks/costs)  
4. Patient values/preferences  
5. Discuss patient ability/self-
efficacy 
6. Doctor knowledge/ 
recommendations  
7. Check/clarify 
understanding  
8. Make or explicitly defer 
decision  
9. Arrange follow-up 
Ideal elements 
1. Unbiased 
information  
2. Define roles 
(desire for 
involvement)  
3. Present evidence 
4. Mutual agreement 
 
General qualities 
1. Deliberation/negotiation 
2. Flexibility/individualized 
approach 
3. Information exchange 
4. Involves at least two 
people 
5. Middle ground 
6. Mutual respect 
7. Partnership  
8. Patient education 
9. Patient participation 
10. Process/stages 
 
Source: Makoul & Clayman, 2006 
1.2 Patient values in shared decision making 
Makoul & Clayman  noted in their review that the most commonly mentioned element 
in SDM was “patient values/ preferences” (Makoul & Clayman, 2006). In the 
President’s Commission, patient values were mentioned numerous times, often 
clustered with “goals”, “attitudes” and/or “preferences” (United States, 1982). The term 
‘patient values’ in the President’s Commission was used to explain the two principles of 
informed consent, which are subjective patient well-being and patient self-
determination. In subjective patient well-being, patient’s values were the subjective 
criteria on which the patient would choose the best health option according to their 
perspective. In patient self-determination, the patient should be allowed to choose their 
preferred medical option after weighing the risks and benefits according to their values. 
This early example indicates the centrality of values in determining patient participation 
in healthcare decisions. However, no specific examples or definitions were provided on 
what values were.  
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Charles et al. discussed patient values as a necessary step in SDM which went beyond 
just eliciting patient preferences i.e. stating which option was preferred (Charles, Gafni, 
& Whelan, 1997). Instead, sharing the decision process with patients meant “eliciting 
patient preferences so that treatment options discussed are compatible with the patient's 
lifestyle and values” (Charles, Gafni, & Whelan, 1997). However, again, no specific 
definition or example was given on what was meant by patient values.  
In 1999, the list of characteristics that patients would bring to the consultation was 
further expanded as “beliefs, values, fears, illness experiences and, increasingly, 
information about various treatment options” (Charles, Gafni, & Whelan, 1999). 
Charles et.al stated that values and beliefs functioned as the filter for the amount of 
information received and how this information was interpreted (pg 655, Charles, Gafni, 
& Whelan, 1999).  
Towle and Godolphin acknowledged that one of the competencies needed by doctors to 
practice SDM was to “…help patients to reflect on and assess the impact of alternative 
decisions with regard to his or her values and lifestyle” (pg 767, Towle & Godolphin, 
1999). This use of the term values was similar to Charles et al in saying that decisions 
should be compatible with a patient’s values (Charles, et al., 1997). However, no 
definition or example of patient values was given.  
Coulter et al did not mention patient values in their checklist of patient information 
material for SDM. However, they acknowledged that “Patients whose doctors are 
ignorant of their values and preferences may receive treatment that is inappropriate to 
their needs” (Coulter, Entwistle, & Gilbert, 1999).  
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For Elwyn et al, their OPTION checklist did not include mention of patient values 
(Elwyn et al., 2003). However, the checklist included these other patient perspectives: 
expectations, concerns and understanding of information.  
Thus, even though patient values were the most commonly mentioned element of SDM, 
a search of the main sources for defining SDM reveals that there is no clear definition of 
the term, much less a consensus or a discussion on what values are. Specific discussion 
on patient values in SDM is located in literature on value clarification exercises, which 
are considered a necessary component of PDAs by the International Patient Decision 
Aids Collaboration (IPDAS) (International Patient Decision Aids Collaboration, 2012).  
The 2012 update to the value clarification section in the IPDAS documents points out 
that most research on value clarification has not focused on patient values per se, but 
more on the use of value clarification methods (Fagerlin et al., 2012). These methods 
include considering pros and cons, utility assessment, prioritization and rating scales. 
Researchers have recognised that values clarification (insight into what a patient 
considers important) is different from preference elicitation (asking the patient to state 
their preference) and that some gaps exist in understanding values clarification 
(Llewellyn-Thomas & Crump, 2013).    
These gaps include a lack of research on implicit value clarification, a weak theory base 
and poor understanding of how patients themselves naturally evaluate healthcare 
options (Fagerlin et al., 2012). In the 2012 update of the IPDAS chapter “Clarifying and 
Expressing Values”, the following points are noted in the authors’ definition of values 
clarification (Fagerlin, et al., 2012):  
10 
 
1) Although values clarification can be understood to be implicit (the patient 
considers what is important to them) or explicit (the patient uses a structured 
method such as a rating scale to determine the importance of each option), the 
explicit clarification methods are better understood as more research evidence is 
available. 
2) No definition of patient values is given in the chapter and only one theory 
(Fuzzy Trace Theory) from a theory base of seven theories mentions the need to 
help patients retrieve relevant values.  
3) Implicit values clarification based on intuitive patient decision processes is little 
understood although evidence indicates that such intuitive processes may be just 
as accurate as explicit value clarification in integrating and reflecting a large 
amount of information.  
1.3 Research gaps in patient values 
From the section above, there are two areas in which gaps in research exist for patient 
values in SDM. Firstly, there is no clear definition of patient values in the literature. 
Although commonly mentioned as being an essential part of SDM, none of the sources 
above provided a clear definition of the characteristics and scope of patient values. 
Charles et al have pointed out that current definitions of SDM are subject to many 
underlying, unclear assumptions (Charles, Gafni, Whelan, & O'Brien, 2005). A clear 
definition of patient values is one of these assumptions.  
Secondly, little is understood about how values intuitively influence patient decisions. 
In order to capture real-life examples of how values work, data should be based on 
patients’ actual decisions, rather than hypothetical scenarios. This data should be 
analysed in light of the larger cultural context and the practice background within which 
11 
 
decisions are made. The former is important as values differ from culture to culture and 
there is a need to explore cultural values in order to adapt SDM to the local cultural 
context (Charles, Gafni, Whelan, & O'Brien, 2006).  
1.4 Patient values in insulin initiation 
A good decision is defined as one that is “informed, consistent with personal values, and 
acted on and in which participants express satisfaction with decision making” 
(O'Connor, et al., 1999). Decisions that depend on patient values cannot be judged on 
the basis of clinical outcomes alone, as good decisions can sometimes result in bad 
clinical outcomes due to the range of variables and odds that affect outcomes 
(O’Connor, Mulley, & Wennberg, 2003). This thesis uses insulin initiation in type 2 
diabetes as an exemplar of patient values in medical decision making. Insulin initiation 
is a preference-sensitive medical decision which is influenced by patient (as well as 
HCP) values. A preference-sensitive medical decision is defined as a medical choice in 
which there is no single best option due to insufficient evidence about outcomes or a 
need to trade off known benefits and harms (Stacey, et.al, 2011).  
In terms of health outcomes, insulin is the best option to lower risk of developing 
diabetes complications. However, patients may consider the risks of side effects and 
other negative outcomes of insulin such as socio-cultural stigma to outweigh the 
benefits from a quality of life perspective and may choose to delay insulin initiation. 
Also, tension may exist between HCP and patient values; the HCP may prioritise health 
outcomes, whilst patients may consider quality of life to be more important. This makes 
insulin initiation a preference-sensitive decision. 
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A preference-sensitive choice is influenced by a wider set of background factors 
(besides medical risks and benefits).  In order to investigate patient values in insulin 
initiation, it was important to understand the process of insulin initiation in the 
Malaysian context. Data was collected on the range of factors influencing insulin 
initiation. This data framed the decisional context in which values in patient decision 
making were to be investigated. An understanding of the background of insulin 
initiation (e.g. barriers, available options, and healthcare system) was incorporated into 
patient interview topic guides (as prompts), thereby helping to inform the investigation 
of patient values.  
1.5 Research question and research objectives 
1.5.1 Research question 
My research question can be stated as: 
What are patient values in medical decision making, using insulin initiation in type 2 
diabetes as an exemplar?   
1.5.2 Research objectives 
There were three research objectives in this study which aimed to answer the research 
question stated above. An inductive approach was used whereby insulin-specific beliefs 
were explored before a general model of patient values was developed.  
1) To identify factors influencing insulin initiation in Malaysia. 
Insulin initiation is a complex decision influenced by a variety of beliefs. In 
order to understand the medical context and healthcare system in which patients 
values are to be investigated, the first objective of the study was to identify the 
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range of factors which influence insulin initiation, which include patient, HCP 
and system factors. Data was collected from patient, HCP and policy maker 
perspectives on the barriers and facilitators to insulin initiation. A systematic 
review of barriers and facilitators was conducted on the medical literature. This 
overview provided an understanding of the medical, cultural and health system 
contexts in which patient values were investigated. 
2) To explore patient values amongst type 2 diabetes patients in Malaysia who 
are making a decision about starting insulin 
This objective focused on identifying values which influenced patients’ 
decisions about insulin. The implicit and intuitive influence of values on patient 
decisions using insulin initiation as an exemplar was explored.  
3) To develop a model of patient values in SDM 
Lastly, using the examples and themes of values derived from patient decisions 
about insulin, a model of patient values for use in SDM was developed.  
1.6 Research background: Malaysia  
The following section describes the socio-cultural environment and health system of 
Malaysia. The research is conducted and analysed in light of the environment described 
here.  
1.6.1 Malaysia’s sociocultural and socioeconomic context 
Malaysia is a culturally and linguistically diverse country located in Southeast Asia 
(Figure 1.1). The country comprises 13 states and 3 federal territories, distributed 
between a peninsular and the island of Borneo. In June 2012, its population totalled 29.3 
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million (Department of Statistics Malaysia, 2012). Malaysia’s population consists of 
three main ethnic groups (Malays, Chinese and Indians) and numerous other smaller 
ethnicities (refer to Figure 1.2). The main ethnic group are the ‘Bumiputeras’ 
(indigenous people) consisting of Malays and other Bumiputeras, who total 62% of the 
total population. There are a sizable number of non-citizen residents in the country 
(8%), who are mostly lower-wage foreign workers. 
 
Figure 1.1: Map of Malaysia  
Source: Central Intelligence Agency 
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Figure 1.2: Population of Malaysia  
Source: Department of Statistics Malaysia, 2012 
 
Islam is the most commonly professed religion (61.3%). However, significant 
populations of Buddhists (19.8%), Christians (9.2%) and Hindus (6.3%) exist 
(Department of Statistics Malaysia, 2010). The official, and most widely spoken, 
language is Malay, but English, Chinese (Mandarin) and Indian (Tamil) are also spoken. 
A variety of Chinese, Indian and indigenous dialects are found in various communities 
in Malaysia. This melting pot of cultures influences healthcare practices in the country 
in various ways. For example, HCPs must navigate issues such as language and 
communication barriers, dissonant religious beliefs, common use of complementary and 
traditional medicine and cultural beliefs about health. Swami et al (2009), sampling 371 
women and 350 men using the Health and Illness Scale to explore lay perceptions of 
determinants of health status, concluded that although Malaysians have a general belief 
structure similar to the West, significant differences in health beliefs were found 
between religious groups.  
Malay 
50% 
Other 
Bumiputera 
12% 
Chinese 
22% 
Indians 
7% 
Others 
1% 
Non-Malaysian 
citizens 
8% 
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Economically, the World Bank (2012) classifies Malaysia as an upper-middle income 
country as it has a 2011 per capita income of USD 8420. The mean monthly household 
income of Malaysia was RM 4029 (USD 1243) in 2009 (Department of Statistics 
Malaysia, 2009). Income distribution is unequal between states, with the administrative 
and economic centres of Wilayah Persekutuan (W.P.) Putrajaya, W.P. Kuala Lumpur 
and Selangor having roughly triple (RM 5488- 6747/ USD 1693-2081) the mean  
monthly household income of the lowest three states (RM 1713-1966/ USD 528-606) 
(Department of Statistics Malaysia, 2009). The poverty rate in Malaysia has declined 
from 8.5% in 1999 to 3.8% in 2009 (Department of Statistics Malaysia, 2009). 
1.6.2 Malaysia’s dual-sector healthcare system 
Malaysia has a dual-sector healthcare system comprising government-subsidised 
universal public healthcare facilities and fee-for-service private healthcare clinics and 
hospitals. Free or nominal-fee healthcare is provided in primary care through a network 
of health clinics (‘Klinik Kesihatan’) throughout the country. These clinics would refer 
patients with more severe conditions to tertiary hospitals located in the major towns or 
cities. Majority of the population is treated in public facilities as costs are lower and the 
government maintains a network of health clinics especially in states and areas where 
the density of both public and private primary care clinics in Malaysia is less than the 
national average of 2.09 clinics per 10000 persons (Clinical Research Centre, 2011). In 
2009, there were 806 public health clinics and 5104 private primary care clinics in the 
country (Clinical Research Centre, 2011). The national doctor to population ratio in 
Malaysia was 1: 791 in 2011 (Health Informatics Centre Planning and Development 
Division, 2012). 
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In primary care, the private sector comprises mostly solo general practice clinics (Ramli 
& Taher, 2008) while public primary care consists of government health clinics and 
university-based primary care clinics. There are about five times more private primary 
care clinics compared to the public sector in Malaysia (Clinical Research Centre, 2011). 
Primary care practice is expected to play a gatekeeper role for secondary care referrals 
(Clinical Research Centre, 2011). 
Beginning with the 1990s, the number of private hospitals began to rise in the urban 
centres as affluent patients could afford the higher fees charged at these hospitals and 
they would be able to avoid the long waiting lists associated with specialist treatment in 
public hospitals. The decade since the millennium has seen the growth of large 
healthcare conglomerates which own and operate more than one hospital. Chee (2008) 
has reported that between 1980 and 2003, the number of private hospital beds increased 
nine times and he foresees that the dual trends of increasing private beds and 
government-backed medical tourism initiatives will lead to a segmented healthcare 
industry where the well-heeled local and foreign private clientele will be treated 
privately. One result of this demand is an exodus of specialists from the public to the 
private. Estimates are that 60% of specialists in the country operate in private facilities 
(Prime Minister’s Department, 1993). 
Addressing long-term finance and access issues is important in light of Malaysia’s 
increasing lifestyle-related disease prevalence. Between 1996 and 2006, Malaysia 
reported a 43% increase in hypertension, 88% increase in diabetes and a 250% increase 
in obesity (Ministry of Health, 2010a). Malaysia has the highest prevalence rate of type 
2 diabetes (11.7%) in the Western Pacific region and this figure is projected to rise to 
13.3% by 2030 (International Diabetes Federation, 2011). As such, healthcare policies 
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target increasing quality, capacity and coverage of the healthcare system and shifting 
the focus from disease treatment towards wellness and disease prevention (Ministry of 
Health, 2010a). The prevention and treatment of type 2 diabetes and cardiovascular 
disease are the two main thrusts of the integrated National Strategic Plan for Non-
Communicable Disease (NSP-NCD) Medium Term Strategic Plan 2010-2014 (Ministry 
of Health, 2010b).  
1.6.3 Policies related to type 2 diabetes and insulin in Malaysia 
Policies related to diabetes are divided into strategic plans and clinical practice 
guidelines. Diabetes was the first non-communicable disease in Malaysia to be targeted 
with a disease-specific plan in the 1980s when the National Diabetes Programme was 
launched following the results of the first National Health and Morbidity Survey in 
1986 (Ministry of Health, 2010b). This was replaced in 2010 with the National Strategic 
Plan for Non-Communicable Disease (NSP-NCD) as the Ministry of Health 
acknowledged that traditional single-disease strategies are inadequate to target and 
control non-communicable diseases. Based on the WHO Western Pacific Regional 
Action Plan for Non-Communicable Diseases (WHO Western Pacific Regional Office, 
2008), the NSP-NCD lists seven strategies to prevent and treat cardiovascular disease 
and diabetes: prevention and promotion; clinical management; increasing patient 
compliance; action with Non-governmental Organizations (NGOs), professional bodies 
and other stakeholders; monitoring, research and surveillance; capacity building; and 
policy and regulatory interventions (Ministry of Health, 2010b). Diabetes-specific 
activities are included under each of the seven strategies and are summarised under 
Table 1.3 (Ministry of Health, 2010b). 
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Table 1.3: Activities targeting diabetes under the seven NSP-NCD strategies  
Strategy Activities 
Prevention and promotion No diabetes-specific activities 
Clinical management 1. Equip all health facilities with minimum clinical 
equipment and tools for assessment and management 
of diabetes 
2. Create a system of supervision to ensure practice is in-
line with Clinical Practice Guidelines and Standard 
Operating Procedures 
3. Reinforce importance of screening for diabetes-related 
complications 
4. Strengthen and expand rehabilitation services of 
diabetes-related complications 
Increasing patient 
compliance 
1. Ensure all health facilities have an NCD Resource 
Centre staffed by appropriately trained diabetes 
educators or suitably trained healthcare personnel 
2. Make available subsidised glucostrips for Self-
Monitoring of Blood Glucose (SMBG) 
Action with NGOs, 
professional bodies and 
other stakeholders 
No diabetes-specific activities 
 
Monitoring, research and 
surveillance 
1. Implement a system to monitor degree of control and 
quality of management of diabetes patients  
2. Nation-wide implementation of National Diabetes 
Registry 
3. Encourage research in diabetes in aspects of: 
a. Health economics of population based 
interventions 
b. Novel approaches for behavioural 
modifications 
c. Novel approaches for clinical management 
Capacity building No diabetes-specific activities 
Policy and regulatory 
interventions 
No diabetes-specific activities 
Source: Ministry of Health, 2010b 
Insulin can only be prescribed by doctors in Malaysia and can be initiated at either 
primary or secondary care settings. Nurse educators play an important role in the public 
sector as doctors would refer patients to the nurses for education and instruction after 
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prescribing insulin. On the other hand, private doctors often seek help from diabetes 
educators, who are sponsored by pharmaceutical companies or non-governmental 
organizations (Lee, Lee, & Ng, 2012). 
The Malaysian clinical practice guideline (CPG) for type 2 diabetes was last updated in 
2009 and insulin therapy was stated as part of the treatment algorithm (Ministry of 
Health, 2009). However, there was no mention of how insulin initiation could be 
implemented in the local healthcare setting. Recognising this gap, a practical guide for 
insulin therapy was developed in 2010 and a section was dedicated specifically to 
addressing patients’ barriers to insulin initiation (Ministry of Health, 2010c). However, 
the recommendations are based on Western data and experts’ opinions.  
1.7 Conclusion 
Patient values are a crucial, yet understudied component of SDM, with a lack of 
research based on actual patient decisions. This study seeks to explore the patient values 
which influence insulin initiation are. This information will help to how these values 
work to influence the patient decision and clarify the range of values which should be 
elicited during values clarification. Insulin initiation is a good exemplar for 
investigating patient values as it is a preference-sensitive trade-off between the risks and 
benefits of insulin and other treatment options. In Malaysia, understanding why patients 
are reluctant to initiate insulin will help to address the lack of timely insulin initiation in 
patients with type 2 diabetes in a complex, multicultural, dual-sector healthcare setting.  
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Chapter 2.0: An overview of patient involvement in healthcare decision making: a 
situational analysis of the Malaysian context 
The following paper presents an overview on the state of patient involvement in 
healthcare decision making in Malaysia. Using situational analysis, including a review 
of a local Malaysian journal database, the section introduces readers to the current state 
of SDM in Malaysia. The chapter reports how little emphasis or support was available 
for advocating that patients should be involved in their medical decisions.  
This chapter contributes to the thesis by describing the current state of SDM in Malaysia 
whereby there is a clear lack of support for patient involvement in research, practice, 
policy and advocacy.  Given this gap, there exists a potential to develop SDM as 
strategy to implement patient-centred care in Malaysia. Developing easily understood 
indigenous models (such as the proposed patient values model) for training of SDM 
skills and concepts will complement existing projects which produce SDM tools (such 
as the DMIT insulin choice PDA).  
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Abstract  
Background 
Involving patients in decision-making is an important part of patient-centred care. 
Research has found a discrepancy between patients’ desire to be involved and their 
actual involvement in healthcare decision-making. In Asia, there is a dearth of research 
in decision-making. Using Malaysia as an exemplar, this study aims to review the 
current research evidence, practices, policies, and laws with respect to patient 
engagement in shared decision-making in Asia.  
Methods  
In this study, we conducted a comprehensive literature review to collect information on 
healthcare decision-making in Malaysia. We also consulted medical education 
researchers, key opinion leaders, governmental organisations, and patient support 
groups to assess the extent to which patient involvement was incorporated into the 
medical curriculum, healthcare policies, and legislation. 
Results  
There are very few studies on patient involvement in decision-making in Malaysia. 
Existing studies showed that doctors were aware of informed consent, but few practised 
shared decision-making (SDM). There was limited teaching of SDM in undergraduate 
and postgraduate curricula and a lack of accurate and accessible health information for 
patients. In addition, peer support groups and ‘expert patient’ programmes were also 
lacking. Professional medical bodies endorsed patient involvement in decision-making, 
but there was no definitive implementation plan. 
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Conclusion  
In Malaysia, there is a lack of patient involvement in decision-making. More research 
and training are necessary to bridge this gap. The authors call for health authorities to 
develop a strategy to explore effective ways to implement SDM in Malaysia.   
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Background 
Involving patients in decision-making is a good clinical practice and, in some countries, 
it is imperative for routine patient care (Coulter, Edwards, Elwyn, & Thomson, 2011; 
General Medical Council, 2009; Secretary of State for Health, 2010; Shared decision-
making demonstration project). This forms part of patient-centred care and is 
increasingly considered to be the gold standard of medical care by the public, clinicians, 
and policy makers (Secretary of State for Health, 2010). There is growing evidence, 
suggesting that involving patients in decision-making helps improve their knowledge 
and healthcare experience and reduce health service utilisation and cost (Coulter & 
Jenkinson, 2005). The evidence also suggests that patients may modify their health 
behaviour and status after being involved in decision-making (Coulter & Jenkinson, 
2005). 
Focus on decision making has led to the development of the shared decision-making 
(SDM) model, whereby patient and doctor share information and values, and the patient 
plays an active role in healthcare decisions (Charles, Gafni, & Whelan, 1997; Makoul & 
Clayman, 2006). However the concept of SDM is interpreted differently in various 
social and cultural contexts. For example, a recent review found wide SDM practice and 
policy variations across 13 countries in the Middle East, Europe, and North and South 
America (Harter, Elwyn, & van der Weijden, 2011). Thus, implementing shared 
decision making remains challenging, even in countries where shared decision making 
is officially endorsed by government, such as the UK and USA (Barry, 2012; Coulter, et 
al., 2011; Frosch et al., 2011). Practising SDM is seen to be even more challenging in 
countries that have scarce healthcare resources and an overburdened healthcare system, 
which are common in Asia. Despite these challenges, there is a growing interest in SDM 
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globally in terms of “scope (as a component of patient-centred care) and spread (as a 
component of healthcare everywhere for everyone)” (International Shared Decision 
Making Conference 2013, 2013). 
In Asia, there is limited knowledge of how the SDM concept has been, or could be, 
integrated into existing practice. At a micro level, little is known about the decision-
making role preference of patients and physicians. At a macro level, it is uncertain 
whether the Western model of SDM is transferable to societies where healthcare 
decisions of individuals are strongly influenced by their families and communities 
(Ruhnke et al., 2000). Asia is not a homogenous continent; for instance, healthcare 
decisions of Chinese, Japanese, and Vietnamese people are influenced by diverse 
concepts of harmony and filial piety, which originate from different religious or moral 
codes (McLaughlin & Braun, 1998). In 2005, Charles argued that SDM should not be 
practised without considering the cultural context, of a clinical consultation (Charles, 
Gafni, Whelan, & O'Brien, 2006).  Studies with ethnic minorities in the West have 
identified the challenges in practising SDM, particularly in communities where the 
concept of SDM is foreign or non-existent (Katz et al., 2011; Peek et al., 2009; Searight 
& Gafford, 2005). 
There is one assumption that people in the East prefer a more clinician-centred 
healthcare system, though there is a lack of evidence. A recent survey in Japan shows 
that patients want to be more involved in healthcare decision-making (Alden, Merz, & 
Akashi, 2011). Although there are still significant differences between Western and 
Asian cultures, globalisation and advancement of telecommunication have blurred 
distinctions significantly over the past two decades. Moreover, the overall improvement 
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in literacy rates and health awareness mean that public health expectations are rising in 
Asia (Benbassat, Pilpel, & Tidhar, 1998; Hirono Ishikawa & Eiji Yano, 2008). 
Therefore, it is prudent and timely to review the current research evidence, practices, 
policies, and laws with respect to SDM in Asia. This article uses Malaysia, a multi-
cultural Asian society, to exemplify the existing and emerging issues of SDM in the 
areas of education, clinical practices, and healthcare policies in Asia.  
Malaysia has a population of 28.3 million and comprises three main ethnic groups: 
Malays (67.4%), Chinese (24.6%), Indians (7.3%), and others (0.7%) (Population and 
Housing Census of Malaysia, 2010). Malaysia is classified by the United Nations as an 
upper-middle income nation and has a dual sector (public and private) healthcare 
system. People pay a nominal fee for public health services, which are often 
overburdened and have long waiting times. On the other hand, the private health sector 
charges a fee for services and people can choose the hospital, clinic, and healthcare 
professionals. A multi-cultural society and a dual-sector health system in Malaysia 
provide an opportunity to study Asian patients’ involvement in decision-making, using 
the SDM concept to analyse the structures that form decision-making practice and 
policy. 
Methods 
The authors met in July 2011 and came to consensus on five key areas, which reflect the 
condition of patient involvement in the Malaysian healthcare system. The five 
categories reviewed were (1) clinical training and education, (2) research, (3) patient 
information and support, (4) laws and regulations, (5) and health policies. 
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Study design  
This study comprised of an environmental scan followed by group consensus methods. 
In the environmental scan, four sources were used to determine the status of patient 
involvement in Malaysia. The research group then met to discuss the findings and 
formulate strategies for increasing SDM in Malaysia.   
Sources of data 
As the study covers a wide range of objectives, a range of data sources were used to 
determine the status of patient involvement in decision making in Malaysia. These 
sources include (1) academicians from main public universities in Malaysia; (2) 
databases searched for literature review; (3) patient support groups and review of 
governmental and non-governmental web sites on health information for patients; and 
(4) Malaysian laws and health policies.  
Identification of eligible material 
The study aimed to include any data or information on the following key areas: SDM 
training and education; research and clinical practice of SDM; patient information and 
support; legislations and policies on or related to SDM. 
Data extraction 
The following methods were used to collect data from the four sources: (1) an online 
survey with academicians from main public universities in Malaysia; (2) a 
comprehensive literature review of patient involvement in decision making; (3) an 
online survey of patient support groups and review of governmental and non-
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governmental web sites on health information for patients; and (4) a document review 
of Malaysian laws and health policies.  
1. The online survey on clinical training and education in SDM 
We wrote emails to 15 academicians in eight most established public (n=6) and private 
medical schools (n=2) to seek information on training and education. The participants 
were selected based on their active involvement in undergraduate and postgraduate 
teaching in their institutions. The participants were asked to provide information on 
whether the patient involvement and SDM were included in the medical curriculum and, 
if so, to what extent they were being implemented in practice. Descriptive data using 
simple frequency count was used to capture the extent to which SDM was incorporated 
into the medical curriculum.  
2. A comprehensive literature review on research and practice of SDM 
We searched PubMed, CINAHL, and MyJurnal (a database of Malaysian publications) 
to identify SDM-related publications up to March 2013. Our search strategies were as 
follows: 
 PubMed: “(patient-centred care OR decision-making OR shared decision-making 
OR patient participation) AND (Malaysia)” and “patient preference [MeSH] AND 
Malaysia” (n = 162) 
 CINAHL: “(patient-centred care OR shared decision-making OR decision-making 
OR patient participation) AND (Malaysia)” (n = 105) 
 MyJurnal “patient” (n = 995).  
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Both qualitative and quantitative studies were included in the review. Published articles 
which met the following criteria were considered for inclusion: qualitative or 
quantitative studies which collected original data; performed in a healthcare setting; 
published in English; and those that reported how patients were involved in medical 
decision-making. Studies that reported patient beliefs and levels of knowledge were 
excluded. Only studies published as full text articles were included in the review. 
Review articles were also excluded as they did not report any original data. Duplicates 
and non-relevant references were removed. One of the researchers identified the 
relevant articles which were reviewed, extracted and synthesised.  
3. Online survey of patient support group and review of official websites for patient 
health information  
We sought information regarding patient involvement in decision-making from four 
established patient support groups for: diabetes, systemic lupus erythematosus, drug 
users, and HIV infection. These groups were chosen as they were the few most 
established support groups in Malaysia. We gathered information from these groups by 
conducting an informal e-mail survey, enquiring about existing programmes for patient 
decision support from both healthcare professionals and peers. For patient information 
and support, we systematically searched the official web sites of the Ministry of Health 
(Ministry of Health), main public and private medical centres, and healthcare-related 
non-government organisations. The amount and quality of patient information were 
appraised according to: the scope of health topics covered by the website; language 
available (English, Malay, Mandarin, Tamil); user-friendliness (readability); and patient 
involvement in the development of the health depository.  
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4. Document review of the laws and policies on SDM 
For standards and policies, we reviewed legislations and policies enacted by the 
Malaysian Medical Council, which is the official body for medical policy, legislation, 
and regulation in Malaysia. The relevant sections which described patient involvement 
were extracted and described in the results.  
Data analysis 
Simple descriptive analysis was use to describe the data collected from the various 
sources. 
Group consensus methods 
The group corresponded via email to discuss and compile the findings of the 
environmental scan. Based on the findings, a strategy to increase awareness and 
implement SDM in Malaysia was formulated (Table 2.1). 
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Table 2.1: Proposed strategy to increase awareness and implement SDM in 
Malaysia 
 Proposed 
strategy 
Description 
1 Education  Incorporating teaching of SDM into undergraduate 
curriculum 
o General communication and consultation skills 
o Risk communication 
o Evidence-based medicine 
 Incorporating a more structured SDM teaching into 
postgraduate curriculum 
o Communication and consultation skills 
o Emphasis on specific areas requiring informed 
consent such as surgeries, chemotherapy, screening 
o Assessment of trainees competency in SDM 
 Incorporating SDM training into continuing professional 
development, including workshops on SDM and how to use 
patient decision aids 
2 Clinical practice  Incorporating SDM in clinical practice guidelines 
 Advocate the use of patient decision aids or other decision 
support tools in patient care 
 Patient involvement in decision making as a quality 
indicator 
 Payment/reimbursement for practices which implement 
SDM or use decision aids 
3 Research  Baseline research on patient involvement in decision 
making at the national level 
 Exploratory studies on the factors influencing decision 
making in a multi-cultural and multi-lingual context 
 Developing and evaluating decision support interventions 
to help patients make informed decisions 
 Develop and evaluate interventions to incorporate SDM in 
routine care 
4 Policy and law  Malaysian Medical Council should consider developing a 
national healthcare policy on SDM 
 The Ministry of Health should improve on the existing 
patient health information system to make the content more 
accurate, user-friendly and accessible to the public 
 Public health campaigns should target at empowering 
people to be more involved in their health care and making 
decisions about their health care 
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Results 
SDM training and education 
Teaching SDM was not explicitly stated as an objective in most undergraduate and 
postgraduate curricula in Malaysia. Only one medical school mentioned SDM in their 
primary care curriculum. However, how SDM is being taught was not clearly defined 
and evaluated. The process of SDM, such as sharing information, offering treatment 
choices, exploring patient preferences, involvement of family in decision-making, and 
sharing the decision, was taught as part of other components of the training programme. 
For example, risk communication is taught under evidence-based medicine; information 
sharing and exploring patients’ ideas, concerns, and expectations form part of the 
communication and consultation skill training; and respecting patients’ autonomy and 
providing them adequate and accurate information to make an informed decision are 
taught in medical ethics and informed consent. Feedback from the respective 
postgraduate coordinators of the discipline of Family Medicine highlighted a lack of 
structured SDM teaching. Most commented that SDM is being taught as part of the 
communication and consultation skill training. Overall, structured teaching of SDM in 
Malaysia is non-existent and, at best, fragmented. 
Research and clinical practice of SDM 
We identified 1262 articles, of which 20 focused on SDM or patient involvement in 
decision-making (Chan & Ahmad, 2012; Che Ngah, 2005; Crabtree, 2005; Eng, 
Yaakup, Shah, Jaffar, & Omar, 2012; Loh, Packer, Yip, & Passmore, 2009; Loh, Yip, 
Packer, & Quek, 2010; Martinez et al., 2005; Mazlina & Julia, 2011; Nugent, 2003; 
Partridge et al., 2005; Siew, 2005; Talib, 2005; S.F Tong & Chen, 2007; S. F. Tong, 
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Low, Ismail, Trevena, & Willcock, 2011; Yen, 2006a, 2006b; Yousuf, Fauzi, How, 
Akter, & Shah, 2009; Yousuf, Fauzi, How, Rasool, & Rehana, 2007; Zainudin, Anisah, 
Rahim, & Shariff, 2012; Zalilah, Mazanah, & Ahmad Zamri, 2008). Studies focused on 
the areas of informed consent, patient autonomy, decisional role, and the information 
needs of patients with diabetes, children, the elderly and patients living with cancer. 
Research on SDM in Malaysia remains scarce. Data suggest that there is a lack of 
information available for patients to make an informed choice and patients and their 
parents are not actively involved in decision-making. Overall, despite patient’s desire 
for quality information (Eng, et al., 2012; Yen, 2006a, 2006b) patients were not given 
enough information to make an informed choice (Lei, Har, & Abdullah, 2011; Yousuf, 
et al., 2009; Zalilah, et al., 2008). Although healthcare professionals, mainly doctors, 
were aware of the importance of taking informed consent, some would choose not to 
practise it if diagnosis was unfavourable or if truth was deemed harmful (Che Ngah, 
2005; Yousuf, et al., 2007). 
Levels of patient-centeredness varied amongst medical specialities (Chan & Ahmad, 
2012). Among the Malaysian paediatric population, the practice of SDM was even less. 
Only 20% of the decisions on resuscitation of pre-term babies were made by the 
parents. 72% and 8% of the decisions were made by the physician and ethics committee, 
respectively (Martinez, et al., 2005). Similarly, Mazlina and Julia found that most 
(58%) of the rehabilitation physicians would practise medical paternalism and over-ride 
a patient’s earlier directive to withdraw life-sustaining treatment (Mazlina & Julia, 
2011). Efforts to encourage patient participation include engaging healthcare 
practitioners in self-management programs (Loh, Yip, Packer, & Quek, 2010) and 
training on patient-centeredness (Nugent, 2003).  
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Patient information and support 
Patient education is an important step towards empowering patient involvement in 
decision-making. Accessibility to accurate, relevant, and readable health information 
increases health literacy and engages patients in the discussion of choosing the best 
option for their health. Low health literacy rate may be an important contributing factor 
to the lack of patient involvement in decision-making in Malaysia (Loh, Packer, Yip, & 
Passmore, 2009).  
The Ministry of Health is the main provider of patient health education resources in 
Malaysia. It recognises the importance of disseminating “accurate, appropriate, and 
relevant information in a timely, equitable, and innovative manner” and “empowerment 
of individuals and communities to enable them to take action on the determinants of 
health” (Health Education Division, 2012). The Ministry has established a health 
education Web site for the public (Ministry of Health). However, the development 
process of these educational materials is not clear and only limited health topics are 
covered (obesity, physical activity, smoking, diabetes, heart disease, and mental health). 
The Web site provides an interactive risk calculator and helps users discuss their results 
further with doctors. However, SDM is mentioned neither implicitly nor explicitly. 
Moreover, the usability, the usefulness, and the comprehensiveness of the health 
information of this Web site have not been evaluated. We are also not sure of the extent 
to which consumers were involved in the development process. Currently, the Web site 
is available only in two languages, that is, English and Malay; however, it is not 
available in Chinese and Tamil, which are spoken by up to one-third of the population. 
Besides the Ministry of Health Web site, other patient information resources are 
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scattered and are mainly produced by private medical centres or voluntary and patient 
support groups.  
Currently, there are no structured peer support or ‘expert patient’ programmes in 
Malaysia. Most programmes involve patients as volunteers or counsellors, providing 
emotional support rather than peer education. However, some patient support groups 
and organisations, such as the National Diabetes Institute, Malaysia, are pursuing links 
with international peer support organisations, such as Peers for Progress (American 
Academy of Familiy Physicians), to empower patients to care for themselves and their 
peers. The recent clinical practice guideline for breast cancer involved breast cancer 
survivors in the development process (Ministry of Health, 2010d). 
Legislations and policies on SDM 
The Malaysian legislation follows the British common law and the main conflict in 
SDM involves the concept of consent to care (Putri, 2010). According to the law, 
patients must have sufficient information regarding the specific condition he or she is 
suffering from and the nature and purpose of care being recommended before giving the 
consent. It is the patient’s right to know and the doctor’s responsibility to warn the 
patient about the risks (that would make a significant difference in the patient’s life if 
they materialise) when undergoing or refusing any proposed care (Cusack). In Malaysia, 
informed consent is often not practised (Che Ngah, 2005) and this is often because of a 
lack of doctor–patient communication (Putri, 2010). 
The Malaysian Medical Council published a guideline on duties of a doctor in 2001, 
which outlined the moral and professional obligations expected of a medical practitioner 
in Malaysia (Malaysian Medical Council, 2001). The guideline states that the 
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relationship between a doctor and a patient should be “collaborative” and they should be 
in a “partnership”. It reaffirms the importance of the doctor–patient relationship, which 
“paves the way for frank discussion in which a patient’s needs and preferences and a 
doctor’s clinical expertise are shared to select the best treatment option”. The doctor is 
also required to “give relevant options when discussing treatment, and the limitations 
and possible complications”. These recommendations concur with the principle of 
SDM, where information is exchanged and decisions are made based on a shared 
understanding and agreement between the two parties. 
Discussion 
This study identified the gap in the research, practice, policies and laws related to SDM 
in Malaysia. The findings from the limited research studies on SDM revealed a low 
health literacy rate among patients, which may be attributed to, or compounded by, 
inadequate health information. Medical practitioners still play a paternalistic role in 
making healthcare decisions for patients and they do not involve patients in decision-
making. It is also noted that these studies involved patients of extreme ages (children 
and elderly) as well as those with life-limiting illnesses. There is a lack of data on how 
adult patients are involved in making diagnostic or treatment decisions in various 
clinical settings. Most studies looked at SDM from the perspective of healthcare 
professionals. None of the studies looked at how patients prefer to be involved in 
decision-making. In a cross-sectional study involving patients from 11 European 
countries, there was a significant difference between what decisional roles patients 
wanted to have and how they were involved in decision-making in the actual clinical 
encounter (Coulter & Jenkinson, 2005). Therefore, future studies should look at 
patients’ preferred roles and their healthcare experiences in decision-making. This will 
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provide a definitive answer to the question of how Asian patients prefer to be involved 
in healthcare decision-making.  
There was an increasing interest in the development, evaluation, and implementation of 
SDM in clinical practice and undergraduate and postgraduate curricula. However, 
efforts were fragmented and not ideal. Teaching and learning of SDM are essential in 
cultivating a patient-centred approach to healthcare and should be an integral part of the 
medical curriculum across all disciplines.  
In addition, the practice of SDM is complicated by the cultural and language diversity in 
Malaysia. Doctors not only have to understand patients’ personal and cultural values, 
but also have to communicate in a language that may not be their mother tongue. Risk 
communication, negotiation, and achieving agreement require high-level 
communication skills and demand high language proficiency. Moreover, the public–
private dual system results in practice variations. Both factors make the implementation 
of SDM a challenging task. Future research should focus on effective ways to improve 
cross-cultural communication and consultations across the two sectors. Interventions to 
improve SDM, such as patient decision aids, may play a role in reducing practice 
variations. 
Health literacy remains low in Malaysia, which could contribute to the lack of patient 
involvement in decision-making (Loh, Packer, Yip, & Passmore, 2009). Studies have 
found that improving health literacy empowers patients to play a more active role in 
managing their health (Hirono Ishikawa & Eiji Yano, 2008; Koo, Krass, & Aslani, 
2006). Patients who know about their health problems and respective treatments are 
more likely to be involved in making healthcare decisions (Griffin SJ et al., 2004; Kim 
et al., 2001; Wetzels, Harmsen, Van Weel C, Grol, & Wensing, 2007). The quality of 
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local health information is generally poor and this is compounded by the lack of 
translation into common languages. This poses a significant barrier to increasing health 
awareness and improving health literacy. Government organisations, non-government 
organisations such as patient and professional bodies, and academic institutions should 
work together to improve the quality of, and access to, patient information.  
Although SDM practice is endorsed by the Malaysian Medical Council, its 
implementation remains challenging. This requires the council to work closely with the 
stakeholders, namely the Ministry of Health, professional bodies, patient support 
agencies and researchers, to develop a strategy to increase the awareness and the 
implementation of SDM in Malaysia. SDM should be incorporated in the policies to 
drive changes within the healthcare system. An example is the Washington State 
Legislation that approved the use of decision aids and SDM when provided with 
treatment choices (Washington State legislation). Currently, there is no health policy in 
Malaysia that specifically addresses the issues related to SDM. National clinical practice 
guidelines suggest only the involvement of patients in making medically informed 
decisions. The council should consider the experiences of countries that have existing 
healthcare policies on SDM, such as the International Patient Decision Aid Standards 
Collaboration (International Patient Decision Aid Standards Collaboration), the Health 
Foundation (Cobble, 2009) and the Foundation for Informed Medical Decision Making 
(Foundation for Informed Medical Decision Making). 
There are limitations in this study. Firstly, limited data sources have been used in this 
study, which comprise mostly secondary data such as literature and Web pages. We did 
not consider grey literature such as reports and dissertations for this study. Secondly, 
our results on SDM training and education are based on a convenience sample, which 
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comprised lecturers in the primary care medicine departments only and not in other 
disciplines. 
Conclusion 
In summary, there appears to be little training or research on SDM in Malaysia. More 
research needs to be done in this area, including baseline information on the preferred 
and actual decision-making roles. The authors have provided a set of recommendations 
on how SDM can be effectively implemented in Malaysia. 
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Chapter 3: Literature review 
The aim of this chapter is to provide a review of the literature based on the three 
objectives identified in Chapter 1.5.2. The first section of the review is focused on the 
barriers and facilitators to insulin initiation in type 2 diabetes (Chapter 3.1). This section 
provides an overview of the range of negative and positive beliefs about insulin. Besides 
patient beliefs, a range of barriers from the HCPs and the healthcare system are 
identified.  
The second section is a systematic review of patient values in medical decision making. 
The scope of the review on definitions of patient values was broadened to medical 
decision making in general because no clear definition existed in SDM. This systematic 
review of patient values in medical decision making (which includes SDM) is reported 
in Chapter 3.2.  
Following this, a review of two value-specific theories from the social sciences is 
presented. These theories describe the characteristics and functions of human values. 
These theories have previously been applied to healthcare research, but not specifically 
to shared decision making. This section discusses the key definitions of values, the 
function of values and how these values can be applied to patient values research in 
SDM (Chapter 3.3). One of these theories is later used to develop the patient interview 
topic guide (Chapter 4).  
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Chapter 3.1: Barriers and facilitators to starting insulin in patients 
with type 2 diabetes: A systematic review  
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Abstract 
Background 
Despite the proven benefits and efficacy of insulin, up to 27% of patients are reluctant 
to initiate insulin therapy. In order to overcome these barriers, it is important to identify 
the factors influencing insulin initiation both from the perspectives of patients and 
healthcare professionals. 
Objectives 
To identify the barriers and facilitators to starting insulin in patients with type 2 diabetes 
Methods 
We conducted a systematic search using PubMed (1966-2011) for all original articles in 
English using Medical Subject Headings (MESH) terms: “type 2 diabetes”, “insulin”, 
and free texts: “barrier” or “facilitate”. Both qualitative and quantitative studies were 
included. Two pairs of reviewers independently selected, assessed and extracted the 
data. Study quality was assessed using Qualsyst. 
Results  
A total of 7104 references were identified: 18 full text articles were selected and 
assessed for eligibility. Finally, 15 papers (8 qualitative and 7 quantitative) were 
included in the review. Good inter-rater reliability was observed for the Qualsyst score. 
Three main themes identified were: patient-related, healthcare professional and system 
factors. The main patient-related barriers were fear of pain, fear of injection, difficulty 
in making dose adjustments and delivery of injection. Insulin was perceived to have 
“negative health outcomes”, was “ineffective” and may worsen quality of life. There 
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were also concerns about the side effects of insulin (hypoglycaemia/weight gain). 
Healthcare professionals’ barriers were: lack of knowledge and skills, poor doctor 
patient relationship and poor communication. System barriers included lack of 
dedicated diabetes services and educational resources. 
Conclusion 
This systematic review identified major barriers in insulin initiation despite the 
availability of newer insulin which are safer and easier to use. Healthcare professionals 
should explore and address these barriers when supporting patients in making decisions 
about starting insulin.  Suitable interventions will need to be developed to overcome 
these barriers. 
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Introduction   
Background 
Clinicians face challenges when advising patients with type 2 diabetes to start insulin, 
particularly in patients who have poor glycaemic control despite maximal oral glucose-
lowering drugs. Up to 27% of patients are reluctant to start insulin when advised to do 
so (Larkin et al., 2008; Peyrot et al., 2005; Polonsky, 2007; UK Prospective Diabetes 
Study (UKPDS) Group, 1998). This is despite clear evidence that good glycaemic 
control reduces micro-vascular, and to a lesser degree, macro-vascular complications 
(Korytkowski, 2002). 
There are many reasons why patients are hesitant to start insulin. This resistance to 
insulin initiation has been termed “Psychological Insulin Resistance” (Nam et al., 2010; 
Polonsky, 2007; Polonsky & Jackson, 2004). Patients concerns can be categorised as 
coping-oriented and knowledge-based barriers (Larkin, et al., 2008). Coping-oriented 
barriers include negative feelings and phobias like depression, anxiety and 
embarrassment, feelings of failure, lack of confidence and needle phobia. Knowledge-
based barriers include myths or misperceptions about insulin including addiction 
concerns, doubting the effectiveness of insulin, fear of hypoglycaemia and inadequate 
knowledge of glycaemic targets (Larkin, et al., 2008). 
However, recent evidence shows that tight glycaemic control, particularly for those on 
insulin, has been associated with increased mortality (e.g. ADVANCE, Veteran trials) 
(Skyler et al., 2009). This has resulted in the revised approach towards titrating glucose-
lowering drugs by considering not just patient clinical profiles but their psychosocial 
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background. Clinicians need to consider the barriers and facilitators to insulin initiation 
when counselling patients who are making decisions.  
Therefore, this systematic review aimed to identify the barriers and facilitators to insulin 
initiation in patients with type 2 diabetes. This review is important because it will 
document the range of factors that may influence patients’ decision to start insulin. 
Effective intervention can be developed to support patients and clinicians in insulin 
initiation only if we have a better understanding of these barriers and facilitators.  
Methods 
The selection and reviewing process of this systematic review is shown in Figure 3.1.1. 
A comprehensive search was conducted using PubMed (1966-2011) for all studies of 
barriers and facilitators of initiating insulin in patients with type 2 diabetes. We used 
Medical Subject Headings (MeSH) “type 2 diabetes” and “insulin” as well as text word 
searches such as “barrier” (or similar terms like “obstacle” or “hurdle” or “limit” or 
“problem” or “difficult” or “hindrance”) and “facilitate” (or similar terms “aid” or 
“assist” or “support” or “encourage” or “promote” or “motivate”). 
  
47 
 
Identification 
 
Screening 
 
 
Eligibility  
 
 
 
 
 
 
Included  
 
 
Figure 3.1.1 Flow chart of studies included in the systematic review 
7104 references identified  
Excluded (n=7024) 
Not relevant (n=7024) 
80 references 
Excluded (n=62) 
a) Not relevant (n = 29) 
b) Review articles (n = 28) 
c) Letters (n = 5) 
18 full-text articles assessed for eligibility 
Excluded (n=7)  
a) Not on insulin initiation (n = 2) 
b) Not on barrier (n = 2) 
c) Patients do not specified the inclusion 
criteria (n = 2) 
d) Not relevant (n = 1) 
11 references + 6 reference mining = 17 references 
Excluded (n=2)  
a) Not on insulin initiation (n = 2) 
15 studies included in review 
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Table 3.1.1: QualSyst scoring criteria for assessing study quality  
Checklist for assessing the quality of quantitative studies 
Criteria 
Yes 
(2) 
Partial 
(1) 
No 
(0) 
N/A 
1 Question / objective sufficiently 
described? 
    
2 Study design evident and appropriate?     
3 Method of subject/comparison group 
selection or source of information/input 
variables described and appropriate? 
    
4 Subject (and comparison group, if 
applicable) characteristics sufficiently 
described? 
    
5 If interventional and random allocation 
was possible, was it described? 
    
6 If interventional and blinding of 
investigators was possible, was it 
reported? 
    
7 If interventional and blinding of subjects 
was possible, was it reported? 
    
8 Outcome and (if applicable) exposure 
measure(s) well defined and robust to 
measurement / misclassification bias? 
means of assessment reported? 
    
9 Sample size appropriate?     
10 Analytic methods described/justified and 
appropriate? 
    
11 Some estimate of variance is reported for 
the main results? 
    
12 Controlled for confounding?     
13 Results reported in sufficient detail?     
14 Conclusions supported by the results?     
Checklist for assessing the quality of qualitative studies 
 Criteria 
Yes 
(2) 
Partial 
(1) 
No 
(0) 
 
1 Question / objective sufficiently 
described? 
    
2 Study design evident and appropriate?     
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Table 3.1.1, Continued 
3 Context for the study clear?     
4 Connection to a theoretical framework / 
wider body of knowledge? 
    
5 Sampling strategy described, relevant and 
justified? 
    
6 Data collection methods clearly described 
and systematic? 
    
7 Data analysis clearly described and 
systematic? 
    
8 Use of verification procedure(s) to 
establish credibility? 
    
9 Conclusions supported by the results?     
10 Reflexivity of the account?     
Source: Kmet, Lee, & Cook, 2004 
Inclusion and exclusion criteria 
Published articles which met the following criteria were considered for inclusion: 
qualitative or quantitative studies; original articles; conducted in a healthcare setting; 
published in English; focused on patients initiating insulin in type 2 diabetes; and 
barriers and/or facilitators. Only full text articles were included in the review. 
Duplicates were identified and excluded. 
Data extraction and synthesis 
Four reviewers worked independently in pairs to assess and extract data from each 
included study. The study quality was assessed using the QualSyst scoring system 
which is a validated tool incorporating both quantitative and qualitative research 
appraisal (Table 3.1.1) (Kmet, Lee, & Cook, 2004). Scores ranged from 0 to 1 where a 
higher score indicates higher quality. Intra-class correlation coefficients (ICC) were 
calculated to determine inter-rater agreement for both quantitative and qualitative 
papers. Any discrepancy was resolved through discussion. Data from included studies 
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were analysed for themes and managed using NVivo version 9 from QSR International 
(Nvivo9, 2010). 
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Table 3.1.2 Barriers and facilitators to insulin overview  
QUALITATIVE STUDIES (Patients, Doctors and Nurses) 
Table 3.1.2, continued 
Reference Level of 
evidence 
(QualSyst 
Score, 
range 0 to 
1) 
 Setting, 
country 
Method Participants Sample 
size 
 
(respons
e rate) 
Theoretical 
framework 
Analysis  Main findings  
(Hunt, 
Valenzuel
a, & Pugh, 
1997) 
0.83 Public clinics 
(n=2) at San 
Antonio and 
Laredo, Texas, 
USA 
In-depth 
interviews. 
Convenience 
sampling from 
patients waiting 
to see internal 
medicine doctors 
or participants in 
a diabetes patient 
education trial 
Patients. 
Mexican 
American, low 
income, type 2 
diabetes ≥  1 
year. 
44 (NA) Not specified Concept 
analysis 
Barriers: Negative 
perceptions of insulin, 
emotional barriers, lack of 
knowledge, socio-
demographic factors, negative 
attitudes, needle phobia, side 
effects of insulin, barriers in 
administrating, 
inconvenience, stigma and 
discrimination 
 
Facilitators: Improved quality 
of life, benefits of insulin 
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Table 3.1.2, continued 
(Phillips, 
2007a) 
0.78 Not specified In-depth 
interview. 
Purposive 
sampling of men 
and women who 
had been 
converted to 
insulin between 2 
to 4 years who 
had a broad range 
of experience 
with diabetes and 
insulin therapy. 
Patients. 
Converted to 
insulin ≥ 1 
year.  
8 (NA) Phenomonolo
gical 
approach 
(Hunt, et al., 
1997)h 
Content 
analysis 
Barriers: Not involving 
patients in decision making, 
HCPs’ lack of knowledge and 
skills, emotional barriers, lack 
of knowledge or 
misconception, interference 
with work and social 
activities 
 
Facilitators: providing patient 
education, improved health, 
benefits of insulin, peer 
support 
 
(Brown et 
al., 2002) 
0.73 Primary care 
practices, 
Canada 
Focus group 
discussions. 
Convenience 
sampling from a 
simultaneous 
quantitative study 
on management 
Primary care 
doctors.  
30 
(33.3%) 
Not specified Constant 
comparis
on 
analysis 
Barriers: : HCPs lack 
knowledge and skills. 
Facilitators: Initiating insulin 
in primary care (vs secondary 
care) 
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Table 3.1.2, continued 
of type 2 diabetes. 
  
(Goderis 
et al., 
2009) 
0.88 GP practices, 
Belgium 
In-depth 
interviews. 
Purposive 
sampling. 
Participants 
randomly selected 
from a stratified 
sample according 
to clinical 
performance 
scores before and 
after an 18 month 
quality 
improvement 
program (QIP). 
The strata were 
weak baseline and 
modest 
improvement; 
weak baseline and 
substantial 
improvement; 
General 
practitioners. 
Participated in 
an 18 month 
QIP. 
 
20 
(90.9%) 
Implementati
on model 
Thematic 
analysis 
Barriers: Patients lack 
knowledge or have 
misconceptions about side 
effects, patients negative 
attitudes, fear of needles and 
pain 
 
Facilitators: HCPs provide 
patient education, patient 
education as part of the 
system 
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Table 3.1.2, continued 
strong baseline 
and modest 
improvement; and 
strong baseline 
and substantial 
improvement. 
(Haque, 
Emerson, 
Dennison, 
Navsa, & 
Levitt, 
2005) 
0.78 Community 
health centres 
(primary health 
service centres), 
South Africa 
Focus group 
discussions (n=5), 
in-depth 
interviews 
(n=10). Purposive 
sampling was 
from 4 categories 
based on work 
experience years: 
<1 year, 1-3 
years, 4-10 years, 
>10 years 
  
Medical 
officers. 
Practicing in 
the Cape Town 
metropolitan 
region. 
Sampling 
based on 
number of 
work 
experience 
years. 
 
46 
(54.1%) 
Grounded 
theory 
Grounde
d theory  
methodol
ogy 
Barriers: Communication 
barriers, HCPs negative 
attitudes, patients negative 
perceptions of insulin, 
patients lack of knowledge/ 
misconception about side 
effects, socio-demographic 
factors, needle phobia, side 
effects of insulin, interference 
with social and work 
activities, lack of educational 
resources 
(Greaves 
et al., 
2003) 
0.83 Primary care 
practices, UK 
In-depth 
interviews. 
Purposive 
Practice 
nurses.  
Holding 
25 
(53.2%) 
Not specified Content 
analysis 
Facilitators: Initiating insulin 
in primary care (vs secondary 
care) 
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Table 3.1.2, continued 
sampling based 
on nurses’ 
relevant expertise 
and experience. 
responsibilities 
for diabetes 
care. 
 
 
(Phillips, 
2007b) 
0.85 Primary and 
secondary care 
practices, UK.  
In-depth 
interview. 
Purposive 
sampling was 
used to identify 
nurses who had 
experience in 
converting 
patients to insulin 
therapy. 
Nurses. Full-
time diabetes 
nurses 
employed in 
the study area.  
4 (80%) Not specified Thematic 
framewo
rk 
Barriers: Not involving 
patients in decision making, 
patients negative perceptions 
of insulin, patients emotional 
barriers, patients poor 
physical health, patients 
negative attitudes, needle 
phobia, side effects of insulin, 
barriers in administering, 
hassle of home glucose 
monitoring, inconvenience, 
stigma and discrimination, 
lack of system diabetes 
services.  
 
Facilitators: Setting 
glycaemic targets for patients, 
involving patients in decision 
making, improved health, 
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Table 3.1.2, continued 
benefits of insulin, initiate 
insulin early, giving dummy 
injections, showing hands on 
demonstrations, peer support, 
give enough time to patient, 
follow up patients 
 
(Sigurdard
ottir, 
1999) 
0.85 Hospital and 
community 
clinics, UK 
In-depth 
interview. 
Purposive 
sampling whereby 
a diabetes care 
coordinator 
helped to identify 
six diabetes 
nurse specialists 
who were 
employed as a 
part of a 
multidisciplinary 
team offering 
diabetic care. 
Diabetes nurse 
specialists. 
Possess at least 
diploma in 
diabetes care, 
been in their 
post for about 
2 years.  
6 (100%) Heideggerian 
hermeneutic 
phenomenolo
gy 
 
Colaizzi'
s 
modifica
tion 
of 
phenome
nological 
inquiry 
Barriers: HCPs lack 
knowledge and skills, lack of 
social support 
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QUANTITATIVE STUDIES (Patients, Doctors and Nurses)  
Table 3.1.2, continued 
Reference Level of 
evidence 
(QualSyst 
Score, 
range 0 
to 1)  
 Healthcare 
setting, 
country 
Method Participants Sample size 
 (response 
rate) 
Instrument Main findings (Top 5 
barriers and facilitators 
by percentage) 
(Ahmed et al., 
2010) 
0.78 Aga Khan 
University 
Hospital, 
Karachi,  
Pakistan 
Cross-sectional 
prospective 
interviewer-assisted 
survey. Consecutive 
sampling on patients 
with  Type 
2diabetes presenting 
to endocrinology 
out-patient clinic 
over a six week 
period 
Patients with 
type 2 
diabetes.> 18 
years old. 2 
groups: current 
insulin users 
(n=210), 
insulin naive 
patients 
(n=107) 
317 (89.5%) 
 
Not specified Barriers: 
- Insulin is a last resort 
(72.9%) 
- Transport of insulin 
difficult (60.5%) 
- Not possible to stop 
insulin once started (56.6%) 
- Insulin injection is 
uncomfortable (55.1%) 
- Perceived to be painful 
(54.8%) 
(Karter et al., 
2010) 
0.80 Managed-care 
settings of 
Kaiser 
Permanente 
Northern 
California 
Cross-sectional 
prospective 
telephone and postal 
questionnaires. 
Block random 
sampling identified 
Patients. 
Poorly 
controlled, 
insulin naive 
and insulin 
eligible T2DM 
169 (44.4%) Not specified Barriers (for the non-
adherent group): 
- Risks and benefits not 
well explained (39%) 
- Belief that insulin causes 
renal failure (32% 
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Table 3.1.2, continued 
(Kaiser) and 
Horizon Blue 
Cross Blue 
Shield of New 
Jersey, 
Northern 
California and 
New Jersey, 
USA 
using pharmacy 
records from two 
groups: respondents 
prescribed, but 
never initiating, 
insulin (n=69) with 
those dispensed 
insulin (n=100). 
patients. -difficulty giving insulin 
due to poor eyesight, 
shakiness or arthritis (30%) 
- Cost of insulin (27%) 
- Patient planned to change 
health behaviours instead of 
starting insulin (25%) 
(M. E. Larkin et 
al., 2008) 
0.84 Massachusetts 
General 
Hospital 
Diabetes 
Center, 
Massachusetts, 
USA 
Cross-sectional, 
prospective self-
completed 
questionnaire.  
 
Purposive sampling 
was used to recruit 
adult, insulin-naive 
patients with type 2 
diabetes at an 
outpatient diabetes 
center in a 
university affiliated 
teaching hospital. 
Patients. > 25 
years old, 
insulin naive.  
100 (NA) A Survey for 
People who 
do not take 
Insulin (SPI) 
 
The Insulin 
Treatment 
Appraisal 
Scale (ITAS) 
Barriers:- Perception that 
the disease is worse (85%) 
- Perception that life would 
be less flexible (82%) 
- Fear of hypoglycaemia 
(76%) 
- Perception that family and 
friends will be more 
concerned (76%) 
 
Facilitators:  
- Maintain good control 
(97%) 
- Prevents complication 
(91%) 
- Improves health (91%) 
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Table 3.1.2, continued 
- Improves energy (85%) 
(Nakar et al., 
2007) 
 
0.80 Central 
District of the 
Clalit Health 
Services 
(district health 
service), Israel 
Patients:  
Case-control 
prospective 
telephone interview. 
Random sampling 
from central register 
of patients of 
chronic disease in a 
health maintenance 
organization 
(HMO).  
 
Doctors: 
Written 
questionnaire. 
Sampling 
population was 
family doctors 
working in the 
district, who 
actively treat 
patients and 
participate in CME 
Patients.  
Study group 
consisted of 
T2DM patients 
who are insulin 
naive on 
maximum 
OHAs. Control 
group 
consisted of 
T2DM patients 
who had begun 
insulin 3-6 
months 
previously. 
 
Family 
doctors. 
Actively treat 
patients and 
participate in 
CME 
Patient study 
group: 92 
(70%), patient 
control group: 
101 (79%), 
doctor group: 
157 (87%) 
Not specified  Barriers (patients): 
- Believe the illness is not 
very serious (46.7%) 
- Fear of addiction (39%) 
- Believe that insulin makes 
one fat (12%) 
- Fear of hypoglycaemia 
(12%) 
- Fear of pain (12%) 
 
Barriers (doctors) 
- Believe patient will not 
comply with treatment 
(92.3%) 
- Patients’ fear of 
hypoglycaemia (79.7%) 
- Patients cannot cope with 
pain (53.9%) 
- Patients are too old 
(47.4%) 
- Have no experience with 
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Table 3.1.2, continued 
studies within 
various frameworks. 
Sampling frame not 
specified.  
activities.  insulin (27.4%) 
(Oliveria et al., 
2007) 
0.83 Henry Ford 
Health System 
(Mixed-model 
health 
maintenance 
system), 
Detroit, USA  
Cross-sectional, 
prospective 
telephone interview. 
Purposive sampling 
of patients who met 
the inclusion criteria 
in computerized 
laboratory results 
database of the 
health maintenance 
system.  
Patients. Two 
groups: 
‘Discontinuers’ 
(patients who 
discontinued 
insulin use for 
at least 120 
days in 
previous year) 
and ‘non-
initiators’ 
(patients who 
did not initiate 
insulin despite 
HbA1c ≥ 9%) 
Discontinuers: 
73 (80%), 
Non-
initiators: 129 
(82%) 
Not specified  Barriers (non-initiators): 
- Using other methods to 
control diabetes (27.7%) 
- Injection-related issues 
(7%) 
- Doctor advised them 
against using insulin (7%) 
 
Barriers (Discontinuers):  
- Doctor advised not to take 
(47.1%) 
- Using other methods to 
control diabetes (17.7%) 
- Believe that diabetes is 
within control/ normal 
(11.8%) 
- Painful injections (11.8%) 
-Hard to maintain blood 
glucose when off schedule 
(8.8%) 
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Table 3.1.2, continued 
(Polonsky, et 
al., 2005) 
0.83 1- day 
diabetes 
conferences, 
San Diego, 
California; 
Raleigh, North 
Carolina; 
Portland, 
Oregon; 
Minneapolis, 
Minnesota; 
Philadelphia, 
Pennsylvania; 
and Honolulu 
and Hilo, 
Hawaii, USA 
Cross-sectional 
prospective self-
completion 
questionnaire. 
Convenience 
sampling by 
including 
questionnaire in the 
participants’ 
conference syllabus 
for return at end of 
conference.  
Patients. 
Participants at 
1-day diabetes 
conferences.  
1267 (33.1%) A Survey for 
People who 
do not take 
Insulin (SPI) 
Barriers: 
- Not confident to handle 
demands of insulin therapy 
(58.1%) 
- Feel that insulin would 
restrict them (56.1%) 
- Feelings of personal 
failure (55.0%) 
- Permanence of insulin 
(53.1%) 
- Fear of pain (50.8%) 
(Hayes, 
Fitzgerald, & 
Jacober, 2008) 
0.93 Primary care 
practice, USA 
Cross-sectional 
prospective email 
questionnaire. 
Convenience 
sampling from 
doctor panel of a 
market research 
firm with >3 years 
clinical practice 
Primary care 
doctors. 
Certified in 
Family 
Practice, 
General 
Practice or 
Internal 
505 (19.8%) Self-
designed 
questionnaire 
Barrier:  
- Insulin can only be 
administered by injection 
(93%) 
- Patients fearful of insulin 
therapy (80%) 
- Training on insulin is too 
complicated for patients 
(58%) 
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Table 3.1.2, continued 
experience, who 
treat > 10 pts with 
T2DM/week. 
Medicine  - Follow up for patients on 
insulin too resource 
intensive for staff (53%) 
- Patients view insulin 
initiation as a personal 
failure (53%)  
 
Facilitator: 
- Patient education (93%) 
- Benefits outweigh the 
risks (88%) 
- Patients feel better once 
accustomed (76%) 
- Patients will avoid 
diabetic complications 
(75%) 
- Demands of insulin 
therapy less than expected 
(63%) 
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Results 
A total of 15 articles were included in this review (Figure 3.1.1). 
Study characteristics  
Majority of the studies extracted were conducted in North America (Hayes, Fitzgerald, 
& Jacober, 2008; Hunt, Valenzuela, & Pugh, 1997; Karter et al., 2010; Larkin, et al., 
2008; Oliveria et al., 2007; Polonsky et al, 2005) and Europe (Goderis et al., 2009; 
Greaves et al., 2003; Nakar, Yitzhaki, Rosenberg, & Vinker, 2007; Phillips, 2007b; 
Sigurdardottir, 1999), with a few from Asia (Ahmed et al., 2010), Canada (Brown et al., 
2002)  and Africa (Haque, Emerson, Dennison, Navsa, & Levitt, 2005) whilst one was 
not specified (Phillips, 2007a). Four studies were conducted in hospitals (Ahmed, et al., 
2010; Karter, et al., 2010; Larkin, et al., 2008; Oliveria, et al., 2007), seven in clinics 
(Brown, et al., 2002; Goderis, et al., 2009; Greaves, et al., 2003; Haque, et al., 2005; 
Hayes, et al., 2008; Hunt, et al., 1997; Nakar, et al., 2007) whilst two studies were 
conducted in both hospital and clinic (Phillips, 2007b; Sigurdardottir, 1999), and 
another study recruited respondents from a conference (Polonsky, et al., 2005) whilst 
one was not specified (Phillips, 2007a). Studies were mainly conducted in patients 
(Ahmed, et al., 2010; Hunt, et al., 1997; Karter, et al., 2010; Larkin, et al., 2008; 
Oliveria, et al., 2007; Phillips, 2007a; Polonsky, et al., 2005), doctors (Brown, et al., 
2002; Goderis, et al., 2009; Haque, et al., 2005; Hayes, et al., 2008)  and nurses 
(Greaves, et al., 2003; Phillips, 2007b; Sigurdardottir, 1999) whilst one study was 
conducted in both patients and doctors (Nakar, et al., 2007). Fourteen studies identified 
barriers to insulin initiation (Ahmed, et al., 2010; Brown, et al., 2002; Goderis, et al., 
2009; Haque, et al., 2005; Hayes, et al., 2008; Hunt, et al., 1997; Karter, et al., 2010; 
Larkin, et al., 2008; Nakar, et al., 2007; Oliveria, et al., 2007; Phillips, 2007a, 2007b; 
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Polonsky, et al., 2005; Sigurdardottir, 1999) whilst only seven studies identified 
facilitators to insulin initiation (Goderis, et al., 2009; Greaves, et al., 2003; Hayes, et 
al., 2008; Hunt, et al., 1997; Larkin, et al., 2008; Phillips, 2007a, 2007b) (Table 3.1.2).  
Quality assessment of included studies 
A total of 8 qualitative studies (Brown, et al., 2002; Goderis, et al., 2009; Greaves, et 
al., 2003; Haque, et al., 2005; Hunt, et al., 1997; Phillips, 2007a, 2007b; Sigurdardottir, 
1999)  and 7 quantitative studies (Ahmed, et al., 2010; Hayes, et al., 2008; Karter, et al., 
2010; Larkin, et al., 2008; Nakar, et al., 2007; Oliveria, et al., 2007; Polonsky, et al., 
2005)  were identified in this review. Overall, most of the studies were of good quality 
and we included all 15 studies in the analysis. Final QualSyst score (maximum 1.0) 
ranged from 0.70 to 0.95 for quantitative studies and 0.65 to 0.95 for the qualitative 
studies. Intra-class correlation was 0.805 suggesting high inter-rater agreement (Shrout 
& Fleiss, 1979). 
Quantitative studies  
Six cross-sectional (Ahmed, et al., 2010; Hayes, et al., 2008; Karter, et al., 2010; 
Larkin, et al., 2008; Oliveria, et al., 2007; Polonsky, et al., 2005) and one case control 
study (Nakar, et al., 2007) were included in this review. Response rates ranged from 
19.8% to 89.5%. Sample size ranged from 100 to 1,267 patient participants varied from 
study to study; from insulin users, (Ahmed, et al., 2010; Karter, et al., 2010; Nakar, et 
al., 2007; Polonsky, et al., 2005) insulin naïve patients, (Ahmed, et al., 2010; Larkin, et 
al., 2008; Nakar, et al., 2007; Polonsky, et al., 2005) discontinuers (Oliveria, et al., 
2007) to non-initiators of insulin (Karter, et al., 2010; Oliveria, et al., 2007)  (Table 
3.1.2). 
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Table 3.1.3 Structured instruments for assessing the barriers and facilitators in insulin initiation in diabetes 
Table 3.1.3, continued 
References Questionnaires/ 
instruments 
Area assessed No. of items Reliability 
and validity 
Participa
nts  
Methods Findings 
Larkin et al., 
2008 
A Survey for People 
who do not take 
Insulin (SPI)  
Perceptions of 
patients on 
insulin therapy  
 
Willingness of 
patients to begin 
insulin therapy  
  
9-item 
questionnair
e 
 
Response: 6-
point Likert 
scale (1 = 
strongly 
disagree, 6 = 
strongly 
agree)  
 
Total score: 
9 to 54 
Internal 
reliability 
(Cronbach’s 
α = 0.834)  
Patients 
with type 
2 diabetes 
not on 
insulin 
Cross-sectional, 
prospective self-
completed 
questionnaire.  
 
Purposive 
sampling was 
used to recruit 
adult, insulin-
naive patients 
with type 2 
diabetes at an 
outpatient 
diabetes center in 
a university 
affiliated 
teaching hospital. 
Barriers:  
- Perception that 
the disease is 
worse (85%) 
- Perception that 
life would be less 
flexible (82%) 
- Fear of 
hypoglycaemia 
(76%) 
- Perception that 
family and friends 
will be more 
concerned (76%) 
 
Facilitators:  
- Maintain good 
control (97%) 
- Prevents 
complication 
(91%) 
 The Insulin 
Treatment 
Appraisal Scale 
Reasons why 
patients were 
reluctant to start 
20-item scale 
Response: 5-
Internal 
reliability 
(Cronbach’s 
Insulin 
naïve and 
insulin 
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Table 3.1.3, continued 
(ITAS) insulin, 
including risk of 
side effects, 
complications or 
changes in 
lifestyle  
Patient's 
perceptions and 
current appraisal 
of insulin 
therapy 
point Likert 
scale (1 = 
strongly 
disagree, 5 = 
strongly 
agree) 
 
Total score: 
0 to 80 
α = 0.884) treated 
patients 
- Improves health 
(91%) 
- Improves energy 
(85%) 
Karter et al., 
2010 
Not specified Not specified Not specified Not specified Patients. 
Poorly 
controlled, 
insulin 
naive and 
insulin 
eligible 
T2DM 
patients. 
Cross-sectional 
prospective 
telephone and 
postal 
questionnaires. 
Block random 
sampling 
identified using 
pharmacy 
records from two 
groups: 
respondents 
prescribed, but 
never initiating 
Barriers (for the 
non-adherent 
group): 
- Risks and 
benefits not well 
explained (39%) 
- Belief that 
insulin causes 
renal failure (32%) 
-difficulty giving 
insulin due to poor 
eyesight, 
shakiness or 
arthritis (30%) 
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Table 3.1.3, continued 
insulin (n=69) 
with those 
dispensed insulin 
(n=100). 
- Cost of insulin 
(27%) 
- Patient planned 
to change health 
behaviours instead 
of starting insulin 
(25%) 
Oliveria et al.,  
2007.  
Self-designed 
questionnaire 
Possible reasons 
for insulin 
discontinuation 
or non-
initiation.  
Not specified Not specified Patients. 
Two 
groups: 
‘Discontin
uers’ 
(patients 
who 
discontinu
ed insulin 
use for at 
least 120 
days in 
previous 
year) and 
‘non-
initiators’ 
(patients 
who did 
Cross-sectional, 
prospective 
telephone 
interview. 
Purposive 
sampling of 
patients who met 
the inclusion 
criteria in 
computerized 
laboratory results 
database of the 
health 
maintenance 
system. 
Barriers (non-
initiators): 
- Using other 
methods to control 
diabetes (27.7%) 
- Injection-related 
issues (7%) 
- Doctor advised 
them against using 
insulin (7%) 
 
Barriers 
(Discontinuers):  
- Doctor advised 
not to take 
(47.1%) 
- Using other 
methods to control 
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Table 3.1.3, continued 
not initiate 
insulin 
despite 
HbA1c ≥ 
9%) 
diabetes (17.7%) 
- Believe that 
diabetes is within 
control/ normal 
(11.8%) 
- Painful injections 
(11.8%) 
-Hard to maintain 
blood glucose 
when off schedule 
(8.8%) 
Hayes et al., 
2008.  
Self-designed 
questionnaire called 
‘I believe…’ 
Patient's 
perceptions and 
current appraisal 
of insulin 
therapy 
30-item 
beginning 
with ‘I 
believe…’  
 
Response: 5-
pointLikert-
type scale (1 
= strongly 
disagree, 5 = 
strongly 
agree) 
Not specified Primary 
care 
physicians
. Certified 
in Family 
Practice, 
General 
Practice or 
Internal 
Medicine 
Cross-sectional 
prospective email 
questionnaire. 
Convenience 
sampling from 
physician panel 
of a market 
research firm 
with >3 years 
clinical practice 
experience, who 
treat > 10 pts 
with 
T2DM/week. 
Barrier:  
- Insulin can only 
be administered by 
injection (93%) 
- Patients fearful 
of insulin therapy 
(80%) 
- Training on 
insulin is too 
complicated for 
patients (58%) 
- Follow up for 
patients on insulin 
too resource 
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Table 3.1.3, continued 
intensive for staff 
(53%) 
- Patients view 
insulin initiation 
as a personal 
failure (53%)  
 
Facilitator: 
- Patient education 
(93%) 
- Benefits 
outweigh the risks 
(88%) 
- Patients feel 
better once 
accustomed (76%) 
- Patients will 
avoid diabetic 
complications 
(75%) 
- Demands of 
insulin therapy 
less than expected 
(63%) 
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Table 3.1.3, continued 
Polonsky et al., 
2005.  
A Survey for People 
who do not take 
Insulin (SPI) 
Perceptions of 
patients on 
insulin therapy  
 
Willingness of 
patients to begin 
insulin therapy 
 
Reasons why 
patients were 
reluctant to start 
insulin, 
including risk of 
side effects, 
complications or 
changes in 
lifestyle 
9-item 
questionnair
e 
 
Response: 6-
point Likert 
scale (1 = 
strongly 
disagree, 6 = 
strongly 
agree) 
 
Total score: 
9 to 54 
Internal 
reliability 
(Cronbach’s 
α = 0.834) 
Patients. 
Participant
s at 1-day 
diabetes 
conference
s. 
Cross-sectional 
prospective self-
completion 
questionnaire. 
Convenience 
sampling by 
including 
questionnaire in 
the participants’ 
conference 
syllabus for 
return at end of 
conference. 
Barriers: 
- Not confident to 
handle demands of 
insulin therapy 
(58.1%) 
- Feel that insulin 
would restrict 
them (56.1%) 
- Feelings of 
personal failure 
(55.0%) 
- Permanence of 
insulin (53.1%) 
- Fear of pain 
(50.8%) 
Nakar et al., 
2007. 
Self-designed 
questionnaire 
Patients’ 
barriers to 
insulin therapy 
Not specified Not specified Patients. 
Study 
group 
consisted 
of T2DM 
patients 
who are 
insulin 
Patients:  
Case-control 
prospective 
telephone 
interview. 
Random 
sampling from 
central register of 
Barriers (patients): 
- Believe the 
illness is not very 
serious (46.7%) 
- Fear of addiction 
(39%) 
- Believe that 
insulin makes one 
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Table 3.1.3, continued 
naive on 
maximum 
OHAs. 
Control 
group 
consisted 
of T2DM 
patients 
who had 
begun 
insulin 3-6 
months 
previously
.  
 
Family 
physicians
. Actively 
treat 
patients 
and 
participate 
in CME 
activities. 
patients of 
chronic disease 
in a health 
maintenance 
organization 
(HMO).  
 
Doctors: 
Written 
questionnaire. 
Sampling 
population was 
family physicians 
working in the 
district, who 
actively treat 
patients and 
participate in 
CME studies 
within various 
frameworks. 
Sampling frame 
not specified. 
fat (12%) 
- Fear of 
hypoglycaemia 
(12%) 
- Fear of pain 
(12%) 
 
Barriers (doctors) 
- Believe patient 
will not comply 
with treatment 
(92.3%) 
- Patients’ fear of 
hypoglycaemia 
(79.7%) 
- Patients cannot 
cope with pain 
(53.9%) 
- Patients are too 
old (47.4%) 
- Have no 
experience with 
insulin (27.4%) 
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Table 3.1.3, continued 
Ahmed et al., 
2010.  
Self-designed 
questionnaire 
Insulin naive 
patients - 
perceptions and 
possible 
difficulties 
related to insulin 
use. 
 
Current insulin 
users – 
experiences and 
difficulties in 
using insulin. 
Not specified Not specified Patients 
with type 
2 diabetes. 
 
> 18 years 
old. 2 
groups: 
current 
insulin 
users 
(n=210), 
insulin 
naive 
patients 
(n=107) 
Cross-sectional 
prospective 
interviewer-
assisted survey. 
Consecutive 
sampling on 
patients with  
Type 2 diabetes 
presenting to 
endocrinology 
out-patient clinic 
over a six week 
period 
Barriers: 
- Insulin is a last 
resort (72.9%) 
- Transport of 
insulin difficult 
(60.5%) 
- Not possible to 
stop insulin once 
started (56.6%) 
- Insulin injection 
is uncomfortable 
(55.1%) 
- Perceived to be 
painful (54.8%) 
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Qualitative studies  
Six studies used in-depth interviews (Goderis, et al., 2009; Greaves, et al., 2003; Hunt, 
et al., 1997; Phillips, 2007a, 2007b; Sigurdardottir, 1999), one used focus group 
discussion (Brown, et al., 2002) whilst one study used both in-depth interview and 
focus group discussion (Haque, et al., 2005). Sample size ranged from 4 to 46. Only 
four studies (Goderis, et al., 2009; Haque, et al., 2005; Phillips, 2007a; Sigurdardottir, 
1999) stated their theoretical framework: phenomenonology (Phillips, 2007a), 
implementation model (Goderis, et al., 2009), grounded theory (Haque, et al., 2005), 
and Heideggerian hermeneutic phenomenology (Sigurdardottir, 1999). Sampling 
method used were mainly convenient (Brown, et al., 2002; Hunt, et al., 1997) and 
purposive (Goderis, et al., 2009; Greaves, et al., 2003; Haque, et al., 2005; Phillips, 
2007a, 2007b; Sigurdardottir, 1999).  Types of analyses used were: concept (Hunt, et 
al., 1997), content (Greaves, et al., 2003; Phillips, 2007a), constant comparison (Brown, 
et al., 2002), thematic (Goderis, et al., 2009; Phillips, 2007b), grounded theory (Haque, 
et al., 2005), and Colaizzi’s modification of phenomenological inquiry (Sigurdardottir, 
1999) (Table 3.1.2). 
Research instruments used in surveys  
Only two (Larkin, et al., 2008; Polonsky, et al., 2005) out of seven quantitative studies 
used validated instruments to identify the barriers and facilitators in initiating insulin in 
patients with type 2 diabetes.  “A survey for people who do not take insulin” (SPI) was 
used in two studies (Larkin, et al., 2008; Polonsky, et al., 2005) whilst the “Insulin 
Treatment Appraisal Scale” (ITAS) was used in one study (Larkin, et al., 2008). Both 
instruments used a Likert scale to assess the barriers and facilitators. Five studies did 
not provide any information on whether the instrument they used was validated 
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(Ahmed, et al., 2010; Hayes, et al., 2008; Karter, et al., 2010; Nakar, et al., 2007; 
Oliveria, et al., 2007).  Four out of 5 studies used self-designed questionnaire (Ahmed, 
et al., 2010; Hayes, et al., 2008; Nakar, et al., 2007; Oliveria, et al., 2007) and one did 
not specify the instrument used (Karter, et al., 2010). Areas assessed were: patient’s 
perception of insulin; difficulties, barriers and willingness to start insulin; reasons for 
hesitance to start, discontinuation and non-initiation (Table 3.1.3).  
Barriers and facilitators to insulin initiation  
Barriers and facilitators can be divided into three categories: patient-related, healthcare 
professional and system factors. The most commonly reported barriers were insulin-
related barriers while patient’s belief that insulin improved their health was the most 
frequently cited facilitator to start insulin. More barriers than facilitators were reported 
(Table 3.1.4). 
Patient-related factors 
Injection-related barriers were the most commonly reported barriers. Nine papers 
identified the fear of injections as a barrier (Ahmed, et al., 2010; Goderis, et al., 2009; 
Haque, et al., 2005; Hayes, et al., 2008; Karter, et al., 2010; Larkin, et al., 2008; Nakar, 
et al., 2007; Oliveria, et al., 2007; Phillips, 2007b) of which five (Ahmed, et al., 2010; 
Haque, et al., 2005; Karter, et al., 2010; Nakar, et al., 2007; Oliveria, et al., 2007) 
differentiated between the fear of pain from injections from the fear of injections 
themselves. Insulin administration was perceived to be difficult and complicated 
(Ahmed, et al., 2010; Hayes, et al., 2008; Hunt, et al., 1997; Karter, et al., 2010; Larkin, 
et al., 2008; Oliveria, et al., 2007; Phillips, 2007b)  Patients found it hard to adjust 
insulin dosages (Karter, et al., 2010) and some thought that insulin was given 
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intravenously (Phillips, 2007b) Home monitoring of blood glucose was seen as an 
additional burden (Karter, et al., 2010) and one study reported that monitoring of blood 
glucose was more painful than insulin injections (Phillips, 2007b). 
Insulin-related side effects, namely hypoglycaemia (Hunt, et al., 1997; Karter, et al., 
2010; Larkin, et al., 2008; Nakar, et al., 2007; Phillips, 2007b; Polonsky, et al., 2005) 
and weight gain (Haque, et al., 2005; Larkin, et al., 2008; Nakar, et al., 2007; Phillips, 
2007b) were cited as barriers in eight studies. Patients were concerned about 
hypoglycaemia (Karter, et al., 2010) even if they had not experienced any previous 
insulin-related side effects (Phillips, 2007a). Concerns about weight gain were 
especially prevalent in patients who were already overweight (Phillips, 2007b). Seven 
papers (Ahmed, et al., 2010; Haque, et al., 2005; Hunt, et al., 1997; Karter, et al., 2010; 
Larkin, et al., 2008; Phillips, 2007a; Polonsky, et al., 2005) reported patient 
misperceptions associating insulin with blindness, renal failure and amputations 
(Ahmed, et al., 2010; Karter, et al., 2010; Larkin, et al., 2008; Polonsky, et al., 2005). 
Nine studies reported negative perceptions which prevented patients from starting 
insulin therapy. Patients perceived insulin to be ineffective (Ahmed, et al., 2010; Nakar, 
et al., 2007; Oliveria, et al., 2007), unnecessary (Karter, et al., 2010), caused health 
deterioration (Larkin, et al., 2008) and worsened quality of life (Ahmed, et al., 2010). 
The permanency of insulin was highlighted as a barrier by three studies (Ahmed, et al., 
2010; Larkin, et al., 2008; Polonsky, et al., 2005) with one study reporting that 53.1% 
of patients who were unwilling to take insulin felt that not being able to stop insulin 
therapy was a barrier (Polonsky, et al., 2005). The belief that tolerance to insulin would 
develop (Ahmed, et al., 2010) and patients would become addicted to insulin (Nakar, et 
al., 2007) were also reported.   
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Table 3.1.4 Taxonomy of barriers and facilitators of insulin initiation in type 2 diabetes 
Table 3.1.4, continued    
Barriers 
 
Number of studies in which 
this factor was identified as 
a barrier (Reference) 
Facilitators Number of studies in which 
this factor was identified as a 
facilitator (Reference) 
Healthcare professional factors 
 Lack of knowledge and skills 5 (Brown, et al., 2002; 
Karter, et al., 2010; Oliveria, 
et al., 2007; Phillips, 2007a; 
Sigurdardottir, 1999) 
 Providing patient education/health 
information 
2 (Goderis, et al., 2009; Phillips, 
2007a) 
 Lack of doctor-patient 
relationship 
4 (Karter, et al., 2010; Larkin, 
et al., 2008; Nakar, et al., 
2007; Oliveria, et al., 2007) 
 Effective communication  2  (Hayes, et al., 2008; Nakar, et 
al., 2007) 
 Communication barriers  2 (Haque, et al., 2005; Karter, 
et al., 2010) 
 Setting glycaemic target with 
patients 
1 (Phillips, 2007b) 
 Not involving patients in 
decision making 
2 (Phillips, 2007a, 2007b)  Involving patients in decision 
making 
1 (Phillips, 2007b) 
 Negative attitudes  1 (Haque, et al., 2005) 
 
  
Patient factors 
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Table 3.1.4, continued    
 Negative perception of insulin 9 (Ahmed, et al., 2010; 
Haque, et al., 2005; Hunt, et 
al., 1997; Karter, et al., 2010; 
Larkin, et al., 2008; Nakar, et 
al., 2007; Oliveria, et al., 
2007; Phillips, 2007b; 
Polonsky, et al., 2005) 
 Improved health (Feeling better with 
insulin and better QoL) 
6 (Ahmed, et al., 2010; Hayes, et 
al., 2008; Hunt, et al., 1997; 
Larkin, et al., 2008; Phillips, 
2007a, 2007b) 
 Emotional barrier 9 (Ahmed, et al., 2010; 
Hayes, et al., 2008; Hunt, et 
al., 1997; Karter, et al., 2010; 
Larkin, et al., 2008; Oliveria, 
et al., 2007; Phillips, 2007a, 
2007b; Polonsky, et al., 2005) 
 Poor physical health (feeling 
unwell) 
1 (Phillips, 2007b) 
 Lack of 
knowledge/Misconception 
about insulin side effects 
8  (Ahmed, et al., 2010; 
Goderis, et al., 2009; Haque, 
et al., 2005; Hunt, et al., 
1997; Karter, et al., 2010; 
Larkin, et al., 2008; Oliveria, 
et al., 2007; Phillips, 2007a;  
Polonsky, et al., 2005) 
 No choice 1 (Nakar, et al., 2007) 
 Socio-demographic factor 5 (Ahmed, et al., 2010; 
Haque, et al., 2005; Hunt, et 
al., 1997; Karter, et al., 2010; 
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Table 3.1.4, continued    
Oliveria, et al., 2007) 
 Negative attitudes 5 (Goderis, et al., 2009; Hunt, 
et al., 1997; Karter, et al., 
2010; Oliveria, et al., 2007; 
Phillips, 2007b) 
  
 Lack of self-efficacy/skills 2 (Larkin, et al., 2008; 
Polonsky, et al., 2005) 
  
Insulin related factors 
 Fear of needle and pain 11 (Ahmed, et al., 2010; 
Goderis, et al., 2009; Haque, 
et al., 2005; Hayes, et al., 
2008; Hunt, et al., 1997; 
Karter, et al., 2010; Larkin, et 
al., 2008; Nakar, et al., 2007; 
Oliveria, et al., 2007; 
Phillips, 2007b; Polonsky, et 
al., 2005) 
 Benefits of insulin (improve sugar 
control, more effective than oral 
medications, prolong life, reduce 
complications) 
6 (Ahmed, et al., 2010; Hayes, et 
al., 2008; Hunt, et al., 1997; 
Larkin, et al., 2008; Phillips, 
2007a, 2007b) 
 Side effects of insulin 7 (Haque, et al., 2005; Hunt, 
et al., 1997; Karter, et al., 
2010; Larkin, et al., 2008; 
Nakar, et al., 2007; Phillips, 
 Timing of insulin initiation – initiate 
early 
1 (Phillips, 2007b) 
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Table 3.1.4, continued    
2007b; Polonsky, et al., 2005) 
 Barriers in administering 7 (Ahmed, et al., 2010; 
Hayes, et al., 2008; Hunt, et 
al., 1997; Karter, et al., 2010; 
Larkin, et al., 2008; Oliveria, 
et al., 2007; Phillips, 2007b) 
 Able to self-adjust 1 (Ahmed, et al., 2010) 
 Hassle of home glucose 
monitoring 
3 (Karter, et al., 2010; Nakar, 
et al., 2007; Phillips, 2007b) 
 Dummy injections 1 (Phillips, 2007b) 
   Hands-on demonstration 1 (Phillips, 2007b) 
Social factors 
 Inconvenience 7 (Ahmed, et al., 2010; Hunt, 
et al., 1997; Karter, et al., 
2010; Larkin, et al., 2008; 
Oliveria, et al., 2007; 
Phillips, 2007b; Polonsky, et 
al., 2005) 
 Peer support 2 (Phillips, 2007a, 2007b) 
 Interference with social and 
work activities 
6 (Ahmed, et al., 2010; 
Haque, et al., 2005; Karter, et 
al., 2010; Larkin, et al., 2008; 
Oliveria, et al., 2007; 
 Partner support 1 (Phillips, 2007a) 
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Table 3.1.4, continued    
Phillips, 2007a) 
 Stigma and discrimination 5 (Hunt, et al., 1997; Larkin, 
et al., 2008; Oliveria, et al., 
2007; Phillips, 2007a, 2007b) 
  
 Lack of social support 1 (Sigurdardottir, 1999)   
System factors 
 Lack of diabetes services 1 (Phillips, 2007b)  Patient education 1 (Goderis, et al., 2009) 
 Lack of education resource  1 (Haque, et al., 2005)  Giving enough time 1 (Phillips, 2007b) 
   Follow up  
o with telephone calls 
o giving telephone contact to 
patients 
o regular follow up 
1 (Phillips, 2007b) 
   Initiating insulin in primary care (vs 
secondary care) 
1 (Greaves, et al., 2003) 
   Referral to specialists 1 (Nakar, et al., 2007) 
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For patient facilitators, the benefit derived from insulin was the most important factor and 
these include: more effective glycaemic control, improved chances of survival and reduced 
risk of complications (Ahmed, et al., 2010; Greaves, et al., 2003; Hayes, et al., 2008; Hunt, 
et al., 1997; Larkin, et al., 2008; Phillips, 2007a, 2007b). Demonstrating the insulin 
injection technique using ‘dummy injections’ would also improve patient’s confidence to 
initiate insulin (Hunt, et al., 1997; Phillips, 2007b). Other facilitators include early 
initiation of insulin (Hunt, et al., 1997; Phillips, 2007b) and the flexibility of self-
adjustment (Ahmed, et al., 2010; Hunt, et al., 1997). 
Sociodemographic barriers to insulin initiation included being elderly (Haque, et al., 2005; 
Karter, et al., 2010), unable to afford the cost of insulin (Hunt, et al., 1997; Karter, et al., 
2010; Oliveria, et al., 2007) and religious obligations (Ahmed, et al., 2010). Elderly 
patients were hesitant to initiate insulin if they had poor vision, unsteady hands or arthritis, 
and if they had little, or no social support (Haque, et al., 2005; Karter, et al., 2010).  
Patients would preferred to use other treatment options (Haque, et al., 2005; Hunt, et al., 
1997; Oliveria, et al., 2007) and had ‘more faith’ in complementary and alternative 
medicines (Haque, et al., 2005). 
One study noted that diabetes as a whole was a very frustrating illness (Phillips, 2007a) and 
there were many psychological barriers to insulin initiation (Brown, et al., 2002). Six 
studies reported that patients felt that starting insulin meant that their diabetes had reached 
an advanced phase of illness (Ahmed, et al., 2010; Hunt, et al., 1997; Larkin, et al., 2008; 
Phillips, 2007a, 2007b; W. H. Polonsky, et al., 2005). Some patients thought that they had 
developed a different form of diabetes (Phillips, 2007a). Patients’ emotional barriers 
included the feeling of personal failure or punishment (Hayes, et al., 2008; Hunt, et al., 
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1997; Karter, et al., 2010; Larkin, et al., 2008; Phillips, 2007a; Polonsky, et al., 2005) and 
feeling a lack of fairness (Larkin, et al., 2008; Polonsky, et al., 2005) when asked to start 
insulin. Other patient barriers included anxiety (Phillips, 2007b), depression (Ahmed, et al., 
2010; Oliveria, et al., 2007), low self-efficacy (Larkin, et al., 2008; Polonsky, et al., 2005), 
forgetfulness (Oliveria, et al., 2007) and being too busy to take insulin (Oliveria, et al., 
2007; Phillips, 2007b). 
Lack of patient education was reported as a barrier (Goderis, et al., 2009; Haque, et al., 
2005). Poor knowledge and misperceptions were not only barriers to insulin initiation but 
also to adherence. One study found that among patients starting insulin, there were 
significantly more non-adherent patients reporting poor health literacy compared to those 
who adhered to insulin (Karter, et al., 2010). 
The facilitators highlighted in the studies included patients desire to feel better 
symptomatically and have better quality of life (Ahmed, et al., 2010; Greaves, et al., 2003; 
Hayes, et al., 2008; Hunt, et al., 1997; Larkin, et al., 2008; Phillips, 2007a, 2007b),  to 
improve their poor physical health (Hunt, et al., 1997; Phillips, 2007b) and having no 
choice (Hunt, et al., 1997; Nakar, et al., 2007). 
Insulin treatment was viewed as inconvenient not only to patients themselves (Hunt, et al., 
1997; Karter, et al., 2010; Larkin, et al., 2008; Oliveria, et al., 2007; Phillips, 2007b; 
Polonsky, et al., 2005) but also with significant others. Physical inconveniences associated 
with insulin include problems with transport (Ahmed, et al., 2010) and insulin cases 
(Oliveria, et al., 2007; Phillips, 2007b). Insulin was viewed as affecting social ties (Ahmed, 
et al., 2010; Haque, et al., 2005; Karter, et al., 2010; Larkin, et al., 2008; Phillips, 2007a), 
family relationships (Larkin, et al., 2008) and work (Ahmed, et al., 2010; Karter, et al., 
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2010; Oliveria, et al., 2007). Support from others was important to patients starting insulin 
and one study noted that a lack of social support could be a barrier to insulin initiation 
(Sigurdardottir, 1999). 
For the facilitators, peer (Phillips, 2007a, 2007b) and partner (Hunt, et al., 1997; Phillips, 
2007a) support are considered as important factors that influence their uptake of insulin 
therapy.  
Healthcare professional factors 
Healthcare professionals’ lack of knowledge and skills were the most commonly cited 
barrier for insulin initiation in patients (Brown, et al., 2002; Karter, et al., 2010; Oliveria, et 
al., 2007; Phillips, 2007a; Sigurdardottir, 1999). Some patients found difficulty in starting 
insulin due to poor communication with their healthcare professionals (Haque, et al., 2005; 
Karter, et al., 2010) and a lack of good doctor-patient relationships (Karter, et al., 2010; 
Larkin, et al., 2008; Nakar, et al., 2007; Oliveria, et al., 2007). Other barriers include 
healthcare professionals’ negative attitudes towards insulin (Haque, et al., 2005; Karter, et 
al., 2010) and not engaging patients in decision making (Phillips, 2007a, 2007b). 
The review found that effective communication (Hayes, et al., 2008; Nakar, et al., 2007) 
and adequate patient education (Goderis, et al., 2009; Phillips, 2007a) were two factors that 
facilitate insulin initiation. Patients were more likely to initiate insulin if healthcare 
professionals set glycaemic targets (Hunt, et al., 1997; Phillips, 2007b) and involve them in 
decision making (Hunt, et al., 1997; Phillips, 2007b). 
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System factors 
Two studies reported on barriers found in the healthcare system. Phillips (Phillips, 2007b) 
reported that a lack of diabetes service in the community was a barrier and Haque et al 
(2005) found that there was a lack of educational resources available for patients in their 
preferred language in South Africa.   
A number of facilitators were identified as important: patient education (Goderis, et al., 
2009; Hunt, et al., 1997), having sufficient time for counseling (Hunt, et al., 1997; Phillips, 
2007b), regular follow up via clinic visits or telephone calls (Hunt, et al., 1997; Phillips, 
2007b)  initiating insulin in primary care (vs secondary care) (Greaves, et al., 2003), and 
referral to specialists (Hunt, et al., 1997; Nakar, et al., 2007). 
Discussion 
This systematic review documented the range of barriers and facilitators patients face 
during insulin initiation. By including both quantitative and qualitative studies, this 
systematic review managed to identify a range of factors (insulin-related, patient, 
healthcare professional, social and system factors) that the healthcare professionals should 
consider when advising patients with type 2 diabetes.  
The quality of the papers were good and most achieved the QualSyst assessment scores of 
more than 0.7. However, the inter-rater reliability was below average (ICC less than 0.6) 
(Shrout & Fleiss, 1979). However, the two teams discussed and arrived at a consensus on 
the quality of the papers. For qualitative studies, three out of eight studies did not specify 
the qualitative approach (Brown, et al., 2002; Greaves, et al., 2003; Phillips, 2007b) but the 
analysis methods were stated in all studies and were appropriate. In two studies, the setting 
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where the studies were conducted were not mentioned. For quantitative studies, the 
response rates of most of the surveys were good (above 70%) except for three studies. The 
doctor survey, which was conducted via email by a research marketing company, achieved 
only 19.8% response rate (Hayes, et al., 2008) while the two patient surveys recorded 
response rates of 33.1% (Polonsky, et al., 2005) and 44.4% (Karter, et al., 2010). The 
former was conducted with patients attending a diabetes conference while the latter used 
telephone to survey those who did not fill in the prescription after it was prescribed by the 
doctors. Interviewer-administered questionnaire survey achieved a better response rate 
compared to those administered via emails, telephones or at conferences. 
The key barriers to insulin initiation in patient with type 2 diabetes appear to be related to 
insulin treatment and patient factors. Fear of pain and needles, concern about the side 
effects of insulin and the complexity of delivering the insulin remain major hurdles in 
insulin initiation. This is despite marked improvement in the delivery process (Brunton, 
2008) and development of newer insulin with better safety profile (Rosenstock et al., 2008). 
Patients perceived starting insulin as an indication of advanced diabetes which may lead to 
complications such as blindness, amputation and renal failure. This misconceptions cause 
delay in patient’s decision to start insulin. Patients also ‘blamed’ themselves for failing to 
control their diabetes and some perceived insulin therapy as a punishment. These negative 
emotions could be avoided by explaining to the patients that the need for insulin therapy is 
part of the disease progression, (UK Prospective Diabetes Study (UKPDS) Group, 1998) 
particularly at the early stage of the illness rather than at the point of decision making (Lee, 
Lee, & Ng, 2013) Another key barrier concerns the healthcare professionals’ ability to 
guide patients in making decisions about starting insulin. Those who lack knowledge and 
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have poor communication skills might face difficulty counselling patients on insulin 
treatment.  
On the other hand, the main facilitators focus on the clinical benefits of insulin in reducing 
symptoms and complications as well as improving survival and quality of life. Providing 
patients with accurate health information and education can help to make a more informed 
decision about starting insulin therapy. In addition, system factors such providing adequate 
time for consultation and regular follow up may allow patients and healthcare professionals 
to discuss their concerns and expectations. Decision support tools such as a patient decision 
aid might be helpful to overcome this barrier (Mathers et al., 2012). 
This systematic review included studies which surveyed or interviewed patients who were 
at different stages of decision making as well as those who were already using insulin. The 
barriers and facilitators faced by insulin-naïve patients might be different from those who 
have already started insulin. There might be recall bias for insulin users and patients who 
have already started on the insulin might rationalise their decision by playing down the 
harms (Ahmed, et al., 2010; Hunt, et al., 1997; Karter, et al., 2010; Nakar, et al., 2007; 
Oliveria, et al., 2007; Phillips, 2007a; Polonsky, et al., 2005). Nevertheless, this systematic 
review aimed to identify the range of factors that influence insulin initiation and not to 
quantify the frequency of these factors. Patients and healthcare professionals have different 
views on which barriers and facilitators are more relevant to the patients. While healthcare 
professionals emphasise on patients’ concerns about side effects of insulin and injections, 
patients were also worried about the lack of social support and emotional impact. 
Therefore, there is a need for the healthcare professionals to ask patients for their concerns 
and address them accordingly as their concerns are often different from those assumed by 
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the healthcare professionals (Brown, et al., 2002; Goderis, et al., 2009; Greaves, et al., 
2003; Haque, et al., 2005; Hayes, et al., 2008; Nakar, et al., 2007; Phillips, 2007b; 
Sigurdardottir, 1999). 
There are limitations in this systematic review. Firstly, this review only searched PubMed 
database and included only English articles. Future systematic review may consider 
expanding to include other databases such as CINAHL and PsycInfo as well as other 
languages.  
Conclusion 
This systematic review has identified the key factors that influence insulin initiation in 
patients with type 2 diabetes: insulin-related, patient, healthcare professional, social and 
system factors. When counselling patients who are considering insulin, it is important to 
explore the barriers faced by patients and address them accordingly. This will ensure that 
patients will make an informed decision about their diabetes treatment. 
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Abstract 
Background: Patient values are the main component of patient participation in medical 
decision making. However, there is no consensus on what patient values are and how they 
should be incorporated in medical decision making.   
Purpose:  This systematic review aimed to identify definitions of patient values within the 
context of medical decision making and synthesize these definitions into an integrated 
model of patient's values.  
Data sources:  Database searches were conducted in April 2011 in Pubmed, CINAHL and 
PsycINFO on the terms patient values and decision making.  
Study selection: Out of a total of 614 articles retrieved, 43 had a definition of patient 
values and were included for review. Slightly over half of these articles linked their concept 
of patient values to a theory or conceptual framework.  
Data extraction: Key phrases which mentioned patient values were extracted by trained 
reviewers. 
Data synthesis: A thematic analysis of the definitions was performed.  
Results: The review did not find a common definition for patient values. However three 
major themes were identified. Firstly, values can be divided into two categories: healthcare 
and decision-making preference. Secondly, there are two dimensions in the structure of 
values: relative priority and longitudinal stability. Thirdly, values function by filtering 
information and determining which goals are most important to patients. These themes are 
synthesized into an integrated model of patient values. By including the dimension of 
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longitudinal stability into patient values, this model is especially useful for long-term care 
situations such as chronic disease management and primary care practice.  
Limitations: Non-English language studies on values have been excluded. These studies 
may be important to inform culture-specific categories of patient’s values. 
Conclusions:  Researchers and practitioners should clarify their use of the term patient 
values in research and practice. A clear definition which embraces a range of concepts will 
help practitioners understand and examine the patient perspective.   
Keywords: Patient values; decision making; conceptual framework 
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Introduction 
Patients are increasingly being involved in medical decision making. This follows a shift in 
healthcare models from a paternalistic model (Charles, Gafni, & Whelan, 1997) to one 
where the patient’s perspective is seen as integral to the healthcare process (Sullivan, 
2003). Collaborative, patient-centred decision-making is viewed as a key process indicator 
of the quality of healthcare (Spring, 2008).  
Patient values are a central component of patient participation. For example, in evidence-
based medicine, patient values are considered alongside best research evidence and clinical 
expertise (Sackett, Straus, Richardson, Rosenberg, & Haynes, 2000). In the shared 
decision-making model, the concept of “patient's values or preferences” was the most 
mentioned concept (Makoul & Clayman, 2006). In research to support patients in decision 
making, good decisions are defined as those that achieve patient value-decision 
concordance (Elwyn, Frosch, Volandes, Edwards, & Montori, 2010; International Patient 
Decision Aids Collaboration, 2006; O'Connor, Tugwell, & Wells, 1998; Stacey et al., 
2011). Patient values are described as being ‘crucial’ (Ikomi & Kunde, 2002), ‘essential’ 
(Makoul & Clayman, 2006) and a ‘guide to medical decision making’(Miller & Bolla, 
1998). 
Acknowledging that patient values are to be incorporated into healthcare decisions is only 
useful if there is a clear definition of what patient values are. Therefore, this review aimed 
to systematically review how the term ‘patient values’ is used within the context of medical 
decision-making and to synthesize a model what patient values are. 
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Methods 
Search strategy 
A three-staged search and data extraction strategy was developed based on the review aims. 
Stage 1 and Stage 2 involved database searching and reference mining to extract relevant 
full-text articles. Stage 3 involved the extraction of data from these articles using a 
standardised data extraction form.  
Stage 1 (Database search) 
Database searches were conducted in April 2011 on Pubmed, CINAHL and PsycINFO, 
which are the three main databases for patient-related literature. The closest Pubmed MeSH 
term to patient values was “patient preference” (defined as “Individual's expression of 
desirability or value of one course of action, outcome, or selection in contrast to others.”) 
(National Center for Biotechnology Information). However, the search with the term 
“patient preference” identified studies describing quantitative decision preferences between 
two or more healthcare options; there was no mention of the concept of patient’s values. 
Furthermore, this MeSH was only created recently in 2010. Therefore, a free text search 
was performed using the Pubmed Advanced Search Builder indexing function to help 
identify similar and related terms. The search results were then combined with the MeSH 
term “Decision Making”. The search yielded a total of 138 articles.  
We also searched the CINAHL database using free-text terms “patient values”, “patient 
attitudes” and “patient beliefs” and they were combined with the major heading “Decision 
Making, Patient”. The search was further combined with “"Definition" OR "Literature 
Review" OR "concept analysis"” to more accurately capture articles discussing the concept 
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of patient values. Lastly, the PsycINFO database was searched using the free-text terms 
(“Value*” OR “Attitude*” OR “Preference*”), “Decision Making” and “Patients”.  
Two independent reviewers (NCJ, LYK) reviewed all titles and abstracts based on a set 
inclusion criteria (Table 3.2.1). A more inclusive stance was adopted at this stage and 
articles which we were uncertain about were included for full-text review in stage 2. The 
results between the reviewers were compared and discrepancies resolved by discussion 
until a consensus was reached.  
Table 3.2.1: Inclusion criteria for articles 
1) Only articles within the context of Medical Decision Making within the context of 
patient and healthcare professional consultation. 
2) The authors state a clear definition of patient values OR the authors give a description of 
how they elicit or clarify patient values. In the latter, the values clarification method will 
then be analysed to provide a definition of patient values. The definition will also be 
inferred if patient values are explicitly mentioned in the article title as this signifies that the 
concept is a focal point of the article. 
3) Only articles published as full text will be included. Articles published only in abstract 
format will not be reviewed. 
4) Only English articles will be reviewed.  
5) The search period will cover articles from 1966 – 4 April 2011. 
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Stage 2 (Stage 1 full text review and snowballed references) 
Full text articles from Stage 1 were reviewed by a trained reviewer (LYK). Only articles 
that explicitly discussed the concept of patient’s values were included for further review. 
Articles that met the inclusion criteria were included for Stage 3. 
References from Stage 2 articles were reviewed and ‘footnote chasing’ (Wilson, 1992) was 
conducted whereby the list of references from Stage 2 articles was searched for more 
articles and the article list was expanded by adding articles that met the inclusion criteria 
until saturation was reached.  
Stage 3 data extraction 
Two researchers (NCJ, LYK) developed the data extraction form and the form was pilot 
tested and further refined. Full text articles from Stage 2 were reviewed by LYK. As the 
purpose of the review was a qualitative synthesis of the patient’s values concept, articles 
were not assessed for strength of quantitative research evidence.  
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Data analysis 
The data was analysed in two ways; theoretically and thematically. Firstly, a theoretical or 
conceptual analysis was performed to identify the theory or conceptual framework used to 
discuss patient values. Secondly, a thematic analysis of the definitions was performed. Key 
phrases which mentioned patient values were extracted and these were used to develop 
themes for the patient values concept, which were further grouped into larger categories.  
Results 
The final number of articles reviewed was 613, of which 43 mentioned the patient values 
concept (Figure 3.2.1). Stage 1 database searching identified 30 articles and a further 13 
were included through Stage 2 reference-searching.  
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Figure 3.2.1: PRISMA search flowchart for definition of patient values (Liberati et al., 
2009).
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In Stage 1, a total of 606 articles were retrieved from the three databases of which three 
articles were duplicated and discarded (Table 3.2.2). Out of 603 articles, 49 articles 
were included for full-text review in Stage 2 based on the titles and abstracts. Two full 
text articles could not be retrieved and attempts to contact the authors were not 
successful, therefore these articles were excluded from Stage 2. In Stage 2, a total of 30 
articles were included for data extraction in Stage 3 after the full text review. A further 
13 articles were included after searching the references of these 30 articles.  
Table 3.2.2: Stage 1 literature search strategy 
Database Search terms Articles 
Pubmed (“Patient value*” OR “patient attitude*” OR 
“patient belief*” OR “patient preference*”) AND 
“Decision Making” [Mesh] 
138 
CINAHL (“Patient value*” OR “patient attitude*” OR 
“patient belief*” OR “patient preference*”) AND 
(MM "Decision Making, Patient+") AND 
("Definition" OR "Literature Review" OR 
"concept analysis") 
212 
PsycINFO  (“Value*” OR “Attitude*” OR “Preference*”) 
AND “Decision Making” AND “Patients” 
256 
TOTAL ( Note: 3 articles discarded) 603 
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Included articles which mentioned patient values are summarised in Table 3.3.3. The 
articles consisted of literature reviews (n=3), essays (n=18), original research reports 
(n=18), book chapters (n=2), and one letter. Patient values were discussed in the 
following contexts: gerontological or end-of-life conditions or advanced directives 
(n=19); other medical conditions (urology, various cancers, transfusion medicine, 
breech deliveries, mammographic screening, prenatal testing, psoriasis, hormone 
replacement therapy) (n=12); medical decision making frameworks (shared decision 
making, evidence based medicine, informed consent, biopsychosocial models) and 
ethics (n=12).  
The theory base for patient values 
A total of 27 articles referred to a theory or conceptual framework when discussing 
patient values. The most common frameworks used were shared decision making 
(n=10), evidence based medicine (n=5), and expected utility theory (n=4) (Table 3.2.4). 
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Table 3.2.3 Articles included for review on patient values 
Table 3.2.3, continued 
No.  
 
Reference Year Manuscript 
type 
Decisional 
Context 
Theory base Description of patient values 
1.  Baron J. Biases in the quantitative 
measurement of values for public 
decisions. Psychol Bull. 
1997;122(1):72-88. (Baron, 1997) 
1997 Discussion The role of 
patient 
values in 
policy 
making 
Baron’s Norm-
endorsement 
Utilitarianism 
"The idea of values is that we have some sort of 
ultimate standards by which we evaluate states of 
affairs (Baron, 1996). We define our good in 
terms of these standards." pg 74 
 
2.  Black K, Emmet C. Nurses' 
advance care planning 
communication: an investigation. 
Geriatr Nurs. 2006 Jul-
Aug;27(4):222-7; quiz 8. (Black 
& Emmet, 2006) 
2006 Research 
article 
Advanced 
Directives, 
end of life 
None Under the Advance Directive Communication 
Practices Mean Subscale and Item Scores, the 
item “Elicitation of patient values” contained five 
items (pg 225): 
1. Impact on self-care 
2. Values of resuming prior lifestyle 
3. Concerns regarding dependence on others  
4. Issues regarding nursing home placement 
4. Costs of treatment 
3.  Black K. Advance directive 
communications practices:social 
worker's contributions to the 
interdisciplinary health care team. 
2005 Research 
article 
Advanced 
Directives, 
end of life 
None The advanced directive phase of "Elicitation of 
patients values" is defined as "Encouraged 
consideration about impact of treatment decisions 
on future ability for self-care, importance to 
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Table 3.2.3, continued 
Soc Work Health Care. 
2005;40(3):39-55. (Black, 2005) 
patient of resuming previous lifestyle, likelihood 
of dependence on others for future care, patient 
concerns about post-acute rehabilitation and 
potential nursing home placement, financial 
concerns about treatment" pg 45 
4.  Brock DW. The ideal of shared 
decision making between 
physicians and patients. Kennedy 
Inst Ethics J. 1991 Mar;1(1):28-
47. (Brock, 1991) 
1991 Discussion Ethics in 
'shared 
treatment 
decision 
making' 
Shared Decision 
Making/ 
Informed Shared 
Decision 
making/ Shared 
Model 
"The patient's role in this division of labor is to 
provide the values- his or her own conception of 
the good- with which to evaluate these 
alternatives, and to select the one that is best for 
himself of herself" pg 28 
5.  Canfield SE, Dahm P. Evidence-
based urology in practice: 
incorporating patient values in 
evidence-based clinical decision 
making. BJU Int. 2010 
Jan;105(1):4-5. (Canfield & 
Dahm, 2010) 
2009 Discussion Urology None Values and preferences are defined as patients’ 
goals, predispositions and beliefs. The phrase 
patient values is explicitly stated in the title. The 
definition of values is quoted as “patient’s 
individual circumstances, values and preferences 
, which are defined as ‘the collection of goals, 
expectations, predispositions, and beliefs that 
individuals have for certain decisions and their 
potential outcomes’ (Montori et al, 2008)” pg 4. 
6.  Charles C, Gafni A, Whelan T. 
Decision-making in the 
physician-patient encounter: 
1999 Discussion  General 
medical 
Shared Decision 
Making/ 
Informed Shared 
Values function as filters in processing medical 
information. "Patients interpret information on 
average treatment outcomes in order to make 
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Table 3.2.3, continued 
revisiting the shared treatment 
decision-making model. Soc Sci 
Med. 1999 Sep;49(5):651-61. 
(Charles, Gafni, & Whelan, 1999) 
practice Decision 
making/ Shared 
Model 
them personally meaningful within the decision-
making context they face (Adelsard and Sachs, 
1996; Turney, 1996; Charles et al., 1998). In so 
doing, their own values and beliefs act as filters 
in processing what information is allowed in and 
how it is understood (Williams and Calnan, 
1996)." pg 655 
7.  Coppola KM, Ditto PH, Danks 
JH, Smucker WD. Accuracy of 
primary care and hospital-based 
physicians' predictions of elderly 
outpatients' treatment preferences 
with and without advance 
directives. Arch Intern Med. 
42001 Feb 12;161(3):431-40. 
(Coppola, Ditto, Danks, & 
Smucker, 2001) 
2001 Research 
article 
Advanced 
Directives, 
end of life 
None Values are the preference for health outcomes 
along different life-sustaining options and their 
requisite risks and benefits "In the patient 
version of the LSPQ, patients imagined 
themselves in each medical scenario and 
indicated their preference for receiving each of 
the 4 medical treatments" Advance Directives 
Values Assessment and Communication 
Enhancement (ADVANCE) project,  pg432 
8.  Coverdale J, McCullough LB, 
Molinari V, Workman R. 
Ethically justified clinical 
strategies for promoting geriatric 
assent. Int J Geriatr Psychiatry. 
2006 Feb;21(2):151-7. 
(Coverdale, McCullough, 
2006 Discussion Geriartric 
Assent 
Coverdale et al’s 
framework for 
patient 
participation 
Values are what is important to patients and 
what their goals are. "Promoting geriatric assent 
in this context means that as part of the overall 
work-up and assessment of the patient’s decision-
making capacities the psychiatrist should elicit 
from the patient his or her values and 
preferences. One way to accomplish this is simply 
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Table 3.2.3, continued 
Molinari, & Workman, 2006) to ask patients what is important to them under 
the current circumstances (McCullough et al., 
1993). One could also ask the patient what his or 
her goals are." pg 153 
 
Long-standing & Stable vs. Current and at-
odds "Sometimes patients with signiﬁcant 
cognitive impairments may express values and 
preferences at odds with their long-standing 
values. Some have proposed treating such values 
as authoritative, when the patient’s current 
quality of life seems satisfactory to him or her 
(Dresser, 1994, 1995). A full discussion of the 
philosophical problems with such a view is 
beyond the scope of this paper. However, we 
suggest that it is not at all clear that current 
values should have controlling authority over 
prior expression of values, because they are 
expressed by an individual whose self has been 
signiﬁcantly diminished by memory loss, thus 
unhinging the patient from his or her past." pg 
153 
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Table 3.2.3, continued 
9.  DeSanto-Madeya S, Nilsson M, 
Loggers ET, Paulk E, Stieglitz H, 
Kupersztoch YM, et al. 
Associations between United 
States acculturation and the end-
of-life experience of caregivers of 
patients with advanced cancer. 
Journal of Palliative Medicine. 
2009 Dec;12(12):1143-9. 
(DeSanto-Madeya et al., 2009) 
2009 Research 
article 
End of Life None Values are a part of culture. "Culture, which 
refers to the beliefs, values, and lifeways of 
people of diverse races and ethnicities, shapes 
how individuals view health, illness, and death" 
page 1143 
10.  Doukas, D. J., & McCullough, L. 
B. (1991). The values history. 
The evaluation of the patient's 
values and advance directives. J 
Fam Pract, 32(2), 145-153.  
1991 Discussion End of life, 
living will, 
advanced 
directives 
None Values as relevant to terminal care are of 
personal importance to patients. The "The 
Values Section” in the Values History 
questionnaire is described as: “The first choice in 
the Values Section of the Values History is basic: 
the question of length of life vs quality of life. 
Next, the patient is asked to identify which values 
relevant to terminal care (eg, based on dignity, 
comfort, or personal philosophy) are important. 
These values-based statements have been found in 
pilot testing with patients to be those that express 
commonly held values in patient health care 
decision making. Obviously these values may be 
supplemented to reflect the values of an 
individual patient. Alternatively, the patient may 
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Table 3.2.3, continued 
add other value-based statements to the list. The 
list provided is a useful starting point."  
11.  Doukas DJ, Antonucci T, 
Gorenflo DW. A 
multigenerational study on the 
correlation of values and advance 
directives. Ethics & Behavior. 
1992;2(1):51-9. (Doukas, 
Antonucci, & Gorenflo, 1992) 
1992 Research 
article 
End of Life None Same definition as Doukas 1991. This paper 
reports a multigenerational survey using the 
Values History (n=105).   
12.  Feldman-Stewart D, 
Brennenstuhl S, Brundage MD, 
Roques T. An explicit values 
clarification task: Development 
and validation. Patient Education 
and Counseling. 2006 
Nov;63(3):350-6. (Deb Feldman-
Stewart, Sarah Brennenstuhl, 
Michael D. Brundage, & Tom 
Roques, 2006) 
2006 Research 
article 
Prostate 
cancer 
Svenson's 
Differentiation 
and 
Consolidation 
(DiffCon) 
Theory of 
Decision 
Making 
Values are qualities that patients consider 
desirable. ‘‘Values’’ refers to qualities that the 
individual considers desirable or not, and in these 
situations they often relate to quantity or quality 
of life" pg 350 
13.  Epstein, R. M. and E. Peters 
(2009). "Beyond information: 
exploring patients' preferences." 
JAMA 302(2): 195-197. (Epstein 
2009 Discussion  General 
medical 
practice 
Shared Decision 
Making/ 
Informed Shared 
Decision 
Values are beliefs underlying preferences. The 
values underlying preferences (eg, a meaningful 
life) also may change as patients get sicker.pg 
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Table 3.2.3, continued 
& Peters, 2009) making/ Shared 
Model and 
Patient- Centred 
Care/ Person-
Centred Practice 
196 
14.  Guyatt GH, Straus SE, McAlister 
FA, Haynes RB, Sinclair J, 
Deveraux PJ, et al. Moving from 
evidence to action: incorporating 
patient values. In: G G, D R, 
editors. Users’ Guides to the 
Medical Literature: A Manual for 
Evidence-Based Clinical Practice: 
The Evidence-Based Medicine 
Working Group. Chicago: JAMA 
& Archives Journals AMA Press; 
2002. p. 567-82. (Guyatt et al., 
2002) 
2002 Book 
chapter 
EBM 
practice 
Evidence Based 
Medicine/ 
Evidence Based 
Practice 
Values are how patients feel about the health 
states/ options. The phrase patient values is 
explicitly stated in the title. No explicit definition 
of patient values. There are two fundamental 
strategies to incorporating patient values: 1. 
Communicating the risks and benefits to the 
patient so that they can incorporate their own 
values and preferences, 2. Ask patients to place a 
relative value on the key outcomes associated 
with management options. (p 571). On pg 575 
there is a description of a ‘health thermometer 
method’ for eliciting patient values which is used 
to elicit how do patients feel about the health 
states in (p. 575) 
15.  Heddle NM. Evidence-based 
decision making in transfusion 
medicine. Vox Sang. 2006 
Oct;91(3):214-20. (Heddle, 2006) 
2006 Discussion Transfusion 
medicine 
Evidence Based 
Medicine/ 
Evidence Based 
Practice 
Values are related to patient choices of 
different treatment options. Under the section 
“Patient preferences and values” the following is 
described "When the term evidence-based 
medicine was ﬁrst coined in the early 1990s, it 
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Table 3.2.3, continued 
was realized that patient’s preferences were an 
important part of the process; however, as the 
concept of evidence-based medicine evolved, it 
became recognized that the patient’s values 
should also be taken into account". There is no 
explicit description of patient values. A case 
scenario involving a couple who was allowed to 
choose the ‘no treatment’ option after a receiving 
Rh-positive blood for anemia even though the 
pregnant patient was Rh-negative was used to 
illustrate “that the decision in this scenario 
incorporate the patient’s own preferences and 
values”. pg 217 
16.  Ikomi A, Kunde D. Managing 
term breech deliveries. Patient 
values are crucial for good 
medical decision making. BMJ. 
2002 Jan 5;324(7328):50; author 
reply -1. (Ikomi & Kunde, 2002) 
2002 Letter Breech 
deliveries 
Evidence Based 
Medicine/ 
Evidence Based 
Practice 
Values are the individual importance placed on 
different birth options. The term patient values 
is explicitly stated in the title. However, the only 
description of values is as follows: "Individual 
women place different value on birth processes 
and outcomes" pg 50 
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Table 3.2.3, continued 
17.  Karel MJ, Powell J, Cantor MD. 
Using a Values Discussion Guide 
to facilitate communication in 
advance care planning. Patient 
Educ Couns. 2004 Oct;55(1):22-
31. (Karel, Powell, & Cantor, 
2004) 
2004 Research 
article 
End of life, 
advanced 
care 
planning 
None Values are: what is most important; what is 
meaningful of good; religious or personal 
beliefs; treatment decision making; feelings; 
surrogate decision making preference; financial 
concerns; family concerns; instruction 
compliance preference. From the revised Values 
Discussion Guide, pg 30:  
1. First, think about what is most important to you 
in your life. What makes life meaningful or good 
for you now? 
2. Now, think about what is important to you in 
relation to your health. What, if any, religious or 
personal beliefs do you have about sickness, 
health care decision-making, or dying? 
3. (a) Have you or other people you know faced 
difficult medical treatment decisions during times 
of serious illness? (b) How did you feel about 
those situations and any choices that were made? 
4. Some people feel a time might come when their 
life would no longer be worth living. Can you 
imagine any circumstances in which life would be 
so unbearable for you that you would not want 
medical treatments used to keep you alive? 
5. If your spokesperson ever had to make a 
medical decision on your behalf, are there certain 
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people you would want your spokesperson to talk 
to for advice or support (family members, friends, 
health care providers, clergy, other)? 
6. Is there anyone you specifically would NOT 
want involved in helping to make health care 
decisions on your behalf?  
7. How closely would you want your 
spokesperson to follow your instructions about 
care decisions, versus do what they think is best 
for you at the time decisions are made? 
8. Should financial or other family concerns enter 
into decisions about your medical care? Please 
explain. 
9. Are there other things you would like your 
spokesperson to know about you, if he or she were 
ever in a position to make medical treatment 
decisions on your behalf? 
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18.  Karel MJ. The assessment of 
values in medical decision 
making. J Aging Stud. 
2000;14:403-22. (Karel, 2000) 
2000 Discussion Aging 
Studies 
None  “A  further  challenge  for  the  development  of  
a  health  care  values  assessment  tool is to  
determine  what  we  mean  by  “values.”  How  
broadly  or  specifically  should  this construct  be  
conceived  to  be  useful  for  the  above-stated  
goals?  Values  most  broadly conceived  may  be  
defined  as “(a)  concepts  or  beliefs,  (b)  about  
desirable  end  states or  behaviors,  (c)  that  
transcend  specific  situations,  (d)  guide  
selection  or  evaluation of  behavior  and  events,  
and  (e)  are  ordered  by  relative  importance”.  
A  number  of  models  exist  regarding  definition  
of  core  values.  For example,  Rokeach  (1973:7)  
distinguished  between  instrumental  and  
terminal  values, respectively  referring  to  
“beliefs  concerning  desirable  modes  of conduct  
or  desirable end-states  of existence.”  Examples  
of instrumental  values  include  ambitious,  
honest, and  independent;  examples  of  terminal  
values  include  equality,  happiness,  and 
wisdom.  It  is unclear  whether  the  range  of  
values  identified  by  researchers  in  this field,  
developed  empirically  through  studies  with  
generally  healthy  people,  apply in  situations  of  
illness  and  disability.  One  hypothesis  is  that  
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the  range  of  values guiding  decision  making  
and  behavior  becomes  restricted  in  ill  health  
or  terminal illness. Health  care  values  might  
be  more  narrowly  conceived  as  beliefs  
pertinent  to health  care  choices  such  as 
meanings  of  pain  and  suffering,  importance  of 
choice and control,  comfort with  risk taking,  
and importance of interpersonal  connection" pg 
412-413. 
19.  Kennedy ADM. On what basis 
should the effectiveness of 
decision aids be judged? Health 
Expect. 2003;6:255-68. 
(Kennedy, 2003) 
2003 Review Effectivenes
s of 
Decision 
Aids 
None Values are patients values about potential 
health outcomes and available options "The 
Decisional Conﬂict Scale measures subject’s 
perceptions of the extent to which they are 
uncertain about which option to choose, the 
factors contributing to this uncertainty and the 
eﬀectiveness of their decision. Of the 16 items 
that make up the scale just one, on the decision 
eﬀectiveness subscale, addresses whether the 
choice reﬂected the patient’s values, and this 
particular subscale exhibits low discriminant 
abilities." pg 265 (Item 14 "My decision shows 
what is important to me") 
 
"...then the eﬀectiveness of decision aids should 
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be judged by the extent to which patients undergo 
treatments that are consistent with their values 
for the potential outcomes of the available 
options."pg 265  
20.  Keyser PK. After Cruzan: the 
"values base" to advance 
directives. Orthop Nurs. 1992 
Sep-Oct;11(5):37-40. (Keyser, 
1992) 
1992 Discussion Advanced 
Directives, 
end of life 
None "Values are the lived sources of meaning for a 
person, and they actively constitute a person's 
history when put into words" pg 39 
21.  Kirk TW, Luck GR. Dying tax 
free: the modern advance 
directive and patients' financial 
values. J Pain Symptom Manage. 
2010 Mar;39(3):605-9. (Kirk & 
Luck, 2010) 
2010 Research 
article 
Advanced 
Directives, 
end of life 
None "This raises the larger question of whether health 
care providers should- or, even can,-evaluate 
which kinds of patient values are appropriate to 
use in medical decision making. The literature is 
replete with evidence that cultural and religious 
values are accorded great respect in medical 
decision making especially at the end of life. Why 
would these kinds of patient values be considered 
valid and appropriate reasons for extending life-
sustaining treatment but ﬁnancial values (which 
could also be construed as values about the 
family) considered inappropriate?" pg 608 
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22.  Llewellyn-Thomas H, Sutherland 
HJ, Tibshirani R, Ciampi A, Till 
JE, Boyd NF. The measurement 
of patients' values in medicine. 
Med Decis Making. 1982 
Winter;2(4):449-62. (H. 
Llewellyn-Thomas et al., 1982) 
1982 Research 
article 
healthcare 
decision 
making 
Expected 
Utility/ Utility 
Theory 
Patient values are stated in the title and defined in 
the text as preference for a health state (according 
to standard gamble theory). 
23.  Makoul G, Clayman ML. An 
integrative model of shared 
decision making in medical 
encounters. Patient Educ Couns. 
2006 Mar;60(3):301-12. (Makoul 
& Clayman, 2006) 
2006 Review Shared 
Decision 
Making 
Shared Decision 
Making/ 
Informed Shared 
Decision 
making/ Shared 
Model, and, 
Lewin’s 
transactional 
theory of 
communication 
"Physicians and patients should discuss the pros 
and cons of options raised, particularly because 
they may have different perspectives on the 
relative importance of beneﬁts, risks, and costs, 
including convenience and opportunity cost. 
These perspectives become evident through 
explication of patient values and preferences – 
including ideas, concerns, and outcome 
expectations – as well as physician knowledge 
and recommendations in the context of the 
decision at hand." pg 305 
24.  Martin VC, Roberto KA. 
Assessing the stability of values 
and health care preferences of 
older adults: a long-term 
comparison. J Gerontol Nurs. 
2006;32(11):23-33. (Martin & 
2006 Research 
article 
Stability of 
values in 
gerontologi
cal decision 
making 
Etzioni’s 
Normative-
Affective model 
of decision 
making 
Values are religious/ spiritual values "Among 
the values and beliefs found to be specifically 
influential in the decision-making process of older  
adults are religion and spirituality." pg 24 
 
Values are used to evaluate medical treatment 
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Roberto, 2006) options. 
"Collectively, these values serve as the foundation 
from which older adults formulate opinions about 
accepting  or rejecting medical treatment 
options." pg 25 
 
Values are consistent beliefs and can be 
prioritized. "In perhaps the most notable values 
study across time and health states, Rokeach and 
Ball-Rokeach (1989) surveyed 1,409 participants 
for a period of 13 years. The participants, 
ranging in age from 11 to 90 years, were asked to 
rank a group of 18 values at four different points 
in time. The researchers described the results as 
incredibly stable, with the top six and the bottom 
six values receiving identical priority rankings 
across the 13 years." pg 25 
25.  McAlister FA, Straus SE, Guyatt 
GH, Haynes RB. Users' guides to 
the medical literature: XX. 
Integrating research evidence 
with the care of the individual 
patient. Evidence-Based 
Medicine Working Group. 
JAMA. 2000 Jun 7;283(21):2829-
2000 Discussion General  Concept Under the section “Patients Values and 
Preferences: 
Values are patient's preferences for 
participation at various stages of DM "..the 
initial step in this process is to determine the 
extent to which your patient wants to be involved 
in decision making" 
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36. (McAlister, Straus, Guyatt, & 
Haynes, 2000) 
 
Values are patient's preference for likelihood 
of being helped or harmed (healthcare 
options)"The first step in this method is the 
exploration of patient values about receiving the 
treatment (vs not receiving it) and the severity of 
adverse events that might be caused by the 
treatment (vs the severity of the target event that 
we hope to avoid with the treatment" - under 
Patients Values and Preferences. 
 
26.  McCormack B. A conceptual 
framework for person-centred 
practice with older people. Int J 
Nurs Pract. 2003 Jun;9(3):202-9. 
(McCormack, 2003) 
2003 Discussion Gerontologi
cal nursing 
care 
Shared Decision 
Making/ 
Informed Shared 
Decision 
making/ Shared 
Model 
Values are what patient's value about their life 
and how they make sense (meaning) of what is 
happening. "It is important to develop a clear 
picture of what patients value about their life and 
how they make sense of what is happening." pg 
205 
27.  Meropol NJ, Egleston BL, 
Buzaglo JS, Benson AB, 3rd, 
Cegala DJ, Diefenbach MA, et al. 
Cancer patient preferences for 
quality and length of life. Cancer. 
2008 Dec 15;113(12):3459-66. 
2008 Research 
article 
Cancer C-SHIP 
(Cognitive-
Social Health 
Information 
Processing) 
Values are the importance of QOL and LOL 
life in cancer treatements. "Since distress can 
impact a patient's ability to process critical 
prognostic and treatment-related information 
relevant to treatment choice, examination of its 
relationship to an individual's values (e.g. 
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(Meropol et al., 2008) importance of quality of life and length of life) 
and communication preferences is essential."pg 2 
 
Values are influenced by emotions "Given a 
potential relationship between affect and values, 
an association between patient distress and QOL 
vs. LOL preferences was investigated." pg 5 
28.  Michaels C, McEwen MM, 
McArthur DB. Saying "no" to 
professional recommendations: 
client values, beliefs, and 
evidence-based practice. J Am 
Acad Nurse Pract. 
2008;20(12):585-9. (Michaels, 
McEwen, & McArthur, 2008) 
2008 Discussion Declining 
HCP 
recommend
ations 
Health Belief 
Model 
Values are how patients define their own 
bodies, identities and experiences. These 
definitions influence a patient to agree or 
disagree with HCPs' 
recommendations."Because values and beliefs 
tend to be deeply held, clients themselves may not 
readily be aware. But, by simply 
listening to a client’s health stories, values and 
beliefs can be identiﬁed. As stated by Holloway 
and Freshwater 
(2007), ‘‘In our society, health professionals are 
seen as members of an elite culture. Their clients 
do often believe in and follow the dominant 
discourse of health professionals. . In storytelling, 
however, participants in narrative inquiry have 
the power to deﬁne their own bodies, identities 
and experience, rather than having their reality 
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shaped by others’’(p. 9). The core belief and 
values that underlie health-related values and 
beliefs will be evident in their stories."pg 588 
29.  Miller DL, Bolla LR. Patient 
values: the guide to medical 
decision making. Clin Geriatr 
Med. 1998 Nov;14(4):813-29. 
(Miller & Bolla, 1998) 
1998 Discussion Advanced 
Directives,  
end of life 
None The term ‘patient values’ is stated in the title and 
the article describes how patient values are to be 
incorporated in end-of-life situations.  
30.  Montori V, Deveraux PJ, Straus 
SE, al e. Decision making and the 
patient. In: Guyatt G, Rennie D, 
Meade MO, DJ C, editors. Users’ 
Guides to the Medical Literature: 
a Manual for Evidence-Based 
Clinical Practice. 2 ed. New 
York: American Medical 
Association; 2008. p. 643-61. 
(Montori, Deveraux, Straus, & al, 
2008) 
2008 Book 
chapter 
EBM 
practice 
Evidence Based 
Medicine/ 
Evidence Based 
Practice 
“We use values and preferences as an 
overarching term that includes patients' 
perspectives, beliefs, expectations and goals for 
health and life. We also use this phrase, more 
precisely, to mean the processes that individuals 
use in considering the potential benefits, harms, 
costs, and inconveniences tof the management 
options in relation to one another.” Pg 644 
31.  Myers RE. Decision Counseling 
in Cancer Prevention and 
Control. Health Psychol. 2005; 24 
2005 Research 
article 
Cancer 
prevention 
and control 
Shared Decision 
Making/ 
Informed Shared 
Decision 
Types of values (under the Preventive Health 
Model) are: Cognitive, Affective and Cultural. 
"For study participants, the distribution of 
prostate cancer screening representations was as 
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(4):S71-S7. (Myers, 2005) making/ Shared 
Model, and, 
Informed 
Decision 
Making/ 
Informed model/ 
Informed 
Choice, and, 
Preventive 
health model 
follows: cognitive-pro (43.5%), affective-pro 
(23.5%), cognitive-con (17.5%), affective-con 
(15.5%). The following statements are examples 
of cognitive-pro decision factors articulated by 
the men: “Testing would show if I am likely to 
have a health problem” and “Screening is just 
part of how I take care of my health.” pg S74 
 
"In a PHM-based decision-counseling session, 
healthcare providers may be able to help patients 
clarify their preferred course of action and 
facilitate movement toward selection of a 
behavioral alternative that is consistent with 
expressed personal values and compatible with 
good medical care" pg S76 
32.  O'Connor AM, Tugwell P, Wells 
GA, Elmslie T, Jolly E, 
Hollingworth G, et al. A decision 
aid for women considering 
hormone therapy after 
menopause: decision support 
framework and evaluation. 
Patient Educ Couns. 1998 
Mar;33(3):267-79. (O'Connor, et 
1998 Research 
article 
HRT after 
menopause 
Shared Decision 
Making/ 
Informed Shared 
Decision 
making/ Shared 
Model 
"Decision aids may also clarify personal values 
by either implicitly or explicitly asking individuals 
to consider the personal importance they place on 
each benefit and risk and to identify the tradeoffs 
they will need to make in choosing one 
alternative...Another potential mechanism..lies in 
the detailed descriptions of benefits and risks 
depicting their impact on physical, emotional and 
social function."pg 269 
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al., 1998) 
33.  Pellissier JM, Venta ER. 
Introducing patient values into 
the decision making process for 
breast cancer screening. Women 
Health. 1996;24(4):47-67. 
(Pellissier & Venta, 1996) 
1996 Review Mammogra
phic 
screening 
Shared Decision 
Making/ 
Informed Shared 
Decision 
making/ Shared 
Model, and, 
Expected 
Utility/ Utility 
Theory 
Values are patients feelings about their current 
larger personal and societal context, their 
disease and their feelings about disease in 
general. Values include how patients perceive 
physicians approval or feelings about 
themselves "Similarly,  patient values regarding 
her current situation (personally, family-wise, 
and community-wise), her feelings about the 
disease (its prognosis and outcomes), and her 
feelings about the disease process in general will 
also affect the conversation. Furthermore, the 
perceived  physician values  by  the  patient and  
the perceived patient values by the physician have 
an impact. They suggest questions like, "Will the 
physician approve of my decision?,"  or "How 
does the physician feel about me personally?" pg 
53 
 
Values are patient's perceptions of how society 
will react and judge their decision."Societal  
values, as perceived  by  the physician  and  the 
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patient, reflect attitudes about  the resource-
allocation priority of the disease, the current 
political climate and community perceptions. 
These values constrain the range of treatment 
options that the physician considers. A patient's 
treatment choice will involve their perception of 
how society will react to and  judge their 
decision." pg 53 
 
Values are equated with utility when eliciting 
patient values is discussed. "Values or utilities 
are assigned to different aspects (attributes) of 
the problem via an assessment procedure, then 
these results are used to calculate an expected 
utility for the decision action." pg 60 
34.  Potter BK, O'Reilly N, Etchegary 
H, Howley H, Graham ID, 
Walker M, et al. Exploring 
informed choice in the context of 
prenatal testing: findings from a 
qualitative study. Health Expect. 
2008;11(4):355-65. (Potter et al., 
2008) 
2008 Research 
article 
Prenatal 
testing for 
Down's 
Syndrome 
Informed 
Decision 
Making/ 
Informed model/ 
Informed 
Choice 
Values are expressions of moral views or 
statements reflecting beliefs about how life 
should be lived. "Acceptability of pregnancy 
termination and the role of fate. Values were 
reﬂected in two major themes: acceptability of 
pregnancy termination and the role of fate. Many 
women directly associated testing decisions with 
potential decisions about abortion." pg 358  
 
Values are also expressed as patient's 
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underlying moral ideals."Some women explicitly 
associated values with religious beliefs. This was 
particularly evident in discussions about the 
morality of pregnancy termination but was not 
exclusively associated with declining testing" pg 
359  
 
Values as defined are contrasted with 
literature which is seen as equating values with 
preferences and the Multidimensional Measure 
of Informed Choice (MMIC) which is seen as 
equating values with attitudes."We deﬁned 
values as expressions of moral views or 
statements reﬂecting beliefs about how life should 
be lived. This deﬁnition diﬀers from the concept 
of values in the decision support literature,16 
which reﬂects preferences for outcomes rather 
than underlying ideals. It also diﬀers from the 
MMIC, where values were operationalized as a 
woman s attitude toward taking a prenatal 
screening test,based on Rokeach. Diﬀerences in 
the deﬁnition and application of the construct of  
values  both across and within disciplines are 
well-documented, emphasizing the need to be 
clear about how they are measured in a par 
121 
 
Table 3.2.3, continued 
ticular study. Although the term  values  is not 
consistently used in the way we deﬁned it, other 
studies support the importance of moral views or 
attitudes toward pregnancy termination and other  
values-type  notions as contributors to women s 
decision making about prenatal screening. Thus, 
it may be that in the context of prenatal testing, 
the deﬁnition of  values that emerged from our 
data is particularly relevant. Values often 
dominated discussions about prenatal testing 
decisions among women who were morally 
opposed to pregnancy termination." pg 361 
35.  Stiggelbout, A. M. and J. C. de 
Haes (2001). "Patient preference 
for cancer therapy: an overview 
of measurement approaches." J 
Clin Oncol 19(1): 220-230. 
(Stiggelbout & de Haes, 2001) 
2001 Discussion Cancer Expected 
Utility/ Utility 
Theory 
Values can be elicited through utility 
assessment methods. Nevertheless, utility 
elicitation is sometimes used in the clinical 
encounter in order to help patients clarify for 
themselves the values that are at stake in the 
decision problem.pg 225 
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36.  Sullivan M. The new subjective 
medicine: taking the patient's 
point of view on health care and 
health. Soc Sci Med. 2003 
Apr;56(7):1595-604. (Sullivan, 
2003) 
 
2003 Discussion Bioethics: 
Reasons for 
including 
patient 
perspectives 
Clinical 
epidemiology 
(“Clinimetrics”) 
Value is a verb for how much patient's value 
their health state. A distinction is made 
between objective and subjective values 
towards health related QOL measures. "For 
reasons like this, Gill and Feinstein (1994) have 
criticized many measures claiming to be HRQoL 
measures for being inadequately sensitive to 
patient values. ‘‘Quality of life can be suitably 
measured only by determining the opinions of 
patients and by supplementing (or replacing) the 
instruments developed by ‘experts’.’’ They argue 
that expert derived categories and weightings in 
questionnaires cannot accurately reﬂect the 
patient’s point of view. Elements of health status 
that are not valued are not distinguished from 
those that are valued. And most important, ‘‘the 
value of the subjective experience of living’’ 
cannot be discerned from expert-designed 
questionnaires." pg 1600 
37.  Tan J, Stacey D, Fung K, 
Barankin B, Bissonnette R, 
Gulliver W, et al. Treatment 
decision needs of psoriasis 
patients: cross-sectional survey. J 
Cutan Med Surg. 2010 Sep-
2010 Research 
article 
Psoriasis  Shared Decision 
Making/ 
Informed Shared 
Decision 
making/ Shared 
Model, and, 
Values are defined as important factors for 
treatment decisions. E.g.: 
- information on risks & benefits 
- being clear on what is important 
- information about options 
- skill or ability to make treatment decisions 
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Oct;14(5):233-9. (Tan et al., 
2010) 
Ottawa Decision 
Support 
Framework 
(ODSF) 
- having access to the HCP 
38.  Tulsky JA, Fischer GS, Rose MR, 
Arnold RM. Opening the black 
box: how do physicians 
communicate about advance 
directives? Ann Intern Med. 1998 
Sep 15;129(6):441-9. (Tulsky, 
Fischer, Rose, & Arnold, 1998) 
1998 Research 
article 
Advanced 
Directives,  
end of life 
None "Patients' personal values, goals for care, and 
reasons for treatment preferences were discussed 
in 71% of cases and were explicitly elicited by 
34% of physicians. For example: 
Physician: Right now, even though you do not 
have a terminal condition, you feel that you would 
not want to be resuscitated? 
Patient: Yes. 
Physician: Why do you feel that way? ' 
Patient: I've been feeling that I don't have that 
much to live for." pg 445 
39.  Ubel PA, Loewenstein G. The 
role of decision analysis in 
informed consent: choosing 
between intuition and 
systematicity. Soc Sci Med. 1997 
Mar;44(5):647-56. (Ubel & 
Loewenstein, 1997) 
1997 Discussion Using 
Decision 
analysis to 
practice 
informed 
consent 
Expected 
Utility/ Utility 
Theory 
"How  do  patients  express  their  values  in  a  
way that  decision  analysis  can  use?  The  most  
common  
method  for  measuring  patients'  values  (or 
"'utilities")  is  the  standard  gamble." pg 648 
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40.  van Kleffens T, van Leeuwen E. 
Physicians' evaluations of 
patients' decisions to refuse 
oncological treatment. Journal of 
Medical Ethics: Journal of the 
Institute of Medical Ethics. 2005 
Mar;31(3):131-6.(van Kleffens & 
van Leeuwen, 2005) 
2005 Research 
article 
Cancer 
treatment 
None “…keeping her breast may reflect personal values 
such as identity, dignity, and/or integrity” pg134 
41.  Vranceanu AM, Cooper C, Ring 
D. Integrating patient values into 
evidence-based practice: effective 
communication for shared 
decision-making. Hand Clin. 
2009 Feb;25(1):83-96, vii. 
(Vranceanu, Cooper, & Ring, 
2009) 
2009 Discussion Decision 
making 
models in 
Medical 
Decision 
making 
Shared Decision 
Making/ 
Informed Shared 
Decision 
making/ Shared 
Model, and, 
Evidence Based 
Medicine/ 
Evidence Based 
Practice, and, 
Patient- Centred 
Care/ Person-
Centred 
Practice, and, 
Biopsychosocial 
illness model 
Patient values are stated in the title. In the article, 
values are elicited on a small or large scale 
according to which model is being used. E.g. 
Biomedical illness model: focus on the values of 
the disease "Cure my pain" while in the 
biopsychosocial illness model: larger value 
context of the patient's life "How confident am I 
to have a child with this illness?" 
 
Eliciting patient's values includes information on:  
- sources of distress 
- social issues 
- behaviourial issues 
- goals 
- resources 
- distinguishing HCP and patient's values 
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42.  White, D. B., Braddock, C. H., 
3rd, Bereknyei, S., & Curtis, J. R. 
(2007). Toward shared decision 
making at the end of life in 
intensive care units: opportunities 
for improvement. Arch Intern 
Med, 167(5), 461-467. doi: 
167/5/461 [pii] (White, 
Braddock, Bereknyei, & Curtis, 
2007) 
2007 Research 
article 
Advanced 
Directives, 
end of life 
Shared Decision 
Making/ 
Informed Shared 
Decision 
making/ Shared 
Model 
"Values and preferences" are one of the 10 items 
evaluated in the study on advanced directives. 
The item "What do you know about patient's 
medical preferences and values?" was coded in 
about 80% of transcripts. 
43.  White DB, Malvar G, Karr J, Lo 
B, Curtis JR. Expanding the 
paradigm of the physician's role 
in surrogate decision-making: an 
empirically derived framework. 
Crit Care Med. 2010 
Mar;38(3):743-50. (White, 
Malvar, Karr, Lo, & Curtis, 2010) 
2010 Research 
article 
Advanced 
Directives, 
end of life 
None Values are patient preference for or against 
life support. "Most simply, these physicians made 
efforts to bring the patient’s values and 
preferences to the fore by asking questions such 
as, “has she ever talked about whether she would 
accept being on a breathing machine longterm?” 
and “if she could sit up in bed, what would she 
say about this decision?” Some physicians also 
made explicit the value-sensitive nature of the 
decisions." pg 746 
* Author-extracted definitions of values are in bold, or if explicitly stated in the text, are underlined.  
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Table 3.2.4, continued 
Theory/ Decision making 
framework 
References Theoretical context for patient’s values 
Shared Decision Making/ 
Informed Shared Decision 
making/ Shared Model  
(Brock, 1991; Charles, et al., 1999; 
Epstein & Peters, 2009; McAlister, et 
al., 2000; Myers, 2005; O'Connor, et 
al., 1998; Pellissier & Venta, 1996; 
Tan, et al., 2010; Vranceanu, et al., 
2009; White, et al., 2007) 
“Patient’s values/ preferences” is the most common element of the 
SDM concept (Makoul & Clayman, 2006); a doctor brings information 
whilst the patient brings values to the physician-patient encounter 
(Brock, 1991); values (both physician’s and patient’s) pervade the 
SDM process (Charles, Gafni, Whelan, & O'Brien, 2005).  
Evidence Based Medicine/ 
Evidence Based Practice 
(Guyatt, et al., 2002; Heddle, 2006; 
Ikomi & Kunde, 2002; Montori, et al., 
2008; Vranceanu, et al., 2009) 
EBM is defined as “the integration of best research evidence with 
clinical expertise and patients’ values” (Sackett, et al., 2000).  
Expected Utility/ Utility 
Theory 
(H. Llewellyn-Thomas, et al., 1982; 
Pellissier & Venta, 1996; Stiggelbout 
& de Haes, 2001; Ubel & Loewenstein, 
1997) 
In utility theory, patient’s values are synonymous with utility functions 
of different health states. A utility is the “subjective value of an 
outcome, or what the outcome is actually worth to an 
individual”(Reed, 2000).  
Informed Decision Making/ 
Informed model/ Informed 
Choice 
(Charles, et al., 1999; Myers, 2005; 
Potter, et al., 2008) 
An informed choice is defined as “one that is based on relevant 
knowledge, consistent with the decision maker's values and 
behaviourally implemented” (O'Connor & O'Brien-Pallas, 1989) 
Patient- Centred Care/ Person- (Epstein & Peters, 2009; McCormack, Patient- Centred Practice requires healthcare professionals to focus on 
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Table 3.2.4, continued 
Centred Practice 2003; Vranceanu, et al., 2009) the patient’s personal and authentic values (McCormack, 2003) as part 
of making the patient the centre of the care process. 
Biopsychosocial illness model (Vranceanu, et al., 2009) The biopsychosocial illness model looks at how illness affects the 
patient’s life as a whole. Values are elicited on a larger scale in the 
biopsychosocial model when compared to the biomedical model of 
viewing illness (Vranceanu, et al., 2009). 
Health Belief Model (Michaels, et al., 2008) The health belief model incorporates 1) individual perspectives, 2) 
modifying factors and 3) likelihood of action in order to understand 
patients’ perspectives on the threat or susceptibility of a disease.  
Patient’s values comprise part of the factors that determine individual 
perspectives that lead to beliefs about disease susceptibility. 
Preventive health model (Myers, 2005) The preventive health model focuses on external and internal factors 
that predict health behaviour. Part of the internal self-system includes 
cognitive, affective and social evaluation. These are the main 
evaluative considerations when making a decision between alternative 
choices and the author specifically explores cognitive and affective 
considerations as part of patient values. Social factors are excluded, but 
no reason is given (Myers, 2005). 
Ottawa Decision Support 
Framework (ODSF) 
(Tan, et al., 2010) The ODSF is a framework for meeting decisional needs by providing 
decisional support. It lists values as part of the Decisional Needs 
category (O'Connor, 2006). 
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Table 3.2.4, continued 
Coverdale et al’s framework 
for patient participation  
(Coverdale, et al., 2006) Coverdale et al (1996, 1997) framework outlines the steps for patient 
participation in the decision-making process. The concept "Evaluative 
understanding" is used to define decision making that is done together 
with values and beliefs. 
Etzioni’s Normative-Affective 
model of decision making 
(Martin & Roberto, 2006) Etzioni's normative-affective model states that people are more 
affected by values and emotions when making decisions than by 
rational cognitive factors. Thus values are given prominence under this 
model as strong influencing factors in decision making.  
Emotion (Affect) and values are distinguished as such: "...values  differ  
from  sheer  affective  involvements  in that  they contain a justification  
and  define a wider  claim  (e.g.  others to whom the  same  right 
applies), while  sheer  affective  states contain  no  such statements. 
(Love for mankind is a value; love for a particular person is an  
emotion.)” (Etzioni, 1988) 
Baron’s Norm-endorsement 
Utilitarianism 
(Baron, 1997) Baron's norm-endorsement utilitarianism (Baron, 1996) argues that 
following normative moral principles will lead to utilitarianism (the 
greater good). These normative moral principles are described as our 
values which are ultimate evaluative standards which we use to 
evaluate states of affairs (e.g. the health states and options for a 
patient.) 
Lewin’s transactional theory of 
communication  
(Makoul & Clayman, 2006) Lewin’s transactional theory of communication was used in the 
integrative definition of SDM as all elements of SDM (including 
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Table 3.2.4, continued 
patient’s values) happened through the exchange and interpretation of 
messages and influence between physician and patient (Makoul & 
Clayman, 2006). 
Clinical epidemiology 
(“Clinimetrics”) 
(Sullivan, 2003) Clinimetrics attempts to incorporate subjective measures of health 
instead of just using morbidity and mortality alone for healthcare 
measurements. It is important to accurately represent patient's values, 
especially in Health-related Quality Of Life measurements (2003).  
C-SHIP (Cognitive-Social 
Health Information Processing) 
(Meropol, et al., 2008) The C-SHIP model is a comprehensive framework of cognitive and 
affective components in health information processing. Patient’s values 
are mentioned under affective components. 
Svenson's Differentiation and 
Consolidation (DiffCon) 
Theory of Decision Making 
(Deb Feldman-Stewart, et al., 2006) The goal of decision making is to choose the best option pre-decision 
(differentiation) and reducing post-decision regret (consolidation). 
Values discovery is part of the differentiation phase and helps patients 
to determine which attributes are most important to them.  
Definitions of patient values 
There were no commonly-referenced sources in the definitions of patient values. Only 
one article had a definition of patient values specific to health: “Health  care  values  
might  be  more  narrowly  conceived  as  beliefs  pertinent  to health  care  choices  
such  as meanings  of  pain  and  suffering,  importance  of choice and control,  comfort 
with  risk taking,  and importance of interpersonal connection” (Karel, 2000). 
Four articles had a sentence stating the authors’ definition of values. Feldman-Stewart et 
al defined values as “qualities that the individual considers desirable or not, and in 
these situations they often relate to quantity or quality of life"(D. Feldman-Stewart, S. 
Brennenstuhl, M. D. Brundage, & T. Roques, 2006). Montori et al defined values and 
preferences together as “We use values and preferences as an overarching term that 
includes patients' perspectives, beliefs, expectations and goals for health and 
life.”(Montori, et al., 2008). Potter et al defined values as "expressions of moral views or 
statements reﬂecting beliefs about how life should be lived.”(Potter, et al., 2008). The 
last article provided the following definition: “The idea of values is that we have some 
sort of ultimate standards by which we evaluate states of affairs” (Baron, 1997). One 
other article stated that patient values were “his or her own conception of the good” 
(Brock, 1991). 
Two articles had definitions of values taken from the social sciences (Karel, 2000; 
Keyser, 1992). One article (Keyser, 1992) referenced a sociological definition of values 
(“Values are the lived sources of meaning for a person, and they actively constitute a 
person's history when put into words”)(Gibson, 1990) while the other article (Karel, 
2000) referred to psychological value theories (“Values  most  broadly conceived  may  
be  defined  as “(a)  concepts  or  beliefs,  (b)  about  desirable  end  states or  
behaviors,  (c)  that  transcend  specific  situations,  (d)  guide  selection  or  evaluation 
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of  behavior  and  events,  and  (e)  are  ordered  by  relative  importance”)(Rokeach, 
1973; S. H. Schwartz & Bilsky, 1987).  
In three articles, patient’s values were deliberately distinguished from preferences and 
attitudes. Values were considered to be underlying, moral ideals and thus more abstract 
than preferences (which are concrete choices between two or more available treatment 
options) (Epstein & Peters, 2009; Heddle, 2006; Potter, et al., 2008) and attitudes 
(which are context-dependent beliefs framed by the healthcare decision) (Potter, et al., 
2008). 
Besides the articles above, the rest of the articles did not state a specific definition of 
patient values but gave examples of values (e.g. importance of quality of life and length 
of life) (Meropol, et al., 2008) or identified the process or strategies for incorporating 
patient values (e.g. utility measurement exercises) (Stiggelbout & de Haes, 2001). By 
combining an analysis of the definitions with the concepts in the other articles, we 
categorised the concept of patient values into three main themes. 
Main themes in patient values 
Three themes of patient values were derived from analysis of the definitions, examples, 
and processes found in the articles. These are: 1) types of values (healthcare and 
decisional), 2) structure of values and 3) function of values.  
Types of patient values 
Patient values could be divided into two main categories: healthcare-related values and 
decision-making values. 
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Healthcare-related values 
The first category of patient values was related to patient values in the context of 
evaluating healthcare-related  risks and benefits (Black, 2005; Black & Emmet, 2006; 
Canfield & Dahm, 2010; Coppola, et al., 2001; Doukas, et al., 1992; Ikomi & Kunde, 
2002; Karel, 2000; Kennedy, 2003; Llewellyn-Thomas, et al., 1982; Makoul & 
Clayman, 2006; McAlister, et al., 2000; McCormack, 2003; Meropol, et al., 2008; 
Miller & Bolla, 1998; Montori, et al., 2008; Ruland & Bakken, 2001; Stiggelbout & de 
Haes, 2001; Sullivan, 2003; Tan, et al., 2010; Ubel & Loewenstein, 1997; Vranceanu, et 
al., 2009). For example when choosing cancer treatments, patients’ decisions are 
affected by their value preferences in terms of quality and/or length of life (Meropol, et 
al., 2008).  
Types of healthcare values 
Articles identified specific types of values or gave examples of patient values. Seven 
types of patient values were identified: personal, affective, cognitive, financial, 
religious, socio-cultural and ethical/moral values. Personal values describe an 
individual’s priorities and sense of meaning (Epstein & Peters, 2009; Deb Feldman-
Stewart, et al., 2006; Karel, 2000; Karel, et al., 2004; Keyser, 1992; McCormack, 2003; 
Michaels, et al., 2008; O'Connor, et al., 1998; van Kleffens & van Leeuwen, 2005). 
Affective values are how patients feel about the decision (e.g. feeling miserable or 
unmotivated to live if they had a terminal condition) (Guyatt, et al., 2002; Myers, 2005; 
Pellissier & Venta, 1996; Tulsky, et al., 1998) while cognitive values are how patients 
appraise healthcare information such as risks and benefits (Myers, 2005). Financial 
values included not only patient treatment costs but also the financial implications of 
health outcomes on others, such as inheritance tax on heirs after death (Black, 2005; 
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DeSanto-Madeya, et al., 2009; Karel, et al., 2004; Kirk & Luck, 2010). Religious values 
are religious beliefs relating to religious issues such as death and the afterlife as well as 
religious rituals and practices (Bosek, 2008). Socio-cultural values are values that are 
determined by a patient’s demographic and socio-economic background such as 
ethnicity, family values, and social support availability (Karel, et al., 2004; Myers, 
2005; Pellissier & Venta, 1996). Ethical or moral values are patient’s conceptions of 
right and wrong, or what outcomes are considered good or ideal (Brock, 1991; Karel, 
2000; Potter, et al., 2008). Patients are more aware of their moral values when faced 
with a moral dilemma such as deciding on whether or not to have an abortion (Potter, et 
al., 2008). 
Decision-making values 
The second category of patient values are values related to patient preferences for 
participation in decision-making (Heddle, 2006; McAlister, et al., 2000). Another type 
of decision making values were patient’s values concerning surrogate decision making 
in allowing others to make decisions on their behalf (Karel, et al., 2004; White, et al., 
2010). These were most often discussed in the context of advanced directives when a 
patient’s decision making ability was diminished by loss of function or absent if the 
patient slipped into a coma.   
Structure of patient values 
Patient values were organized along two dimensions: relative priority and longitudinal 
stability. Firstly, patient values are ordered by relative importance whereby some values 
are prioritised over others (Karel, 2000). Two articles indicated that patients possessed a 
core set of values (Karel, 2000; Martin & Roberto, 2006). These core values are 
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context-independent ideals such as happiness or wisdom that are desired by a patient 
regardless of whether or not they are facing a healthcare decision.  
Values were prioritised or ranked in relation to each other. For example, religious or 
spiritual values were seen as being more important than other values in gerontological 
patients who were confronted with their own mortality and drew a continuing sense of 
purpose from their religious beliefs (Martin & Roberto, 2006). However it was 
acknowledged that decision making is incredibly complex and experiments to elicit 
rank-ordered values have found that patients themselves find it difficult to rank which 
values are most important (Karel, 2000).  
Secondly, although values are relatively stable over time (Martin & Roberto, 2006), it 
was possible that a patient’s values could change over time. Possible reasons for this 
change include a worsening health (Coverdale, et al., 2006), or improved knowledge of 
their disease (Epstein & Peters, 2009). 
Description of how values function 
Some papers described the function of values in the decision making process. Firstly, 
values are motivational in the sense that they direct patients towards making a decision 
because values determine which goals or end states are most important or desirable to a 
person (Canfield & Dahm, 2010; Coverdale, et al., 2006; Karel, 2000; Montori, et al., 
2008). For example a patient considering a urological procedure would weigh the 
relative importance of urinary, sexual and bowel function on their overall well-being 
and this would motivate their decision (Canfield & Dahm, 2010). Secondly, patient’s 
values act as an informational filter and determine how information is processed for 
decision making (Charles, et al., 1999).  
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A model of patient’s values 
We developed an integrated model of patient’s values based on themes identified from 
the systematic review (Figure 2). Patient values from two categories (healthcare-related 
and decision-making related) are arranged in a hierarchy of values, whereby some 
values are considered to be more important than others. Although values are ranked 
according to relative priority, this hierarchy of values may change over time. Changes to 
value priorities are due to influencing factors such as changing health states or patient 
knowledge. 
We would like to propose a definition of patient values in medical decision making as  
“healthcare priorities that may change over time depending on patient health state and 
knowledge, and the patient’s decision making role preferences”. 
 
Figure 3.2.2: A model of patient values in medical decision making 
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Discussion 
This review summarises the main themes for the patient values concept from the 
literature. All authors recognised that it was important to incorporate patient values and 
values were an integral part of conceptual or theoretical frameworks (Table 3.2.4).  
However, few authors actually clarified what they meant by the term.  
This plurality of definition stems from two possible reasons. The first is epistemological 
as the term ‘patient values’ itself is intrinsically broad in definition and open to various 
interpretations. Therefore, authors found it useful to use the term values as label for a 
variety of constructs. For example, the term was used to refer to health utilities (a 
measurable outcome) as well as moral conceptions of what is good (a philosophical 
concept). This polysemy is not confined to medicine; in the social sciences, the values 
construct is oft-debated and various measures for human values have been developed 
(Rohan, 2000). Given the usefulness of the term in health disciplines, models and 
decisions, it would be overly restrictive to suggest that a particular definition should be 
considered right while another wrong. Rather, authors should clarify their concept of 
patient values when using the term and not assume that their readers share their concept 
of values. 
 The second possible reason for multiple meanings stems from the growth of the patient-
centred paradigm (Bensing, 2000). From the results, the use of the term ‘patient values’ 
is most often used within evidence-based medicine and shared-decision making models 
(Table 3.2.4). Both of these models are supportive of patient-centred care and the term 
patient values is used to express the idea that patients should also participate in 
consultations. As these models are discussed and refined by the research community, 
the concept of patient values remains dynamic (thus leading to broad definitions) as 
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researchers discuss how best to involve patients in medical decision making. 
Researchers should keep in mind that in order to remain true to patient-centred 
philosophy, definitions of values should not come from researchers only but also from 
patients themselves. For example, one study defined patient values based on qualitative 
interview data from patients with type 2 diabetes who were making a decision about 
insulin therapy and the values that affected their choice (Lee, Low, & Ng, 2013).  
The results summarise the various categories of values and highlight that these 
categories are structured according to two dimensions: relative priority and longitudinal 
stability (Figure 3.2.2). The concept of relative priority is supported by research on 
similar concepts such as life goals (Schwartz, Hazen, Leifer, & Heckerling, 2008). 
Studies have found that patients are more willing to trade life years or health to achieve 
family goals compared to other types of goals such as wealth, job, education, 
health/fitness, travel, and personal fulfilment (Schwartz, et al., 2008). Indeed, most 
research on patient values has focused on the use of value clarification methods (e.g. 
considering pros and cons of each treatment option, utility assessment, prioritization and 
rating scales) in order to make explicit patients preferred options (Fagerlin et al., 2012). 
However, some researchers consider these methods to be preference elicitations (asking 
a patient to identify which option is preferred) and argue that value clarification 
(helping a patient understanding why an option is preferred) is also needed in 
consultations (Llewellyn-Thomas & Crump, 2013). Broader categories of values such as 
life goals should also be discussed with patients in consultations.  
The second dimension of longitudinal stability should be considered in light of current 
perspectives on the stability of values over time. Traditional values theory views values 
as being stable and relatively static over time (Rokeach, 1973). On the other hand, 
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research on constructed preferences believes that preferences are constructed only when 
a decision is posed and cannot be elicited outside of a specific decisional context (Payne 
& Bettman, 1999). We suggest that it is necessary to revisit a patient’s values as both 
values and preferences may change over time in response to disease progression or 
paradigm shifts.  
There are a few limitations to this study. The list of value categories is not an exhaustive 
list of all types of values. As this review only included English-language articles, 
studies on values published in other languages have been excluded. These studies may 
be important to inform culture-specific categories of patient’s values.  
Future research can focus on identifying trigger events which may influence value 
priority and longitudinal research on why and how value priorities change (Makoul & 
Clayman, 2006). While it is recognised that values are relatively stable (Martin & 
Roberto, 2006), values may change due to deteriorating health states (Coverdale, et al., 
2006) and interactions with significant others such as family or doctors (Karel, 2000). 
By knowing when priorities are likely to change, healthcare professionals will revisit a 
decision in a timely manner. This is especially relevant in the context of chronic 
conditions and primary care where, often, decisions need to be made over a more 
prolonged period. 
In conclusion, clear definitions of patient values are important for research as well as 
practice. Clarifying patient values in consultations is especially crucial as disagreement 
between patients/families and a healthcare provider over treatment decisions is 
considered to be the highest ranked ethical challenge facing the public in health care 
(Breslin, MacRae, Bell, & Singer, 2005). Figure 2 summarises the various categories 
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and dimensions of values; it serves as an educational tool and quick reference guide in 
training healthcare professionals to understand and examine the patient perspective.  
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Chapter 3.3 The values construct in social science  
The review of patient values (Chapter 3.2) showed there is no agreed definition of what 
values are in medical decision making. In medicine, the term “values” is broadly used to 
describe a variety of constructs. Value-specific research, which defines and measures 
values in a valid and reliable manner, is well-established in the social sciences 
(Braithwaite & Scott, 1991; Rohan, 2000). In social science, value theories are focused 
explicitly on the subject of human values, as compared to medical decision making in 
which values are only a component of the overall theory. Value-specific theories try to 
define values, differentiate values from beliefs and attitudes, and measure which values 
are most preferred in society. 
The two most prominent value theorists in social psychology are Milton Rokeach and 
Shalom Schwartz. The two theories share similarities as the latter’s theory builds on the 
former. In the following section, the basic tenets of their theories are described and the 
relation of these value constructs to the idea of patient values are discussed. The section 
ends with a review of healthcare literature on studies that have used the two value 
theories in order to provide an idea of how these theories might be applied to 
researching healthcare decision making values. 
3.3.1 Definitions of values 
Both Rokeach and Schwartz defined values as personally and socially preferable goals. 
Rokeach formally defined values as “an enduring belief that a specific mode of conduct 
or end-state of existence is personally or socially preferable to an opposite of converse 
mode of conduct or end-state of existence” (pg 30, Rokeach, 1973). Schwartz 
emphasized the motivational aspect of values and identified values according to 
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motivational needs arising from biological, social and survival or welfare concerns 
(Schwartz, 1992). 
Rokeach also discussed the differences between values, beliefs and attitudes. For 
Rokeach, values are closely related to the concepts of beliefs and attitudes. A belief is 
defined as “any simple proposition, conscious or unconscious, inferenced from what a 
person says or does, capable of being preceded by the phrase “I believe that...” 
(Rokeach, 1968). Thus a person may possess hundreds or even thousands of beliefs. 
Values are a kind of belief which are more personally and socially prominent than 
others. He defined attitudes as a cluster of beliefs around a single subject- “a relatively 
enduring organization of beliefs around an object or situation predisposing one to 
respond in some preferential manner” (pg 112, Rokeach, 1968). Attitudes are what 
predispose a human to acting preferentially in relation to an object or situation.  
Values possess the following five criteria (Schwartz & Bilsky, 1987): 
1) Values are beliefs. They are beliefs tied inextricably to emotion, not objective, 
cold ideas. 
2) Values are a motivational construct. They refer to the desirable goals people 
strive to attain. 
3) Values transcend specific actions and situations. They are abstract goals. The 
abstract nature of values distinguishes them from concepts like norms and 
attitudes, which usually refer to specific actions, objects, or situations. 
4) Values guide the selection or evaluation of actions, policies, people, and 
events. That is, values serve as standards or criteria. 
5) Values are ordered by importance relative to one another. 
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3.3.2 Structure of values 
Rokeach believed in a central-peripheral system of beliefs. A person’s beliefs are 
ordered according to how connected beliefs are to one another. Core or central beliefs 
were more connected to other beliefs compared to more peripheral beliefs. Within this 
structure of beliefs, values could be considered to be more core beliefs as they were 
enduring and universal, and therefore more connected to a variety of beliefs.  
Rokeach divided values into two types; goals (terminal values) and modes of conduct 
(instrumental values). Examples of goals included such things as a "comfortable life (a 
prosperous life)" and "self-respect (self-esteem)," while mode of conduct values 
included being "broad-minded (open-minded)," "forgiving (willing to pardon others)," 
and "helpful (working for the welfare of others)". In order to measure which values 
were most important to people, Rokeach developed the Rokeach Values Survey (RVS) 
(Rokeach, 1973). Respondents were instructed to rank order 18 terminal and 18 
instrumental values in the order which was most important to them personally.  The list 
of values was drawn from a variety of sources based on intuition about what constituted 
a reasonably comprehensive sample of possible human values. 
Rokeach’s theory was criticized for lacking a formal structure i.e. the list of 36 values 
was an unrelated list of words and no indication is given on how prioritizing one value 
affects another (Rohan, 2000). In contrast to Rokeach’s list of 36 values, Schwartz’s 
theory only had 10 basic universal values (Table 3.3.1). For Schwartz, a structure of 
values was developed based on the hypothesis that these 10 values could be arranged 
according to how congruent or conflicting their motivations were to each other. In order 
to develop this model, Schwartz collected data from 20 countries on importance ratings 
of different values. Data was then analysed using the intercorrelation matrix of Pearson 
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correlations between the importance ratings of the values with the Guttman-Lingoes 
Smallest Space Analysis (Schwartz, 1992).  
Table 3.3.1: Ten universal values in Schwartz’s theory of values 
Universal value Description 
1. Self-Direction Independent thought and action; choosing, creating, exploring. 
2. Stimulation  Excitement, novelty, and challenge in life. 
3. Hedonism  Pleasure and sensuous gratification for oneself. 
4. Achievement Personal success through demonstrating competence 
according to social standards. 
5. Power  Social status and prestige, control or dominance over people 
and resources. 
6. Security  Safety, harmony, and stability of society, of relationships, and 
of self. 
7. Conformity Restraint of actions, inclinations, and impulses likely to upset 
or harm others and violate social expectations or norms. 
8. Tradition Respect, commitment, and acceptance of the customs and 
ideas that traditional culture or religion provide the self. 
9. Benevolence Preserving and enhancing the welfare of those with whom one 
is in frequent personal contact (the ‘in-group’). 
10. Universalism Understanding, appreciation, tolerance, and protection for the 
welfare of all people and for nature. 
Source: Schwartz, 2006 
According to Schwartz, values were divided along two main dimensions: openness to 
change- conservation (following their own intellectual and emotional interests in 
unpredictable and uncertain directions vs. preserving the status quo and the certainty it 
provides) and self-enhancement-self-transcendence (looking after the consequences of 
own and others' actions for the self vs the social context) (Schwartz, 1992 p. 43). A 
circular structure of a values system was constructed, based on how the different values 
were more congruent (closer together in the circle) or more in conflict with each other 
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(Schwartz, 1992, 2006) (Figure 3.3.1). For example, the value of security (social order) 
is opposite the value of stimulation (exciting life).  
 
Figure 3.3.1 Theoretical model of relations among ten motivational types of values  
Source: Schwartz, 2006 
One criticism of both lists of values is that the lists can be seen to be incomplete 
(Braithwaite & Scott, 1991). Indeed, it is hard to imagine that given the diversity of 
cultures and complexity of individual differences that an exhaustive list of values is 
possible. Pragmatically, some studies modify the lists to include values that are relevant 
to the research context, such as including health as a terminal value (Kristiansen, 1985).  
3.3.3 Application of value theories to the patient values concept 
The value theories described above can be applied to the concept of patient values in 
three ways. Firstly, they help to formally define what values are. Values are core beliefs 
which are personally or socially preferable, are enduring, and limited in number. The 
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latter is to say that a patient would not have a large number of values influencing their 
choice, but only a small number which are personally important.  
Secondly, the theories explain how patient values are related to attitudes. Attitudes are 
beliefs about a certain topic. For example, misconceptions (wrong beliefs) about insulin 
can lead to a negative attitude about insulin. However, it would be wrong to call this 
attitude a value as values are more enduring; once the misconceptions are addressed, the 
attitudes may change, but the values are the same. Research on patient values should go 
beyond measurements of attitude and beliefs, which are condition-specific.  
Thirdly, the value theories help to inform how values influence patient choice. Based on 
the five criteria of values listed by Schwartz and Bilsky (Chapter 3.3.1), values would 
influence patients’ choices in five ways: 1) values would influence patients’ emotional 
beliefs about their health options, 2) values would motivate patients to want to achieve a 
desired health state, 3)values would be more abstract than just norms or attitudes about 
specific health options, but instead would be beliefs that are applied to all areas of life, 
4) values would serve as an evaluative lens through which information about medical 
options are interpreted, and 5) value hierarchies would be different in each individual 
patient and what one patient wants may be entirely different from another patient facing 
the same medical condition.   
3.3.4 Healthcare studies which have used the value theories of Rokeach and 
Schwartz 
Antecedents are available for the use of both value theories in healthcare research. A 
literature search for health-related studies that have used either Rokeach’s or Schwartz’s 
value instrument was conducted in Pubmed in December 2011 using the search terms 
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("values" AND ("rokeach's theory"[All Fields] OR "rokeach's value theory"[All Fields]) 
for Rokeach’s theory of values and (“Shalom SH” [author]) for Schwartz’s theory of 
values. The search was further expanded using the ‘Related Citations’ function in 
Pubmed. Overall, the search revealed that most research focused on the measuring of 
concrete value differences between countries, cultures and gender. Application of the 
theories of values to the healthcare context was limited to a few studies, which are 
reported below.  Two types of studies have been conducted on values and health. The 
first category comprises studies that investigate the effect of adverse health events on 
personal values, while the second category of studies investigated how interventions to 
change personal values promote health behaviour. The studies are reported using these 
two categories. In addition to these two categories, some studies investigated if ‘health’ 
in itself was a type of value.  
3.3.4 (a) The effect of adverse health events on patient’s values 
Patient’s values were changed due to major adverse health events. Some studies 
investigated self-reported within-subject changes in patient’s values. In a study using 
the Rokeach Value Survey as the study instrument, 50 cancer patients were asked to 
evaluate their current values and retrospective values before being diagnosed with 
cancer (Greszta & Sieminska, 2011). Out of 36 values measured, 16 values were 
significantly more important, 11 were decreased in importance and nine were 
unchanged. For patients with cancer, value clusters which had to do with ‘setting things 
right’ became more important: religious morality, personal orientation (e.g. friendships), 
self-constriction (e.g. being obedient and honest), family security and delayed 
gratification (e.g.wisdom and harmony). Values that had to do with self-ambition and 
achievements became less significant in light of cancer diagnosis: immediate 
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gratification, self-expansion and competence (e.g. a sense of accomplishment). Patient’s 
values were changed because the diagnosis of cancer was a significantly emotional 
event and the author’s suggested that the mechanism of change was to shift priorities 
towards those values which could still be achieved despite being ill (such as spiritual or 
moral values) and to move away from values whose goals were compromised by the 
limitations of illness (e.g. self-ambition).  
However, another study on 67 patients undergoing coronary artery bypass graft surgery 
using the Rokeach Values Survey found that measurements of values taken one day 
before surgery and 6 months after surgery did not show any significant change between 
the top three (honest, loving, responsible) and bottom three values (logical, obedient, 
imaginative) of patients (Flanagan, 1998).  
One other study used the Portrait Values Questionnaire based on Schwartz’s Theory of 
Values to measure the values of 64 palliative care patients with advanced cancer or 
amyotrophic lateral sclerosis (Fegg, Wasner, Neudert, & Borasio, 2005). The most 
important personal values were benevolence, self-direction, and universalism, whereas 
power, achievement, and stimulation were the least important. Compared to data from 
healthy adults, palliative care patients scored higher in benevolence and lower in self-
enhancement values. It was reported that self-transcendence values were higher than 
self-enhancement values in all patients and this was attributed to the coping process 
involved.  
It can be summarised that adverse health events would change patient’s values, whereby 
patients would re-prioritise their values in light of the illness being faced. Patients 
would shift towards values which were aimed at ‘setting things right’ (Greszta & 
Sieminska, 2011) and self-transcendence (Fegg, et al., 2005) as patients would want to 
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set their relationships in order rather than to focus their actions on themselves, more so 
in palliative patients.  
3.3.4 (b) Interventions aimed at patient’s values 
Some studies were on healthcare interventions aimed at using values to promote health 
behaviour. A technique called value self-confrontation (VSC) was developed by 
Rokeach (1973) in which target participants’ values were measured using the Rokeach 
Value Survey and they were asked to compare their value priorities against value 
priorities from positive and negative reference groups. Behaviour change is effected 
when: 1) a person becomes aware of their previously unnoticed value priorities, 2) they 
notice the discrepancy between their values and perceived morally or socially 
competent groups (the positive set) and similarities with the negative set, and lastly 3) 
the person consciously adjusts their value priorities to resemble the positive set, which 
leads to behaviour change. VSC was found to be successful for encouraging more 
weight loss over 2 months in overweight adults in a study comparing VSC (n=30), 
group discussion (n=24) and a non-treatment control group (n=30) (Schwartz & Inbar-
Saban, 1988). Only personally important values are used for VSC as values that were 
not important would have little impact on behaviour. In this study, only two values were 
chosen, which were ‘wisdom’ and ‘happiness’. These were obtained from a preliminary 
study on obese patients who were successful or unsuccessful at losing weight.  
3.3.5 Conclusion  
Rokeach and Schwartz describe universal, context-independent values in their research. 
In SDM values are elicited in reference to the healthcare options (for example, by 
asking the patient to weigh the risks and benefits of differing options). Thus, the use of 
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the term ‘values’ in SDM is more similar to the Rokeach’s ‘attitudes’ which are beliefs 
surrounding a specific object and/or situation. In the case of SDM, the object would be 
the healthcare decision being made and the context would be a doctor-patient healthcare 
setting.  
One implication of this is that the current scope of values clarification in SDM may be 
too narrow and not really address core patient values. According to Rokeach, attitudes 
are less enduring than values, because attitudes change with the reference objects. By 
eliciting attitudes or beliefs instead of values in a values clarification exercise, HCPs 
may not really address core concerns of the patient. Research on patient values needs to 
explore in depth the range of values which influence patient decision making so that 
important values are not excluded from the consultation. The methodology for 
establishing this range of values is detailed in the next chapter.  
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Chapter 4: Methodology 
The previous chapter reviewed the literature and identified the research gaps in the three 
research objectives from Chapter 1.5.2. This chapter describes the study design, 
conceptual framework and methods used to investigate these research objectives. 
Although the methods are also described as part of the research articles in Chapter 5 
(Results), this chapter provides the reader with a more coherent view of the overall 
study design and the differences and similarities between the HCP and patient methods. 
It was important to capture patients and HCP perspectives (rather than patients alone) as 
the HCP perspectives informed the healthcare context in which patient values were 
investigated. 
4.1 Qualitative approach 
While quantitative research undergirds objective biomedical advances (for example, 
development of easier and cheaper insulin regimes), subjective factors such as patient 
adherence and decisional preferences are best explored qualitatively from patient 
perspectives (The PLoS Medicine Editors, 2007). The results of qualitative research are 
complementary to quantitative research as qualitative themes can inform HCPs on 
patient preferences, thus informing the patient values component of evidence-based 
practice (Pope & Mays, 1995; Sackett, Straus, Richardson, Rosenberg, & Haynes, 
2000). 
A qualitative approach was chosen for this study based on three reasons. Firstly, a 
qualitative approach was suited to the exploratory nature of the research. Apart from 
statistical data on the percentage of insulin users in Malaysia, there is little research 
available which explains why the use of insulin remains underutilized despite poor 
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control in patients with type 2 diabetes. Although there are existing instruments to 
measure prevalence of barriers to insulin initiation, Malaysia’s unique socio-cultural 
and dual healthcare-sector settings mean that there may be beliefs and barriers in the 
country which are not found elsewhere and therefore not included in these 
questionnaires.   
Secondly, qualitative methods enabled investigation of the process of how patient 
values influenced choice during insulin initiation. Whereas quantitative research can 
only measure the relationship between inputs and outputs, qualitative research enables 
exploration of the process of interaction between input and output (Silverman, 2006), 
which in this study are the inteprative role that values play. In this study, individual in-
depth interviews (IDIs) with patients were used to understand how different values 
affected the patient’s decision. IDIs allow the researcher to be interactive and sensitive 
to the language and concepts used by the interviewee, and to maintain a flexible agenda 
(Britten, 1995). The IDI aims to go beyond simplistic descriptions of the phenomena, to 
explore what participants say in more detail, and to uncover new areas or results that 
were unknown at the start of the study (Britten, 1995). The use of IDIs in this study is 
consistent with recommendations that qualitative interviews are particularly suitable for 
exploring six areas: behaviour or experience; opinion or belief; feelings; knowledge; 
sensory; and background or demographic (Patton, 1987; Britten, 1995). Patient values 
are related to all six areas.  
Thirdly, qualitative analysis enabled the development of a structured model of patient 
values from unstructured interview data. As shown in Chapter 3.2, there is no clear 
definition of patient values in medical decision making. Research on patient values 
lacks a theoretical framework, and uncertainty exists on how broad or specific a useful 
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definition of values should be (Karel, 2000). Combining a general theory of values with 
an SDM-specific framework in the topic guide enabled the study to explore both general 
and specific values during interviews with patients. Then, using thematic analysis, the 
researchers moved from specific nodes to a general model of patient values.   
In terms of specific qualitative methodology, an interpretive descriptive approach was 
employed in the study (Thorne, 2008). By the term interpretive, this approach is 
philosophically grounded in the hermeneutic and constructivist schools, whereby the 
researcher interprets what is said by the participants (St. George, 2010). On the other 
hand, the interpretation also occurs from the participant perspective as values are used 
to interpret the suggestion to start insulin and participants share what the decision means 
to them viewed through the lens of values. The interpretive stance in this study is also 
elaborated in Chapter 5.1 Methods.  
The term descriptive refers to the act of writing about the subject being investigated, 
which is an important part of the process of making sense of qualitative research. 
Holstein and Gubrium (2005) define description as “Description- This is the act of 
giving an account of that which we perceive”. Thorne (2008) sees the role of description 
as a way to understand the complex social contexts in which research is conducted in 
order to be able to apply the results of the research into similar situations.    
Pragmatically, interpretive description is motivated by a desire to see that qualitative 
results are valuable for clinical practice. Interpretive description goes beyond merely 
exploring ‘how’ or ‘why’ questions to a ‘so what’ approach whereby the researcher is 
interested in applying this research to actual clinical situations. Indeed, in this study the 
goal developing a patient values model based on actual clinical decisions is intended to 
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help HCPs understand what types of values influence patient decision-making 
behaviour.      
The version of grounded theory described by Strauss (‘Straussian’) was employed in the 
study. In general, the choice of grounded theory was to achieve the research objective of 
generating a model of patient values based on patient perspectives whereby grounded 
theory has as its goal the inductive development of theory or concepts that emerge from 
the data (Strauss & Corbin, 1990). The use of Strauss and Corbin’s method of coding 
for patient data and how the model was developed is described in Chapter 4.8.2 as well 
as Chapter 5.5.  
In this study pre-research literature review was conducted based on two reasons. The 
first reason was to establish the use of a qualitative approach as the most appropriate 
methodology for exploring patient values (Cutcliffe, 2000). The systematic review of 
patient values (Chapter 3.2) showed that in a thorough review of the literature, no model 
of patient values existed in SDM, nor was there consensus on what patient values are. 
Little is known about the topic of patient values; a grounded theory approach with its 
emphasis on starting with a broad approach to the phenomenon before inductive theory 
development is useful in an under-researched field as the researcher remains open to the 
various possible directions in which the theory can develop. Indeed, in this study, the 
literature search for definitions of values were not limited to the medical field but 
definitions of values from social science were also included.  
The second reason was to identify a theoretical construct to serve as the conceptual 
framework from which to explore patient values during interviews. Cutcliffe (2000) has 
pointed out that prior reading may be needed in order for the researcher to clarify 
concepts and build an emergent theory on these. Given that the term values is 
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intrinsically broad in definition, there was a need to identify at least the key attributes of 
what values are. Heath (2004) has pointed out that using existing concepts to frame the 
area of inquiry contradicts the grounded theory approach of the theory emerging from 
the data if a theory is simultaneously emergent (from the data) and built on concepts 
selected from literature.  Other researchers however have attempted to develop 
grounded theory after conducting concept analysis on the literature (Jezewski, 1995). In 
this study, the use of Schwartz’s theory of human values (Schwartz, 2006) as the 
theoretical construct was justified for two reasons. Firstly, the value attributes described 
in the theory were broad enough to encompass the range of patient values. Secondly, 
Schwartz’s theory served only as a guide to developing a comprehensive topic guide for 
interviews and was not used to code or organize the data. It was not used simultaneously 
with the interview data for coding (for example, by using the attributes as a preset 
coding framework) and the model of patient values was developed from the Straussian 
coding framework of open, axial and selective coding.  
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4.2 Study design 
The following section reports the study design in more detail, consisting of the 
conceptual framework, sampling and recruitment, data collection, and lastly data 
analysis. If needed, the details are divided into HCP and patient sections to describe the 
respective methods used.  
4.3 Conceptual framework: The Ottawa Decision Support Framework, Schwartz’s 
Theory of Values  
This study was based on the SDM model, which aims to help clinicians and patients 
practice EBM by making a decision together based on the integration of clinician’s 
knowledge and patient values (Makoul and Clayman, 2006; Barratt, 2008). Drawing on 
the Ottawa Decision Support Framework (ODSF), which is a framework to support 
SDM in practice, a HCP interview topic guide was developed (O'Connor, Tugwell et 
al., 1998; O'Connor, Drake et al., 1999; O'Connor, 2006). The ODSF identifies the 
range of decisional needs that need to be addressed during a healthcare decision (refer to 
Figure 4.1). These needs are decisional uncertainty, knowledge and expectations, 
values, support and resources, decision attributes (type, timing, stage of leaning) and 
personal/ clinical characteristics. Thus, the framework includes both treatment-specific 
needs (e.g. knowledge and expectations) to more system-level needs such as support 
and resources. This framework was selected as it provides a comprehensive overview of 
the range of factors which influence a preference-sensitive decision.  
For the patient interview topic guides, the five criteria of values found in Schwartz’s 
theory of human values were used to explore the concept of values with patients 
(Schwartz, 2006). These key attributes are (1) values are concepts or beliefs, (2) values 
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pertain to desirable end states or behaviours, (3) values transcend specific situations, (4) 
values guide selection or evaluation of behaviour and events, and (5) values are ordered 
by relative importance (Schwartz and Bilsky, 1987). Schwartz’s theory of values relates 
to more general human values and was chosen in order to explore patient values in as 
much depth and breadth as possible, rather than limiting the scope of values to a narrow 
range of health-related values.  
 
 
Figure 4.1 The Ottawa Decision Support Framework  
Source: O'Connor, Tugwell et al. 1998 
4.4 Study setting 
The study setting is diverse in terms of healthcare setting (public and private). Diversity 
in the setting was based on the principle of maximum variation sampling. Patton (1990) 
explains that the strategy of maximum variation sampling is to capture and describe the 
central themes or principal outcomes that cut across a great deal of participant or 
program variation. The logic of maximum variation sampling is that any common 
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themes or patterns which emerge from a heterogeneous sample can be considered core 
experiences or beliefs shared across groups (Patton, 1990). The procedure for 
maximizing a sample is by identifying diverse characteristics or criteria for constructing 
the sample. In the case of this study setting, the healthcare setting was one of the sample 
characteristics used. Other criteria for both HCP and patients are described under 
purposeful sampling in Chapter 4.5.2.  
Healthcare professionals 
The study was conducted amongst HCPs who provided diabetes care in the three 
healthcare settings in Malaysia: the government health clinics; government university-
based primary care clinic and hospital; and private general practice (GP) clinics and 
hospitals. Key government policy makers who were involved in shaping the national 
diabetes strategic plans were also interviewed. A spectrum of practice experience was 
represented. The HCPs came from three different states (Wilayah Persekutuan Kuala 
Lumpur, Selangor and Negeri Sembilan) and from both urban and semi-rural locations.  
Investigating the views of HCPs was part of the dialogical approach in Straussian 
grounded theory, which acknowledges that theory construction is a dialogical process 
between the various stakeholders. This constructivist approach is a shift away from the 
more positivist philosophy of the original Glaser and Strauss model; Strauss and Corbin 
developed an approach to grounded theory that was post-positivist, constructivist and 
relativist (Cooney, 2010). Anells (1997) noted that Strauss and Corbin acknowledged 
that researcher and researched create the theory together, therefore, macro-social factors 
influence action and that reality cannot be fully known but are linked to time and place. 
In this study, the influence of macro-social factors was informed by an understanding of 
the HCP and system factors in which patients made their decision to initiate insulin. For 
158 
 
example, patients in public and private settings would have different experiences in 
terms of cost, consultation time and clinic setting. Such factors would in turn influence 
the decision making process. 
Patients 
Patient settings were similar to the HCPs.  Patients were recruited from the three 
healthcare settings in Malaysia, came from the three states stated above and lastly, were 
from both urban and semi-rural locations. For a more detailed description on diabetes, 
insulin, and the healthcare system in Malaysia, refer to Chapter 1.6.3.  
4.5 Sampling and recruitment 
4.5.1 Inclusion Criteria  
Healthcare professionals 
The inclusion criteria were HCPs who were involved in insulin initiation in both 
primary and secondary care, as well as policy makers who were involved in insulin-
related policies in Malaysia.  The range of participants included endocrinologists, 
family medicine specialists, government policy makers, general practitioners, 
government medical officers and diabetes nurse educators.  
Patients 
The inclusion criteria were patients with type 2 diabetes who were making or had made 
a decision about insulin initiation within the past one year. The initial criterion only 
included patients who were currently making a decision about insulin i.e. had recently 
been asked to start insulin by their doctor, and were deciding on accepting or rejecting 
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the doctor’s advice. However, this inclusion criterion was later expanded to include 
those who had made a decision about insulin within the past one year.  
There were two reasons for this; firstly, wide variation was found in the time frame for 
insulin decision making. This was because as part of a chronic treatment regime, insulin 
is not often confined to an acute, time-critical decision frame. Patients are known to 
delay insulin initiation despite poor HbA1c control (Calvert, McManus et al., 2007) and 
many patients initiate and then discontinue insulin due to concerns with injections, 
medication interaction, side-effects and doctor’s advice to discontinue insulin (Oliveria, 
Menditto et al., 2007). Secondly, patients with gestational diabetes or emergency insulin 
requirements had little time to make a decision about insulin as their conditions were 
acute. Such patients could only be interviewed retrospectively after they had initiated 
and used insulin.  
One limitation of including patients who had already started insulin is that patients who 
initially held negative beliefs about insulin may have rationalised the decision and 
justified their choice to start insulin as a correct one. As such, there is a possibility that 
patients interviewed post-initiation may have ‘changed’ their values.  Another limitation 
is that patient memory of their decision making process at the time of initiation may be 
diminished after time. This may lead to a less than accurate recollection of their 
concerns and values as occurred during the initiation of insulin. However, as the 
methodological frame is a descriptive qualitative analysis, these limitations do not 
influence the study findings. Future methodological strategies to explore these issues 
includes the use of longitudinal case studies to investigate how decisions may be 
justified or changed over time and critical discourse analysis to explore if the patient 
justifies their views in the course of the interview.     
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4.5.2 Sampling and recruitment 
Healthcare professionals 
Purposive sampling was used whereby stakeholders who were involved in insulin 
initiation in both primary and secondary care were identified and HCPs from each 
stakeholder group were invited to participate in the study. HCPs were sent an invitation 
email or letter explaining that the purpose of the study was to interview HCPs about 
their experience with insulin initiation in order to develop a PDA. 
These stakeholders included both primary and secondary care HCPS: endocrinologists, 
family medicine specialists, government policy makers, general practitioners, 
government medical officers and diabetes nurse educators. As explained in the section 
above, maximum variation sampling involved the identification of diverse criteria for 
constructing the sample. Including a range of primary and secondary care HCPs covered 
the spectrum of HCPs who were involved in insulin initiation in Malaysia. Patton 
(1990) notes that data obtained from maximum variation sampling is useful because it 
will yield both high-quality descriptions of unique individual experiences as well as 
important shared patterns that cut across cases and are significant because they derive 
out of diversity. Indeed the HCP results reported in Chapter 5 are a combination of 
larger thematic categories illustrated by unique individual quotes.  
For government policy makers, key informants from both the clinical as well as 
policymaking arms in the Malaysian Ministry of Health were identified. Some HCPs 
also played a role in formulating insulin-related policies and guidelines and were 
interviewed on both practice and policy aspects.  
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Patients 
Purposive sampling was used in order to achieve maximal variation based on three 
factors: healthcare setting, patients’ decision about insulin, and ethnicity of patients. The 
rationale for choosing these three factors was to ensure that a range of views was 
captured from the main socio-cultural and decision making dimensions. Purposive 
sampling involved the deliberate choice of sample participants to achieve a 
representative sample of views from the broad socio-demographic spectrum in the 
population (Pope & Mays, 1995). In this study, patients were recruited from both public 
and private settings as well as from both rural and urban settings. HCPs were asked to 
identify and recruit patients who were both open to insulin as well as adverse to it. 
Patients who had prior experience with insulin use but had now stopped using it if they 
had initiated insulin within the past one year were also included. Constant 
communication with key clinicians to update them on the required sample was 
maintained. 
HCPs from the various healthcare settings were asked to help identify and recruit 
suitable patients. This was done by explaining the study to the clinicians and 
distributing brochures detailing the inclusion criteria for our study and our contact 
information. Clinicians recruited patients whom they knew had recently been advised to 
start insulin while nurses assisted by referring patients whom they knew had recently 
been counselled to start insulin. Interviews were conducted soon after insulin had been 
introduced in order to capture patients’ initial experience and values in regards to 
insulin initiation. 
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4.6 Research instrument 
4.6.1 Topic guide  
Healthcare professionals 
The HCP interview topic guide (Appendix B) was developed based on the conceptual 
framework (ODSF), literature review and expert opinion. The first draft of the topic 
guide was informed by the Patients ANd Decision Aids (PANDAs) study, which 
involved one of the study supervisors (Academic Unit of Primary Medical Care School 
of Medicine and Biomedical Sciences University of Sheffield).  
The ODSF identifies the various types of decisional needs that need to be addressed 
when a decision needs to be made. These needs are: decisional conflict; knowledge and 
expectations; values; support and resources; decision (type, timing, stage, leaning); and 
personal/clinical characteristics (O'Connor, Tugwell et al. ,1998). These needs in turn 
require decision support from the HCP or other resources. The topic guide explored 
these needs as relating to insulin initiation and the support provided by the HCP to 
patients.  
Literature review and expert opinion from the DMIT research team provided examples 
which were included as prompts for the questions. For instance, examples of barriers 
commonly encountered in insulin initiation were listed so that these could be explored 
with participants.  
The topic guide was iteratively modified based on modification and consolidation of the 
items, and participant background (for example, policy makers were asked additional 
questions about insulin-related health policies).  
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The final version of the HCP topic guide consisted of 16 questions divided into four 
parts (Appendix B). The first part was a general introduction about HCPs’ experiences 
in starting insulin (e.g. number of diabetic patients treated, decisions faced by patients 
with diabetes). Part two focused on patients’ decision making needs during insulin 
initiation (barriers, feelings, concerns, informational needs, influence of significant 
others). Part three consisted of questions related to how HCP’s supported the patients 
who were making decisions (discussing options; explaining risks and benefits; role of 
HCP in decision making; exploring patient values, ideas, concerns and expectations; 
coaching and motivation; help or resources needed to overcome barriers faced with 
patients). The last part consisted of HCP’s views on four different types of methods for 
decision support (one-to-one counselling, discussion groups, information materials, 
PDAs).  
For policy makers, an additional three questions about health policies related to insulin 
were added (policies related to insulin in Malaysia, roles of various categories of HCPs, 
barriers to shaping policies).  
The same guide was used for HCP focus group discussions (FGDs). A separate topic 
guide was not necessary as the FGDs aimed to cover the same topics. 
Patients 
The patient interview topic guide was developed based on the conceptual frameworks 
(ODSF and Schwartz’s Theory of Human Values), literature review, expert opinion and 
emerging themes from the HCP interviews. The outline of the patient topic guide was 
based on the HCP topic guide (introduction, insulin decision-making, decision support, 
views on methods of support). The patient topic guide was modified to explore the area 
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of patient values in more depth, as well as to incorporate emerging themes which 
emerged from patient interviews (Appendix C). Questions were modified to explore the 
attributes of values described in Schwartz’s Theory of Human Values. A description of 
how the various questions explored these value attributes is described in Chapter 5.5.  
The literature review and expert opinion (from the DMIT research team) was used to 
provide examples barriers to insulin initiation which served as prompts during the 
interviews. Some barriers emerged from the HCP interviews (for example, the use of 
complementary and alternative medication).  
The final patient topic guide consisted of 16 questions divided into six parts. The first 
part was a general introduction to the patient’s history of diabetes management. The 
second part was focused on the decision to initiate insulin (time when advised, HCP 
who advised, stage of readiness to start). The third part related to the patient decision 
making process (knowledge and beliefs about insulin; sources of knowledge and beliefs, 
barriers to starting insulin, informational needs,  how the patient chooses between 
options, what support is needed to help make the decision).  The fourth part explored 
the patient values (priorities) at this current point of decision making (types of life 
priorities influence of priorities on insulin initiation).  
The fifth part concerned patients decision making roles (significant others who were 
involved in the decision, preferred decisional role). The last part consisted of patient’s 
views on four different types of methods for decision support (one-to-one counselling, 
discussion groups, information materials). Both participant information sheet and topic 
guide were translated into Malay and Chinese by researchers or translators who were 
fluent in these languages.  
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4.7 Data collection 
4.7.1 Semi-structured in-depth interviews and focus group discussions 
Healthcare professionals 
Both IDIs and FGDs were conducted with HCPs. For the FGDs, participants were 
selected and grouped based on their practice background and location to ensure 
homogeneity and to capitalise on their shared experiences (Kitzinger, 1995). IDIs were 
used for key opinion leaders, such as government policy makers, and also for those who 
were unable to commit to a focus group session due to their busy schedule. The use of 
IDIs, FGDs and field notes provided the basis for the triangulation of the data. Although 
all interviews were conducted in English, some participants used Malay-language words 
and phrases during the interviews. 
Patients 
Semi-structured IDIs were conducted with patients in their preferred language (English, 
Malay or Chinese). Interviews lasted 30-45 minutes per interview. Researchers arranged 
to interview patients at a time and location of their convenience, including their homes 
or workplaces if patients were unable to travel due to work commitments or infirmities. 
Participants were reimbursed for their time and travel.  
4.7.2 Recording and Field Notes 
Digital voice recorders were used to record each interview or FGD session. Before and 
during each interview, the researcher took care to build rapport with the participants 
through the use of ice-breaker questions and giving verbal and non-verbal cues to 
indicate active listening during the interview.  
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After the interview, initial impressions and thoughts about the patients and HCPs were 
recorded in a research diary. Any insights that were gleaned from post-interview 
conversation were also included as field notes. These notes were later sifted and 
transferred as memos in Nvivo9 for easy access when coding and analysing the 
interview transcripts 
4.8 Data management, analysis and saturation 
4.8.1 Data management 
Data analysis was facilitated by the use of Nvivo9- a qualitative research software 
(Nvivo9, 2010) - to manage transcripts, themes and quotes, while keeping in mind the 
context of the quotes within the individual interviews. Interviews were transcribed 
verbatim and checked for accuracy. English and Malay interviews were transcribed 
verbatim while Chinese interviews were translated into English for analysis. Malay 
interviews were not translated as all researchers were familiar with the language. These 
transcripts were transferred into Nvivo9 for analysis and coding.  
4.8.2 Data analysis 
A thematic analysis was used for data analysis, based on Strauss and Corbin’s method 
of open, axial and selective coding (Strauss and Corbin, 1990). The choice of the 
Straussian instead of the Glaserian version of analysis was based on the more structured 
approach to coding employed by Strauss. Strauss prescribed clearer guidelines for data 
analysis (Strauss & Corbin, 1990) (for example, describing the steps of open, axial and 
selective codes) whereas Glaser believed that a more open, less structured approach was 
important for the theory to emerge without being prematurely forced to do so (Glaser, 
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1992). The Straussian approach was chosen as the more explicit and systematic guides 
on analysis were found to be helpful, rather than restrictive. 
The researchers coded two interviews line by line to develop an initial list of codes 
(open coding). A process of constant comparison was employed whereby subsequent 
interviews were coded using this list and new themes which emerged from new 
interviews were added to the list upon consultation with the research team (Glaser, 
1965).  
The open codes were organised and re-organised into broader categories based on 
thematic similarities between open codes (axial coding) as researchers collaborated on 
interpreting the data in monthly face-to-face discussion meetings. Throughout the 
coding process, codes were checked by researchers to ensure consistency of coding and 
consensus on axial and selective codes.  
Finally, selective coding was used to generate central or core categories from the axial 
codes. For the HCP data, the core categories that emerged described the main categories 
of factors influencing insulin initiation. These were patient, HCP and system factors. 
For the patient data, based on the goal of developing a model of patient values, selective 
coding was conducted to generate central or core categories based on connecting and 
consolidating axial codes which were related to patient values. Three core categories 
emerged, which were treatment-specific values; life priorities and philosophies; and 
socio-cultural and personal values. For example, ‘denial’, ‘feeling punished’ and ‘social 
stigma’ were open codes from interview transcripts. These were consolidated into the 
axial code ‘negative emotions about insulin’. This axial code was connected together 
with other axial codes (‘positive emotions about insulin’,  ‘positive factual beliefs about 
insulin’, ‘negative factual beliefs about insulin’) to form the central category of 
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‘treatment-specific values’ based on the common characteristic that all these axial 
categories described insulin-specific beliefs.   
4.8.3 Data Saturation 
Data collection was stopped when data saturation was reached. Evidence of data 
saturation was obtained when no new axial or selective codes emerged from the data, 
showing that the core categories had already been captured (Strauss and Corbin, 1990; 
Bowen, 2008). A secondary saturation criterion was based on the saturation of open 
codes, evidenced by repeated coding within the same codes. For example, in Appendix 
E (Section E.1.2), items such as “Severity of disease” (believing that insulin use meant 
diabetes was severe) and “Pain” (fear of pain from injections) were repeatedly coded in 
10 and 7 participants respectively. Bowen (2008) supports the use of axial codes as the 
primary criteria for saturation by explaining that the saturation of data should be based 
on the lack of emerging themes, signifying that core concepts for the theory have been 
captured.  
The coding frameworks are included as Appendix D (HCP) and Appendix E (patient). 
4.9 Rigour in research 
Rigour is required in both quantitative and qualitative studies. When describing rigour 
in quantitative research, validity (how accurately the study measures the target 
construct) and reliability (how repeatable are the study results) measures are examined. 
In qualitative research, rigour is defined as ‘The striving for excellence in research 
through the use of discipline, scrupulous adherence to detail and strict accuracy’ (Burns 
& Grove, 1997, p793). Three criteria are considered when describing the rigour of a 
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qualitative study: credibility, transferability and auditability (Lincoln & Guba, 1985; 
Twycross & Shields, 2005). These criteria are described in the context of this study.  
Credibility is the degree of confidence a researcher inspires in the reader (Lincoln & 
Guba, 1985) and can be achieved through the use of prolonged data collection, 
verification or member-checking, and theoretical verification (Twycross & Shields, 
2005). In this study, the data was collected over a prolonged period; eight months for 
HCPs (October 2010- May 2011) and over one year for patients (Jan 2011- Feb 2012). 
Member checking was not performed as it was logistically difficult to reconvene 
participants from various states. Theoretical verification (comparison with previous 
studies) is discussed in Chapter 6.2 where similarities between the patient values model 
and the biospychosocial model are noted.  
 Transferability in qualitative research is how much similarity readers can see in the 
results which may relate to other settings (Twycross & Shields, 2005). From the 
researcher perspective, transferability is related to the concept of generalizability, in that 
generalizability is how probable the findings from a smaller, more focused condition or 
setting can be said to be similar to findings in larger or different settings. Transferability 
of the study results are discussed in Chapter 6.4. In brief, the patient values model is 
probably transferable to other healthcare conditions as it was developed from Straussian 
analysis and it contains general categories of values which can be applied to other 
medical decisions besides insulin initiation. Furthermore, the participants were sampled 
from a variety of backgrounds and practice settings, thus aiding the generalizability of 
the results to other settings. Also, the researcher needs to provide a lot of detail about 
the setting and the events which take place. In this thesis, the reader is provided with 
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details on the Malaysian healthcare setting (Chapter 1), and the actual participant quotes 
used to develop the codes (Chapter 5).  
For auditability, the researcher needs to ‘provide a sufficiently clear and full account of 
the research process so that the reader can judge the dependability of the qualitative 
study’ (Twycross & Shields, 2005). Qualitative research is often exploratory and 
involves various degrees of subjective interpretation. The interpretive process needs to 
be sufficiently detailed to let the reader judge if they can depend on the methods that the 
researcher has used to analyse the data and arrive at conclusions. In this study, 
dependability means that readers can judge if the descriptive interpretive method 
accurately captures the themes of the participant quotes. The research process involved 
in this study has been described at length in both Chapter 4 (Methods) as well as the 
methods sections for each of the research manuscripts.  
4.10 Research ethics 
This study received ethics approval from the Medical Research and Ethics Committee, 
Ministry of Health, Malaysia, Reference Number: NMRR 10-1233-7299, and the 
Medical Ethics Committee, University of Malaya Medical Centre (MEC-UMMC), 
Reference Number: 841.6 (Appendix F). Minor changes to the consent form for a 
cleaner layout and language translations were submitted as amendments to the MEC-
UMMC and were approved by the ethics committee.  
4.9.1 Participant information sheet, consent form and demographic data form 
Before conducting an IDI or FGD, researchers gave participants a copy of the 
Participant Information Sheet (PIS) (refer to Appendix G for the HCP PIS and 
Appendix H for the patient PIS). The patient PIS was available in English, Malay and 
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Chinese. This document explained the purpose of the study, the procedures involved, 
the benefits of the study, the possible drawbacks, the participant’s right to withdraw at 
any time, and a list of contact persons for the study. After the participants had read the 
PIS, they were given an opportunity to ask questions about the study.  
If participants agreed to participate, they were asked to give their consent using a 
consent form (Appendix I). All participants gave written consent to participate in the 
research and for their interviews to be audio-recorded. In cases where the participant 
was illiterate, the information sheet was read out to the patient and patients indicated 
their consent by initialling the consent form. However, most illiterate participants were 
accompanied by a literate family member who was able to read and explain the 
information sheet to them.  
Participants also completed a brief demographic data form (Appendix J for HCPs, 
Appendix K for patients). Participants were assured that personal data would be kept 
confidential and that their identities would be anonymised.  
4.11 Research funding 
Funding for the research was provided by the DMIT 3-year research grant under the 
Health and Translational Medicine Cluster, University Malaya Research Grant 
(Reference Number UMRG 236/10HTM).  
4.12 Reflexivity  
Researchers themselves are the instrument through which data is analysed and 
interpreted (Watt 2007). Purely objective interpretation is impossible in qualitative 
research, as each researcher differs in terms of their personality, background and values. 
Instead of striving for objectivity and removal of bias, qualitative research incorporates 
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the practice of reflexivity to make clear the personal framework through which data is 
interpreted (Watt, 2007). By making clear their personal background, the researcher 
enables readers to understand why the data is interpreted in a certain way, and more 
importantly, to evaluate if the interpretations are within an acceptable and logical 
framework, i.e. the researcher does not make the data say what it does not say. This 
process of personal reflection on how the researcher interacts with the data is known as 
reflexivity. 
There are three factors which influenced the way I approached the research process. 
These are: being a psychology graduate; prior work on heuristics decision making; and 
lastly learning how to use qualitative research for the first time. Because of my 
background as a psychology major, my interviews and analysis tended to focus more on 
personal traits and values. I did read to gain basic knowledge on diabetes drugs and 
health measures, but my interviews did not focus much on the medical, but more on the 
psychological. In contrast, I observed during interview sit-ins that medically-trained 
researchers would often explore the details of the treatment regimens when interviewing 
patients in much more detail.   
Secondly, my undergraduate dissertation on was on the topic of heuristics, which are 
cognitive time-saving short cuts employed for quick decision making. Studying 
heuristics made me realize that decision making was often non-rational and I was 
interested to explore the intuitive side of patient decision making where values were 
used as criteria to evaluate the decision to initiate insulin. The main theory related to 
intuitive decision making in medical decision making is Reyna’s Fuzzy Trace Theory, 
which suggests that patients make decisions based on a ‘gist’ interpretation of the 
information. Values are said to play a role in evaluating the gist representations of 
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information, together with principles and knowledge (Reyna, 2008). However, the 
theory was not useful as no definition of values was provided. Coming from a social 
science background, I expanded my search for value theories into the broader social 
science field, especially psychology.  
Thirdly, I had never worked with qualitative research methodologies before this study 
as qualitative research was not taught in undergraduate curricula. Thus, I endured a 
steep learning curve when I chose a qualitative research approach, beginning with a 
simple understanding of qualitative research which progressed into a more complex 
understanding of the approaches and philosophies underlying the qualitative approach. 
For example, I initially used a simple thematic analysis for analysing the HCP data (see 
Methods in Chapter 5.1), which was initially labelled as grounded theory. A reviewer 
pointed out that the method described was more accurately labelled as thematic 
analysis. Subsequently, especially for the patient data, a more systematic approach to 
data analysis and theory generation based on Straussian grounded theory was utilised.  
4.13 Language considerations 
Issues related to multilingual qualitative research were given consideration. These 
issues are separate from the need for accurate translation of the participant information 
sheet and topic guide, which were standard practice in this study. Baumgartner (2012) 
states that there are two language issues to be considered in multilingual qualitative 
research: 1) which language should be used as the inquiry language for each of the 
interviews? and, 2) which language should be used in the data analysis and at which 
stage of the research is this most appropriate to transition from the inquiry language to 
the target language of research?  
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For the first issue, it is important to conduct interviews in a language that was most 
comfortable for the participant to enable them to express themselves comfortably. It 
also allows for emotional and cultural language nuances to be captured in the interviews 
(Baumgartner, 2012). Most HCP interviews were conducted in English as most 
professionals in Malaysia are fluent English speakers. Only one HCP interview was 
conducted in Malay. For the patients, given that most Malaysians are multilingual, the 
researcher (YK) was able to conduct most of the interviews with patients in either 
English or Malay (n=19). Three interviews were conducted in Mandarin by two other 
researchers (CJ, PY) as YK is not fluent in the language. Very often interviews involved 
a mix of multiple languages or phrases as is common in everyday conversation.  
For the second issue, Baumgartner highlights that consideration must be given to the 
type of coding used whereby some researchers code the interviews in the source 
language in order to retain the original phrases used in coding. In this study, the coding 
framework was developed in English via a process of constant comparison. As the 
analysis was a descriptive thematic analysis, interviews in Malay were not translated as 
fluency with both languages meant that the researcher could easily understand the 
meaning of the participant and identify the appropriate English code. Mandarin 
interviews were translated into English by a trained translator and independently 
checked by a reviewer. The translation of Mandarin interviews was necessary as YK 
was not fluent in the language. Although emotional nuances and cultural phrases may 
have been lost, this does not adversely affect the descriptive thematic analysis of the 
translated transcript as the content and subject matter were clear in the translation.  
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4.14 Conclusion 
In summary, a qualitative study design was chosen to explore the topic of patient values 
in medical decision making. Using the Ottawa Decision Support Framework and 
Schwartz’s Theory of values as conceptual frameworks, topic guides were developed 
for use in IDIs and FGDs. The study was conducted amongst HCPs and patients from 
the various healthcare settings in which insulin is initiated in Malaysia. Purposive 
sampling was used to identify participants and recruitment was stopped when saturation 
was reached. The interviews were transcribed verbatim and managed using qualitative 
data analysis software. Thematic analysis was conducted based on Strauss’ technique of 
open, axial and selective coding. The results of the analysis are reported in Chapter 5.  
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Chapter 5: Results 
Chapter 5 reports the results of the study in the format of research publications. The 
study sought to answer three research objectives outlined in Chapter 1.5.2. These were 
(1) to identify factors influencing insulin initiation in Malaysia, (2) to explore patient 
values among type 2 diabetes patients in Malaysia who are making a decision about 
starting insulin, and (3) to develop a model of patient values in SDM. The results were 
reported as four original research articles and one research letter.  
The first three articles relate to the first research objective. These first three articles 
(Chapters 5.1, 5.2 & 5.3) were published from the HCP data and describe the context in 
which patient values are explored, which is insulin initiation. The articles illustrate how 
insulin initiation is a complex decision involving many factors. The first article entitled 
“A qualitative study on healthcare professionals’ perceived barriers to insulin initiation 
in a multi-ethnic population” (Chapter 5.1) reports on the range of patient, HCP and 
system barriers to insulin initiation from a HCP perspective. The second article is “How 
can insulin initiation delivery in a dual-sector health system be optimized? A qualitative 
study on healthcare professionals’ views” (Chapter 5.2) and reports on how a dual-
sector healthcare system poses problems for insulin initiation for HCPs and patients 
who lack access to resources. The third article is a research letter entitled “Tactics in 
counseling patients to start insulin” (Chapter 5.3) and describes the persuasive 
strategies that HCPs use to convince patients to start insulin.  
The fourth and fifth articles (Chapter 5.4 & 5.5) are related to the second research 
objective, which is to explore patient values in insulin initiation. These articles report 
the analysis of data collected from patients. The systematic review of patient values in 
medical decision making (Chapter 3.2) showed that patient values could be divided into 
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two main categories: decision making preferences and healthcare values. Patient 
decision making preferences are reported in the fourth article which is entitled “Factors 
influencing decision-making role preferences: A qualitative study of Malaysian patients 
with type 2 diabetes during insulin initiation” (Chapter 5.4). Patient healthcare values 
are reported in the fifth article “Exploring patient values in medical decision making: a 
qualitative study” (Chapter 5.5). Three categories of healthcare values are reported: 
insulin-specific values; life priorities and philosophies; and socio-cultural and personal 
background.  
The third research objective of developing a model of patient values is reported in 
Chapter 5.5. This conceptual model of patient values was developed from the three 
categories of values which emerged from the patient interviews. Explanation of the 
rationale underlying the arrangement of the categories in the patient values model is 
provided in the discussion section of Chapter 5.5. 
While each chapter in the Results is reported with its own objectives, findings and 
conclusions, each chapter contributed to the final objective of developing the model of 
patient values. This is because it was important to understand context when developing 
the patient values model. Especially for the first category or ‘layer’ of the values model, 
which are context-dependent beliefs and feelings, awareness of the context helps to 
inform why patients expressed certain beliefs or feelings about insulin. For example, 
one context is interactional, whereby values are influenced by the doctor-patient 
relationship. Understanding that doctors often practice paternalistic styles (Chapter 5.3) 
helps to inform why some patients feel punished or threatened when asked to start 
insulin (Chapter 5.5). Another context is resource availability, whereby an 
understanding of the cost factors involved in insulin initiation in the dual-sector health 
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system (Chapter 5.2), for example a lack of subsidies for self-monitoring of blood 
glucose helps to inform why patients express concern about the cost of insulin treatment 
(Chapter 5.5).  
Chapters 5.1, 5.2 and 5.3 were based on the same HCP data. The differences in number 
of participants between Chapters 5.1 and 5.2 (n=38); and Chapter 5.3 (n=41) are due to 
the former being written up earlier during the ongoing process of data collection. The 
extra three participants did not change the saturation of the data codes, but added to the 
richness of the participant data through new quotes.  
Chapters 5.4 and 5.5 were based on the same patient data. As above, the differences in 
number of participants (Chapter 5.4, n=22; and Chapter 5.5, n=21) are due to the 
differences in time of manuscript preparation.   
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Chapter 5.1: A qualitative study on healthcare professionals’ perceived 
barriers to insulin initiation in a multi-ethnic population 
Yew Kong Lee, Ping Yein Lee, Chirk Jenn Ng
 
Published as Lee, Lee, & Ng. (2012). BMC Family Practice 13, 28. 
Author contributions:  
YKL, PYL and CJN were involved in developing the interview topic guides used for 
data collection, facilitating the data collection interviews and focus groups, and 
analysing the data for reporting. All authors read and approved the final transcript. 
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Abstract  
Background 
Nationwide surveys have shown that the prevalence of diabetes rates in Malaysia have 
almost doubled in the past ten years; yet diabetes control remains poor and insulin 
therapy is underutilized. This study aimed to explore healthcare professionals’ views on 
barriers to starting insulin therapy in people with type 2 diabetes.  
Methods 
Healthcare professionals consisting of general practitioners (n=11), family medicine 
specialists (n=10), medical officers (n=8), government policy makers (n=4), diabetes 
educators (n=3) and endocrinologists (n=2) were interviewed. A semi-structured topic 
guide was used to guide the interviews by trained facilitators. The interviews were 
transcribed verbatim and analysed using a thematic analysis approach. 
Results 
Insulin initiation was found to be affected by patient, healthcare professional and system 
factors. Patients’ barriers include culture-specific barriers such as the religious purity of 
insulin, preferred use of complementary medication and perceived lethality of insulin 
therapy. Healthcare professionals’ barriers include negative attitudes towards insulin 
therapy and the ‘legacy effect’ of old insulin guidelines; whilst system barriers highlight 
the lack of resources, language and communication challenges. 
Conclusions 
Tackling the issue of insulin initiation should not only happen during clinical 
consultations. It requires health education to emphasise the progressive nature of 
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diabetes and the eventuality of insulin therapy at early stage of the illness. Healthcare 
professionals should be trained how to initiate insulin and communicate effectively with 
patients from various cultural and religious backgrounds.  
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Background  
The incidence of diabetes is increasing globally (IDF, 2009; Tunstall-Pedoe, 2006) 
particularly in the Asia Pacific region (Cheng, 2010). Currently, Malaysia has the 
highest prevalence rate of diabetes (11.6%) in the Western Pacific region (Letchuman et 
al., 2010) and it is the 10
th
 highest in the world (IDF, 2009). This alarming rise in the 
prevalence of diabetes has been attributed to increasing affluence, rapid urbanization, 
and a diet rich in carbohydrates (Letchuman, et al., 2010). In addition, Malaysia having 
an upper-middle-income economy, high treatment costs of diabetes and its associated 
complications have imposed a substantial healthcare burden to her already stretched 
health system (The World Bank, 2012). As such, in 2010, the Ministry of Health of 
Malaysia has included diabetes as a priority area in the National Strategic Planning for 
Non-Communicable Diseases (Ministry of Health, 2010b). 
Malaysia has a dual-sector healthcare system comprising government-subsidised public 
healthcare facilities and more expensive, private healthcare clinics and hospitals (Chee, 
2008). Patients are free to choose where they receive treatment, but patients prefer to 
seek treatment in government facilities as treatment costs are lower there compared to 
private clinics. Out-of-pocket expenditure was 40.5% of total healthcare expenditure in 
2009 (The World Bank, 2009). In primary care, the private sector comprises mostly solo 
general practice clinics (Ramli & Taher, 2008) whilst public primary care consists of 
government health clinics and university-based primary care clinics. There are about 
five times more private primary care clinics compared to the public sector in Malaysia 
(Clinical Research Centre, 2011). Primary care practice is expected to play a gatekeeper 
role for secondary care referrals (Clinical Research Centre, 2011).  
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The quality of diabetes care in private primary care clinics is doctor-dependent as 
clinics are mostly solo practices employing nursing aides with little formal training 
(Clinical Research Centre, 2011; Ramli & Taher, 2008). In the public sector, the quality 
of care also varies, often better in the urban health clinics and university-based primary 
care clinics due to the presence of family medicine specialists and multidisciplinary 
diabetes teams (Ramli & Taher, 2008). Clinics in the public sector provide more 
comprehensive diabetes services but have a high patient load compared to private 
clinics (Clinical Research Centre, 2011). 
The majority of patients with diabetes are managed in the government facilities; the rest 
are treated by private general practitioners or take complementary and alternative 
medications (Letchuman, et al., 2010). Despite the established risk of microvascular 
complications associated with hyperglycaemia (UKPDS Group, 1998), diabetes control 
remains poor in the Malaysian primary care setting. Eighty percent (80%) of the patients 
in the private (Mafauzy, 2005), and 69.1% in the public setting, failed to achieve an 
HbA1c level of less than 7.0% (Ismail et al., 2011).  One main reason for poor control is 
the lack of timely treatment intensification such as initiation of insulin therapy (Donnan, 
Steinke, Newton, & Morris, 2002). In a community based national health survey, only 
7.2% of Malaysian patients with type 2 diabetes used insulin, either alone or as 
combination therapy (Letchuman, et al., 2010), compared to 36% in the United States 
(Centers for Disease Control and Prevention). 
The Malaysian clinical practice guideline (CPG) for type 2 diabetes was last updated in 
2009 and insulin therapy was stated as part of the treatment algorithm (Ministry of 
Health, 2009). However, there was no mention of how insulin initiation could be 
implemented in the local healthcare setting. Recognising this gap, a practical guide for 
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insulin therapy was developed in 2010 and a section was dedicated specifically to 
addressing patients’ barriers to insulin initiation (Ministry of Health, 2010c). However, 
the recommendations are based on Western data and experts’ opinions. There is little 
research on what barriers the multi-ethnic Malaysian patients with type 2 diabetes face 
when deciding to initiate insulin. Studies from other countries have described various 
barriers to insulin initiation such as needle phobia, low self-efficacy and feelings of 
personal failure (Larkin et al., 2008; Polonsky, Fisher, Guzman, Villa-Caballero, & 
Edelman, 2005). It is reported that up to a third of patients are unwilling to start insulin 
therapy when advised to do so (Larkin, et al., 2008; Polonsky, et al., 2005).  
Insulin can only be prescribed by doctors in Malaysia and can be initiated at either 
primary or secondary care settings. Nurse educators play an important role in the public 
sector as doctors would refer patients to the nurses for education and instruction after 
prescribing insulin. On the other hand, private doctors often seek help from diabetes 
educators, who are sponsored by pharmaceutical companies or non-governmental 
organizations. 
Malaysia’s multi-cultural society consists of three main ethnic races (Malays, Chinese 
and Indians) and many other smaller ethnic groups (Swami et al., 2009), which may 
influence how both healthcare professionals and patients view insulin therapy. This 
study, therefore, aimed to identify barriers to insulin initiation from the healthcare 
professionals’ perspective. It is only through understanding the barriers to insulin 
initiation that healthcare professionals can address patients’ concerns and help them 
make decisions about starting insulin. This study was part of a larger three-year 
complex intervention study which aimed to develop a local patient decision aid for 
insulin initiation.  
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Methods 
Design 
Qualitative, semi-structured interviews and focus groups were used to identify and 
explore barriers to insulin initiation as viewed by healthcare professionals. A qualitative 
methodology was used as it allowed us to explore and probe the beliefs, experiences and 
views of the healthcare professionals concerning insulin initiation as encountered in 
their respective local practices (Pope & Mays, 1995).  
For the focus group discussions, we selected and grouped the participants based on their 
practice background and location to ensure homogeneity and to capitalise on their 
shared experiences (Kitzinger, 1995). The focus groups consisted of two groups of 
private primary care doctors (n=4, n=7), public family medicine specialists (n=8) and 
public medical officers in a university hospital primary care clinic (n=8). In depth 
interviews were used for key opinion leaders, such as government policy makers, and 
also for those who were unable to commit to a focus group session due to their busy 
schedule. The use of in-depth interviews, focus group discussions and field notes 
provided the basis for the triangulation of the data. Although all interviews were 
conducted in English, some participants used Malay-language words and phrases during 
the interviews as Malay is the national language. 
Setting 
The study was conducted amongst healthcare professionals who provided diabetes care 
in the three healthcare settings in Malaysia: the government health clinics; government 
university-based primary care clinic and hospital; and private general practice (GP) 
clinics and hospitals. Key government policy makers who were involved in shaping the 
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national diabetes strategic plans were also interviewed. A spectrum of practice 
experience was represented. The healthcare professionals came from three different 
states and from both urban and semi-rural locations.  
Participants, recruitment, sampling 
Purposive sampling was used whereby we identified stakeholders who were involved in 
insulin initiation in both primary and secondary care and contacted healthcare 
professionals from each stakeholder group. They included: endocrinologists, family 
medicine specialists, government policy makers, general practitioners, government 
medical officers and diabetes nurse educators. A pattern of snowball sampling 
developed as the participants named individuals and organizations who were involved 
in diabetes care particularly healthcare professionals who initiated insulin therapy. 
Sample size was determined by data saturation whereby interviews were stopped when 
no new themes emerged from the interviews. 
Data collection 
An interview topic guide was developed based on literature review, clinical knowledge 
and research experience (Table 5.1.1). The same guide was used for both individual and 
focus group discussions. Participants consented to be audio-recorded and interviews 
were carried out by either one of two researchers who were trained to conduct 
qualitative interviews and facilitate focus groups. Care was taken to avoid potential 
participant response bias by avoiding, whenever possible, having participants 
interviewed by close acquaintances, lecturers or colleagues. An assistant took detailed 
notes and observed non-verbal cues during the interviews and these observations acted 
as field notes. Between October 2010 and May 2011, we conducted ten 30-40 minute 
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individual interviews and four one hour-long focus groups. We stopped data collection 
when data saturation was reached for both interviews and focus groups. The interviews 
and focus groups were audio-recorded and transcribed verbatim. The transcripts were 
checked for accuracy and used as data for analysis. 
Table 5.1.1 Barriers to insulin initiation interview/focus group topic guide 
 Is starting insulin a difficult decision for your patients? 
 How do they feel when making this decision? 
 What are the things that patients consider before they decide whether or not to start 
insulin? 
o Information 
o Values 
o Influence from others 
 What barriers do you face when advising them to start insulin? 
 What kind of help do you need to overcome these barriers? 
 What barriers do you face when shaping policies on insulin treatment? (additional 
question for policy makers) 
 
Data analysis 
A hermeneutic-phenomenological approach was employed when analysing the data, 
which was viewed as being both descriptive and interpretive (Van der Zalm & Bergum, 
2000). The interpretive focus of hermeneutics occurred from the ‘outside’, whereby two 
of the researchers’ backgrounds as clinicians influenced how they not only interpreted 
the data but also how their interactions with the participants during interviews were 
188 
 
influential in constructing the text. The hermeneutic perspective was also acknowledged 
on the ‘inside’, from the perspective of the participants, whereby data was viewed as 
consisting of how participants interpreted barriers to insulin initiation, both from their 
perspective as healthcare providers, and also on behalf of their patients (Cohen, Kahn, 
& Steeves, 2000). The researchers familiarised themselves with the data by reading and 
re-reading the transcripts. Three researchers coded two transcripts (interviews with a 
primary care physician and a government policy maker) independently and created a list 
of nodes (themes). Subsequently, the researchers used this framework to code (label) the 
two other transcripts individually. The coding was then compared for inter-rater 
consistency and any coding discrepancies were resolved by discussion until consensus 
was reached on the list of nodes and the coding descriptions. The finalised list of nodes 
and coded transcripts were imported into Nvivo9 software which formed the basis for 
future coding.  
The remaining transcripts were distributed among the three researchers (YK, PY, CJ) 
and coded individually. Any new nodes emerging during coding were added to the list 
upon consultation with the other researchers. The list of nodes was regrouped into larger 
categories as a pattern of themes emerged from the data. 
Two of the researchers (CJ, PY) are family medicine specialists and the third is a 
postgraduate psychologist (YK) and thus data analysis was from both clinical and non-
clinical perspectives. The researchers constantly reflected and debated on the potential 
biases which they might carry with them due to their backgrounds to improve credibility 
of the analysis.  
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Ethics approval 
This study received ethics approval from the Medical Research and Ethics Committee, 
Ministry of Health, Malaysia. 
Results  
A total of 38 healthcare professionals participated in the study. Besides individual 
interviews, two focus group discussions were conducted with general practitioners in 
private practice (n= 7; n=4), one focus group with family medicine specialists from 
public health clinics (n=9), and another focus group (n=8) with medical officers from a 
public hospital-based primary care clinic. Participants’ demographic data are shown in 
Table 5.1.2.  
Three main categories of barriers emerged from the analysis and are reported below: 
patient barriers, healthcare professional barriers and system barriers (Table 5.1.3). 
Quotations are verbatim whereby colloquialisms and Malay-language words (with 
translations), if any, are not re-worded in order to give perspective on Malaysia’s multi-
lingual setting.  
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Table 5.1.2 Demographic profile of participants 
Characteristics Number 
(n= 38) 
% Mean + SD 
(Range) 
Age   47.0 + 9.9 years  
(30-66 years) 
Sex    
Female 29 76.3  
Male 9 23.7  
Ethnicity    
Malays 13 34.2  
Chinese 12 31.6  
Indians 10 26.3  
Others 3 7.9  
Professional background    
General practitioner 11 36.7  
Family medicine specialist 10 33.3  
Medical officer 8 21.1  
Government policy maker 4 13.3  
Diabetes nurse educators 3 10.0  
Endocrinologists 2 6.7  
Healthcare sector    
Public 24 63.2  
Private 14 36.8  
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Table 5.1.3 Barriers to insulin initiation faced by Malaysian healthcare 
professionals 
Patient barriers 
 Fear of side effects and pain 
 Misconceptions about insulin 
o Insulin is lethal 
o Insulin is a punishment 
o Insulin is a stigma 
o Insulin is a medication for old people 
o Insulin causes sexual dysfunction 
o Insulin is unlawful for Muslims 
 Inconvenience in starting insulin 
 Seeking alternative treatment 
 Lack of knowledge and self-efficacy 
 Negative influence from family members 
 
Healthcare professional barriers 
 Negative attitudes towards insulin 
 Lack of motivation and confidence 
 Training-related barriers 
 Conflicting advice from the healthcare professionals 
 
System barriers 
 Lack of continuity of care 
 Lack of manpower 
 Lack of resources 
 Language barriers 
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Patient barriers 
The participants highlighted a range of barriers faced by patients when starting insulin. 
The list includes fears associated with insulin; patients’ perceptions of insulin; lack of 
knowledge and self-efficacy.   
Fear of side effects and pain 
The healthcare professionals found that patients’ fear of side effects, such as 
hypoglycaemia and weight gain, were common barriers faced by patients. 
“(Patients are) afraid of hypo. Because they have seen people with hypo, it’s so 
bad. They lost consciousness and they talk nonsense and all that.”  
Family medicine specialist, public health centre 
 
“The youngsters especially…they are very worried about weight gain.”  
Medical officer, public university primary care clinic 
 
Other emotional factors that influenced patients’ decision on starting insulin included 
patients’ fear of needles and pain. 
 “All of us are brought up (to believe that) injection is pain. So a lot of them 
have a (pause) idea that it is associated with pain”  
Diabetes nurse educator, public university hospital 
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“The moment we say injection, for them, injection is the long needle…the big 
needle. So that’s the idea…” 
Medical officer, public university primary care clinic 
Misconceptions about insulin 
- Insulin is lethal 
The healthcare professionals cited that patients’ perceived insulin as a drug with ‘lethal’ 
complications. Patients believed that they would die soon after initiating insulin because 
they observed that the disease deteriorated in other patients soon after insulin initiation. 
As a result, they perceive that insulin is the cause of severe diabetic complications. 
“It's..it's a...especially among the elderly patients, they'll be told that when they 
reach the stage where they need insulin, err...that's one foot in the grave 
already”  
Endocrinologist, private hospital 
 
“...so they (patients) feel that the moment they put insulin, after a few years is 
kidney damage, then dialysis. So they have that fear, every time they’ll ask us, 
“Doctor if I use insulin, will my kidneys get damaged?”” 
General practitioner, private practice 
- Insulin is a punishment 
Some patients perceived insulin as a ‘punishment’ to them. The healthcare professionals 
believed that this could be due to doctors framing insulin as a penalty for failing to 
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control their disease. A doctor quoted a patient as saying “...one doctor very garang 
(‘fierce’), you know, scolded me because my sugar is like this. And said if it’s not okay, 
I’ll start you on insulin. So for (me) it’s a punishment”.  
- Insulin is a stigma 
According to the healthcare professionals, using insulin might be perceived by some 
patients as a stigma as they associated needles with drug abuse. One endocrinologist 
observed that, 
“I’ve no idea why they think they will be addicted to insulin...I don’t know what 
it is about insulin perhaps it’s the fact there’s a needle and I don’t know whether 
they think it’s dadah (drugs) or what, but very often like, ‘Oh does it mean 
sampai mati saya kena ambil (I have to take insulin until I die) or umm... does it 
mean I can’t come off it, imply that I addicted...dependent on it...’”. 
Patients also worried about having to inject insulin during social functions where they 
would be surrounded by other people. 
“How to inject in front of public, like I go for dinner, I’m going to attend a 
dinner with everybody on the round table. So when can I inject myself...am  I 
going to inject myself in public…or where can I go myself injection?”  
   Medical officer, public university primary care clinic 
- Insulin is a medication for old people  
Younger patients viewed diabetes as an ‘old people’s disease’ and considered insulin as 
only needed for the elderly.  
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“They (young people) got a stigma… Because you see, insulin, and diabetes, is 
old peoples’ disease.”  
General practitioner, private practice 
- Insulin causes sexual dysfunction 
Insulin was also associated with men’s sexual dysfunction. 
“They think by taking this tablet (diabetes medication), it makes them, you 
know… ED (erectile dysfunction), so no injection, any medicine, or any 
injection”  
General practitioner, private practice 
- Insulin is unlawful for Muslims 
Muslim patients were concerned over the origin of insulin as many still believed that it 
was a porcine derivative, which is unlawful under Islamic religious law.    
“ I think they were thinking that the insulin is from, what do you call this, non-
halal (‘lawful’)…ah…products”  
Family medicine specialist, public health centre 
Inconvenience in starting insulin 
Patients also perceived insulin therapy as inconvenient and interfering with their 
lifestyle.  
“Yeah, I think some of them said inconvenience because they said uh especially 
those already retired, they actually want to go into you know, different-different 
places, different child each month, or go to the relatives’ house and all that. So, 
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yeah to bring, they thought that they actually have to keep that in the fridge all 
the time. So, it’s actually inconvenient for them. Also for injection lah. I mean, if 
they’re actually go out, injections probably a problems for them.”  
Family medicine specialist, public health centre 
Seeking alternative treatment 
Complementary and traditional medications for diabetes were also preferred for diabetes 
control.  
“And when you tell them, your diabetes has come to a stage where you need, er, 
injections, they will say they have uh…these herbs and so on. They want to try 
out herbs first.”  
General practitioner, private practice
  
Lack of knowledge and self-efficacy  
Patients with diabetes often considered starting insulin therapy as a complex task and 
this caused patients to delay insulin therapy. Patients felt overwhelmed by the 
instructions and were not confident to handle injections.  
“...let’s talk about older people, for the older people, they always know insulin 
is more complicated rather than just following medicine. So they always say that 
I cannot handle it, so I don’t want it.” 
    Diabetes nurse educator, private practice 
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Patients’ lack of self-efficacy stemmed from worries about following the insulin 
regimen in novel situations such as during festive meals, which are a common 
occurrence in Malaysian culture.  
“ ...there is a lack of self-efficacy...Now self-efficacy is mainly can you handle in 
a s-situation, in a situation that you are in. And is not just what you can do, can 
you handle it? Even if you know how to give yourself injection, if you have to go 
for some s-social function. What do you do? What do you do?” 
    Diabetes nurse educator, private practice 
Being elderly, relying on others for care, suffering from visual impairment and having 
irregular mealtimes also caused patients to hesitate over starting insulin. 
“For my patient, like elderly, we have resistant to start insulin because cannot 
read the pen- too small and then blur.... So, because cannot see, cannot 
read...they got the eye problem” 
    Family medicine specialist, public health centre 
The healthcare professionals felt that some patients lacked knowledge and were 
reluctant to start insulin, especially those who had a short history of diabetes. Some 
were not aware of the natural progression of diabetes and the need for insulin 
eventually.  
“In fact probably they’re already diabetes for many years but just diagnosed for 
two years. So they thought, you know, it’s...it’s just too early. It’s just too early 
for them to actually go for insulin.”  
Family medicine specialist, public health centre 
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 Negative influence from family members 
Another barrier noticed by the health care professional is some patients with diabetes 
were facing negative influence and poor support from family members especially from 
their spouse to initiate insulin.  
“(Patient) agreed to have insulin...Next day he came back and said “My wife 
doesn't want me to...start insulin”...My personal feeling is that he's completely 
under her thumbs, and she has decided “My husband doesn't need insulin”. 
     Endocrinologist, private hospital 
Healthcare professional barriers 
Healthcare professional barriers to initiating insulin therapy comprised psychological 
barriers such as negative attitudes towards insulin therapy, lack of motivation and 
confidence. Unfamiliarity with starting insulin therapy was also highlighted. 
 
Negative attitudes towards insulin 
Some healthcare professionals felt that it was unlikely for patients to change their 
negative attitudes towards insulin and to modify their lifestyle to suit the insulin 
regimen. These healthcare professionals were unwilling to take time to teach patients 
about insulin therapy, and viewed insulin as a hassle.  
“I also discuss (insulin) with, um…the FMS (Family medicine specialists) or in 
Terengganu and the physicians…and a matter of factly it’s…it’s as if they just 
accept the fact (that patients won’t start insulin). “It’s difficult here! The patient 
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doesn’t want to do, what can we do...Patient don’t want insulin, so what can we 
do?” 
Government policy maker   
Lack of motivation and confidence 
Some doctors were not motivated to start patients on insulin themselves as they could 
refer patients to an endocrinologist or a diabetic nurse. Furthermore, some doctors still 
subscribed to the old school of thought that insulin could only be initiated in a hospital 
setting and not in clinics.  
“I don’t push… I don’t push, because I let the specialists handle it. Yeah, I refer 
them to the specialists...”  
General practitioner, private practice 
Besides motivation, some doctors lacked confidence in starting a patient on insulin. 
Reasons included feeling uncomfortable with needles and unfamiliarity with the various 
insulin regimens and devices. Some healthcare professionals blamed the patients for 
their reluctance to accept insulin. Even those who were successful at initiating insulin 
viewed the counselling process as a battle to be won and one requiring considerable 
mental preparation. 
 “...we ourselves have got such a mental block. I mean, as doctors it’s very easy 
to preach, but when it comes to needles I think we doctors also freak out. So 
when we had to inject it was like, ‘Oh dear...must I do it?’”  
General practitioner, private practice 
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Training-related barriers 
Training-related barriers include: organizational policies that do not support staff who 
want further training and the quality of the training programme.  
“...even though they (sponsors) write there black and white for the (diabetes) 
educator from the clinic to go (for training)… we are not at liberty to improve 
ourselves”   
   Diabetes nurse educator, public university hospital 
 
“…the training in the Ministry (of Health) is very much didactic, not so much 
practical.”     
     Government diabetes policy maker 
Conflicting advice from the healthcare professionals 
Conflicting information given by healthcare professionals, peers and media tended to 
delay patients’ decision in starting insulin. 
“...the GP told him...“No, why you so silly start on injection for? I give you 
medicine. Forget it, throw it all away.” So he went back to oral medicine....and 
he came back 6 months later with renal failure.”  
General practitioner, private practice 
Doctors in the private sector felt that the decision to start insulin or not was out of their 
control as patients could “shop with another doctor who will tell them that they don’t 
need (insulin)” (Diabetes nurse educator, private practice).  
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System barriers 
System barriers to insulin initiation could be divided into four main areas: lack of 
continuity of care, manpower, resources and language barriers.  
Lack of continuity of care 
The lack of continuity of care in primary care made insulin initiation and management 
challenging. Therefore, patients were often unable to maintain the follow-up which is 
crucial to address individual patient’s concerns about insulin. The lack of continuity of 
care is particularly problematic in the public sector due to high turnover of doctors. 
Patients are often not being given a choice on who they would like to consult as they are 
unable to book to see the same practitioner at each visit.  
“So, I’ve learned that it’s important to…to…to know your patient well but the 
only problem with MOH (Ministry Of Health) is that you can’t see the same 
doctor...… so this fact about not having the same doctor, patients don’t like it. 
They don’t like it.”  
     Endocrinologist, public hospital 
Lack of manpower 
The lack of manpower was apparent especially in the government hospitals and clinics. 
Despite recognising the important role of a nurse educator in insulin counselling, only a 
small number of diabetes nurse educators and dieticians were trained in the government 
sector and, when present, they had to handle heavy patient loads. Although privately-
sponsored diabetes nurse educators were available to help educate patients on starting 
insulin in private clinics, there were very few of them. 
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Lack of resources 
While insulin is subsidized in the public clinics and hospitals, there is no financial 
assistance for glucometers and test strips. This hampers insulin initiation.  
“The other thing is that I think, uhh...most of our patient do not have home 
blood sugar monitoring. This is actually very difficult in starting insulin. To 
actually titrate insulin, especially for BIDS (bedtime insulin daytime 
sulphonylurea) regime, it’s very difficult.”  
Family medicine specialist, public health centre 
Education materials about insulin were not easily available and most insulin-prescribing 
doctors preferred to sketch out information on blank paper. There was also a lack of 
dedicated diabetes education rooms and facilities. Counselling patients about insulin 
initiation was seen as time consuming especially in government clinics with heavy 
patient load.  
“...the workload...500, 600 patient a day and per doctor we are seeing umm, 70 
to 100. Not a good day, one MC (medical leave), one taking leave, 100 a day. So 
I was you know, practicing there, I have to be a regular MO (Medical Officer), 
so I can find it is difficult to counsel patient in this kind of situation. Time is 
definitely you know really un-under constraint” 
   Family medicine specialist, public health centre 
Language barriers 
Language issues made it difficult for healthcare professionals to communicate with 
patients. Some patients from rural and agricultural estates can only speak their native 
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language. This poses a big communication barrier if the healthcare professional and the 
patient are from different ethnic and linguistic backgrounds. 
“...the big, important issue is language barrier...we actually do not have 
enough...uh...Indian staff.”  
                             Family medicine specialist, public health centre 
Discussion  
This study highlights the wide range of barriers to insulin initiation in Malaysia and 
provides an overview as to why the use of insulin remains low. What is remarkable is 
the similarity of the barriers encountered in a multicultural, Asian country to barriers 
reported in studies conducted in the West. A Pubmed search of qualitative studies which 
focus on barriers to insulin initiation identified eight studies from North American (J. B. 
Brown et al., 2002; Hunt, Valenzuela, & Pugh, 1997), UK (Greaves et al., 2003; 
Phillips, 2007a, 2007b; Sigurdardottir, 1999), European (Goderis et al., 2009) and South 
African (Haque, Emerson, Dennison, Navsa, & Levitt, 2005) settings. Thematic 
consistency is apparent between these studies and our study, suggesting that these 
barriers are widely held ideas that the results of this study are generalizable.   
Studies on psychological insulin resistance amongst multi-ethnic populations have 
found that ethnicity is an important determining factor. Studies in the west have found 
that Hispanic and ethnic minorities are less willing to start insulin therapy (Nam, 
Chesla, Stotts, Kroon, & Janson, 2010; Polonsky, et al., 2005). Reasons for this 
resistance include perceived lack of access to care and language barriers between 
healthcare provider and patient (A. F. Brown et al., 2003; Caballero, 2006). Malaysian 
society consists of three main racial groups, each with distinct cultural practices and 
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close-knit community structures. The healthcare professionals cited patients’ 
misconceptions of insulin as a major barrier. Our study identified three misperceptions 
that arise out of this multicultural setting: religious barriers, use of complementary 
medicines and lethal connotations about insulin.  
The majority of Malaysia’s population are Muslim, in which the origin of food and 
products must comply to strict religious standards in order to be considered lawful 
(‘halal’). Healthcare professionals need to reassure Muslim patients that modern, 
synthetic insulin is not derived from a porcine source (Qureshi, 2002), which is strictly 
forbidden except under emergency situations (Fatwa Committee of the National Council 
for Islamic Religious Affairs Malaysia, 1983). Another concern for Muslim patients is 
the use of insulin during Ramadan, where the Muslims would be on a full-day fast from 
food and drink (Salti et al., 2004). Healthcare professionals (including non-Muslims) 
must be able to advise Muslim patients on appropriate insulin regimes during the fasting 
month of Ramadan (Benaji et al., 2006).  
Patients’ preference to try out complementary therapies before insulin usage is often 
overlooked by the healthcare professionals in Malaysia. In a local study, the use of 
complementary therapies was prevalent among people with type 2 diabetes mellitus 
(Hasan, Ahmed, Bukhari, & Loon, 2009). Half of Malaysian patients with chronic 
diseases do not report their use of complementary therapy to their doctors or 
pharmacists (Hasan, et al., 2009). This is of concern as the use of traditional herbs has 
been identified elsewhere as a barrier to insulin therapy whereby patients were 
perceived to have more faith in herbs than in insulin (Haque, et al., 2005). Increasing 
healthcare professional awareness on complementary and traditional therapies will help 
to reduce healthcare professionals’ anxiety in advising patients on the use of such 
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therapies (Corbin Winslow & Shapiro, 2002). Healthcare professionals need to play a 
more active role in asking their patients about their use of complementary therapies 
when initiating insulin (Busse, Heaton, Wu, Wilson, & Mills, 2005). 
Patients often associate insulin usage with co-morbidities.  Although it has been 
reported elsewhere that patients associate insulin with disease severity (Hunt, et al., 
1997; Peyrot et al., 2005), this misconception appeared to be more serious among the 
Malaysian patients who consider insulin to be lethal. Healthcare professionals should, 
therefore, address this misconception by counselling patients about the natural 
progression of diabetes at early stage of the illness. It should be emphasised to patients 
that early initiation of insulin helps to reduce morbidity and mortality. The myth about 
the association between insulin and advanced disease and deaths should be dispelled by 
providing accurate and timely information to the patients. 
In this study, most system barriers are similar to those found elsewhere, including short 
consultation times, rapid staff turnover and lack of continuity of care (Haque, et al., 
2005). However, further matrix analysis of the data identified two issues which were 
only identified in healthcare professionals from the public healthcare system in 
Malaysia. Firstly, the lack of continuity of care is particularly problematic in the public 
healthcare setting due to fast turnover of doctors and patients not being given a choice 
on who they would like to consult. Continuity of family physician care in patients with 
diabetes is associated with better quality of life (Hanninen, Takala, & Keinanen-
Kiukaanniemi, 2001), and lower mortality and hospitalization in elderly patients  
(Worrall & Knight, 2011). According to Prochaska’s transtheoretical model (James O. 
Prochaska, 2008), insulin initiation requires patients to move from stages of 
precontemplation, contemplation and finally to action, with patients often cycling back 
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and forth between these stages (J. O. Prochaska, DiClemente, & Norcross, 1992). 
Continuity of care would play an important role as healthcare professionals assess the 
stage of patient’s readiness to initiate insulin and customize a follow-up plan to help 
patients initiate and optimize the use of insulin (Singer, 2007). 
The language barrier was especially pressing in rural and semi-rural locations of the 
public healthcare system. Patients with limited language proficiency have problems 
with healthcare access, comprehension, adherence and receive lower quality of care 
overall (Jacobs, Chen, Karliner, Agger-Gupta, & Mutha, 2006). As a self-administered 
injection, insulin requires an understanding of injection techniques and self-titration. 
Thus, difficulty in communication during patient education still poses a substantial 
barrier to insulin initiation in Malaysia. Strategies to overcome language barriers in 
practice include employing a diverse healthcare workforce and using translation 
services when necessary (Campos, 2007). Preparing healthcare professionals to serve in 
diverse communities can be done by offering medical language courses in medical 
schools to help familiarise students with medical terminologies they will encounter in 
different communities (Groman & Ginsburg, 2004). 
Both public and private healthcare professionals stated that the lack of resources was an 
important barrier to insulin initiation. Diabetes nurse educators are an important, but 
lacking resource for insulin initiation, with less than 600 diabetes nurse educators in the 
country serving a diabetes population of approximately 1.6 million (Tan, Magarey, 
Chee, Lee, & Tan, 2011). The cost and lack of availability of self-monitoring of blood 
glucose (SMBG) contribute to patients’ reluctance to start insulin. Although the cost of 
insulin is subsidized in Malaysia, glucometers and test-strips are not. There is evidence 
to suggest that the frequency of SMBG is inversely related to out-of-pocket expenses 
207 
 
(Nyomba, Berard, & Murphy, 2002, 2004) and countries with the highest relative strip-
cost have the lowest use of self-monitoring (SMBG International Working Group, 
2008).  Thus, one place to start is to look into providing patients with financial 
assistance to acquire glucometers and test-strips for SMBG as they are essential for 
monitoring the response to and side effects of insulin therapy.   
Patients perceive that their diabetes is advanced once they are advised to start insulin 
therapy (Polonsky, et al., 2005). This perception may stem from the healthcare 
professionals’ belief that insulin could only be started once the patients reach maximum 
numbers and doses of oral glucose-lowering drugs. Previous Malaysian CPGs 
recommended that insulin should only be considered in patients with poor glycaemic 
control after lifestyle modifications and maximum oral glucose-lowering therapy 
(Ministry of Health, 2004). In the latest CPG released in 2009, the recommendation has 
been changed and healthcare professionals are now advised to start insulin early, 
especially for patients who have poor glycaemic control at diagnosis. More research is 
needed on the prevalence of the ‘legacy effect’ of past guidelines and changes made 
from previous guidelines should be highlighted during the training and dissemination of 
new guidelines (Home, Mant, Diaz, & Turner, 2008).  
The strength of this study lies in the fact that the sample encompassed all healthcare 
sectors and stakeholders who were involved in insulin initiation. We were thus able to 
gain an in-depth understanding of the barriers to insulin initiation from a wide range of 
perspectives. Analysis of barriers according to participant ethnicity did not reveal 
significant differences in terms of themes mentioned as healthcare professionals treat 
patients from various ethnicities and encounter a range of barriers in patients. However, 
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participant responses highlighted the nature of culture-specific barriers as the examples 
provided were often specific to one culture, such as the names of traditional herbs.  
There are a few limitations in this study. Only participants from three states (Kuala 
Lumpur, Selangor and Seremban) in Malaysia were included in this study. The culture 
of patients in other states, in particular the East coast of the peninsula and East 
Malaysia, might be different and hence the patients might face different barriers when 
starting insulin. This limits transferability. Future studies should include participants 
from other states of Malaysia. As sample size was determined by thematic saturation, 
the sample population was too small to be analysed according to healthcare professions. 
Lastly, only healthcare professionals’ perspectives were included for this study. 
However, this study forms part of a larger study and we are embarking on a study 
exploring patients’ views and perceived barriers to starting insulin.  More research is 
necessary to explore the patients’ perspectives of insulin therapy. This will help 
substantiate the findings from this study and identify the needs of patients when starting 
insulin.  
Conclusions  
Tackling the issue of insulin initiation should not happen only at the point of decision 
during clinical consultations. A more comprehensive healthcare education programme 
should be designed and implemented. Patients should be informed early on about the 
natural progression of diabetes and the need for insulin therapy 10-15 years after the 
diagnosis. At the macro level, understanding the barriers to insulin initiation helps 
government policy makers develop effective public educational programmes; design 
and implement training curriculum of healthcare professionals; and plan the resources 
necessary to manage this disease. At the micro level, the awareness of the barriers to 
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insulin initiation helps the healthcare professionals to explore and address patients 
concerns and help them to make an informed decision about insulin initiation.  
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Abstract  
Background: The prevalence of type 2 diabetes is increasing at an alarming rate in 
developing countries. However, glycaemia control remains suboptimal and insulin use 
is low. One important barrier is the lack of an efficient and effective insulin initiation 
delivery approach. This study aimed to document the strategies used and proposed by 
healthcare professionals to improve insulin initiation in the Malaysian dual-sector 
(public–private) health system.  
Methods: In depth interviews and focus group discussions were conducted in Klang 
Valley and Seremban, Malaysia in 2010–11. Healthcare professionals consisting of 
general practitioners (n=11), medical officers (n=8), diabetes educators (n=3), 
government policy makers (n=4), family medicine specialists (n=10) and 
endocrinologists (n=2) were interviewed. We used a topic guide to facilitate the 
interviews, which were audio recorded, transcribed verbatim and analysed using a 
thematic approach. 
Results: Three main themes emerged from the interviews. Firstly, there was a lack of 
collaboration between the private and public sectors in diabetes care. The general 
practitioners in the private sector proposed an integrated system for them to refer 
patients to the public health services for insulin initiation programmes. There could be 
shared care between the two sectors and this would reduce the disproportionately heavy 
workload at the public sector. Secondly, besides the support from the government health 
authority, the healthcare professionals wanted greater involvement of non-government 
organisations, media and pharmaceutical industry in facilitating insulin initiation in both 
the public and private sectors. The support included: training of healthcare 
professionals; developing and disseminating patient education materials; service 
212 
 
provision by diabetes education teams; organising programmes for patients’ peer group 
sessions; increasing awareness and demystifying insulin via public campaigns; and 
subsidising glucose monitoring equipment. Finally, the healthcare professionals 
proposed the establishment of multidisciplinary teams as a strategy to increase the rate 
of insulin initiation. Having team members from different ethnic backgrounds would 
help to overcome language and cultural differences when communicating with patients.  
Conclusion: The challenges faced by a dual-sector health system in delivering insulin 
initiation may be addressed by greater collaborations between the private and public 
sectors and governmental and non-government organisations, and among different 
healthcare professionals.  
Keywords: Insulin initiation, dual-sector health system, Malaysia, diabetes, private 
sector.  
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Background  
The United Kingdom Prospective Diabetes Study (UKPDS) has found that 
intensification of glycaemic control prevents and delays diabetes-related complications 
(UK Prospective Diabetes Study (UKPDS) Group, 1998). This often requires oral 
glucose-lowering drugs in addition to lifestyle modification. However, because of 
progressive insulin depletion, the majority of patients with type 2 diabetes will require 
insulin to achieve optimal glycaemic control 5–10 years after diagnosis (DeWitt & 
Hirsch, 2003; UK Prospective Diabetes Study (UKPDS) Group, 1998). Internationally, 
most studies found only about 26–34% of patients with type 2 diabetes achieved 
optimal glycaemic control (Fox, Gerber Pharmd, Bolinder, Chen, & Kumar, 2006; 
Kosachunhanun et al., 2006; Liebl, Mata, & Eschwege, 2002; McFarlane et al., 2002). 
This could be related to low employment of an insulin regimen (Eliasson, Cederholm, 
Nilsson, & Gudbjornsdottir, 2005; Koro, Bowlin, Bourgeois, & Fedder, 2004; 
Kosachunhanun, et al., 2006). 
In Malaysia, the prevalence of type 2 diabetes ranks seventh in the world (International 
Diabetes Federation, 2009a) and is the highest in the Western Pacific region 
(International Diabetes Federation, 2009b). A recent study found that 81.9% of 
Malaysian adults with diabetes seen at the primary care setting did not achieve the 
recommended glycaemic goal of less than 6.5% haemoglobin A1c (Ismail et al., 2011). 
One important reason for poor glycaemic control is the delay in initiating and 
intensifying insulin therapy (Donnan, Steinke, Newton, & Morris, 2002). In Malaysia, 
studies have reported very low usage of insulin among patients with type 2 diabetes 
(Ismail, et al., 2011; Letchuman et al., 2010).  
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Many factors contribute to the delay in insulin initiation in clinical practice: patient 
factors, such as psychological insulin resistance; clinician factors, such as lack of 
training and confidence; and system factors. Common system barriers include: short 
consultation times, rapid staff turnover and lack of continuity of care (Haque, Emerson, 
Dennison, Navsa, & Levitt, 2005), and these barriers vary across different health 
systems. Malaysia has a dual-sector healthcare system comprising public (government 
subsidised) and private (fee for service) sectors. Almost three-quarters of patients with 
diabetes are managed in the public sector, which often has a high patient load and 
turnover of doctors (Letchuman, et al., 2010). Furthermore, patients in the public sector 
are often not given a choice of which doctor they would prefer to consult. Therefore, to 
improve optimisation of glycaemic control and update of insulin, effective and efficient 
strategies are needed, particularly those targeting the healthcare delivery system. This 
study aimed to explore the views of Malaysian healthcare professionals (HCPs) on the 
strategies that would facilitate insulin initiation among patients with type 2 diabetes. 
Methods 
Design 
We conducted semi-structured interviews and focus group discussions with HCPs to 
explore the strategies they used or proposed to improve service delivery in order to 
facilitate insulin initiation. A qualitative methodology allowed us to explore views on 
healthcare delivery systems related to the practise of insulin initiation in local practice 
situations (Pope & Mays, 1995). This also enabled us to have a more holistic view of 
service delivery and strategies for its improvement (Bogdan & Taylor, 1975; Patton, 
1980).  
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HCPs participating in the focus group discussion were grouped according to their 
practice background and location. This was to ensure homogeneity and to capitalise on 
shared experiences among the HCPs (Kitzinger, 1995). For logistic reasons, we 
conducted individual in-depth interviews with key opinion leaders, such as government 
policy makers. The use of in-depth interviews, focus group discussions and field notes 
served to triangulate of the data.  
Setting 
In Malaysia, insulin therapy is initiated by HCPs from government hospitals and health 
clinics; university-based hospitals and primary care clinics; and private hospitals and 
general practice clinics. In this study, we recruited the HPCs from three states (Wilayah 
Federal Territory, Negeri Sembilan and Selangor) and from both urban and semi-rural 
locations. Two key policy makers from the Ministry of Health who were involved in 
developing and implementing the national diabetes strategic plan were also interviewed.  
Participants, recruitment and sampling 
We used purposive sampling to identify the stakeholders who were involved in insulin 
initiation. They comprised family medicine specialists, general practitioners (GPs), 
government medical officers and diabetes nurse educators, endocrinologists and 
government policy makers. We used the ‘snowballing’ technique to recruit participants 
by asking stakeholders to identify individuals and organisations who were involved in 
insulin initiation. We interviewed and analysed in an iterative manner until no new 
themes emerged. The recruitment was stopped when researchers discussed and reached 
consensus that the analysis had reached thematic saturation.  
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Data collection 
An interview topic guide was developed based on literature review and expert opinion. 
The questions in the topic guide were based on the conceptual framework where health 
care professionals, patients and the health care delivery system are factors that may 
influence the initiation of insulin (Haque, et al., 2005). We interviewed the HCPs using 
open-ended questions and used prompts only if important issues did not emerge 
spontaneously during the interview. The HCPs were informed that the interview focused 
on patients with type 2 diabetes who are indicated to start insulin.  The HCPs were 
asked about the barriers, facilitators and their experience of insulin initiation and this 
has been reported elsewhere (Lee, Lee, & Ng, 2012). They were also asked to suggest 
strategies they used or would recommend to optimise insulin initiation.  Three trained 
researchers conducted the individual interviews and focus groups using the topic guide.  
We sought written consent from all the participants for audio-recording and the 
interviews. An assistant took field notes on non-verbal cues and interview dynamics. 
Between October, 2010, and May, 2011, we conducted individual interviews and focus 
groups, lasting about 30 and 60 minutes, respectively. We reached data saturation after 
ten individual interviews and four focus groups. All the interviews were audio recorded, 
transcribed verbatim and the transcripts were used as data for analysis. 
Data analysis 
A thematic analysis approach was used. The researchers familiarised themselves with 
the data by reading and re-reading the transcripts. Three researchers coded two 
transcripts (interviews with a primary-care physician and a government policy maker) 
independently and a list of free nodes (themes) was created. The free nodes were 
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merged to form larger categories. This framework, consisting of categories and themes, 
was used subsequently to code (label) another two transcripts by the researchers 
independently. The coding was then compared for inter-rater consistency and any 
discrepancies were resolved by discussion. Consensus was reached on the final list of 
nodes and their descriptions. This final list of revised nodes was imported into Nvivo9 
software and served as the framework for coding the rest of the transcripts. New themes 
that were identified were added to the list upon consultation with the research team.  
Two of the researchers (CJN and PYL) are family medicine specialists and the third is a 
postgraduate psychologist (YKL). The researchers were conscious of their personal and 
professional views on insulin initiation. The team underwent constant reflection and 
open discussion throughout the interviews and analysis to reduce possible biases. This 
study was part of a larger 3-year study that aimed to develop a patient decision aid for 
people with type 2 diabetes who are considering insulin therapy.  
Ethics approval 
This study received ethics approval from the University of Malaya Medical Centre 
Medical Ethics Committee and the Medical Research and Ethics Committee of the 
Ministry of Health, Malaysia. 
Results 
Characteristics of the participants  
A total of 38 HCPs participated in the study: 11 general practitioners, ten family 
medicine specialists, eight medical officers, four government policy makers, three 
diabetes educators and two endocrinologists. Of the 38 HCPs, 24 were from the 
government sector and 14 from the private sector. Their mean age was 47 years (range 
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30–66 years). There were 29 women and nine men; and 13 Malays, 12 Indians, 10 
Chinese and three other races.  
Three main strategies to improve insulin initiation emerged from the data: (1) 
collaboration between the public and private sector; (2) greater involvement of 
pharmaceutical industry, media and non-government organisations (NGOs); and (3) 
establishment of multidisciplinary teams.  
Collaboration between the public and private sector  
Doctors from the private sector lacked resources to initiate insulin. Therefore, HCPs 
suggested that the government medication subsidies be made available to patients on 
diabetes follow-up at private facilities. The public sector, on the other hand, faced the 
problem of a heavy workload and limited consultation time. Shared care between the 
public and the private sectors would help to overcome the barrier of limited consultation 
time in the public sector. 
“The Government should set aside a fund, where… it’s not that only poor people 
should do this thing, I think it should be sort of like… we GPs have no backup. 
(Government should set aside a fund to be used by private sector GPs for people 
treated by GPs; currently these GPs have no backup) They should let us, maybe 
with the patient’s IC (identity card), prove ourselves that our patients are 
diabetic, and we should at least be able to get the needles and some basic things 
from the Ministry.” (GP, private practice) 
“… like my patients I see from the hospitals, they are going to the Klinik 
Kesihatans (Government Health clinics). All their HbA1c is about 9, 9.5… I 
don’t blame the doctors, because how much time do they have in contact with 
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the patients? So there should be a sharing treatment on diabetics with private 
clinics where they should be able to see these doctors and the Government 
should subsidize their treatment or something, ok in 6 months’ time you go back 
here, get your thing, but other times go and visit your nearest clinic, GP clinic, 
where they can spend more time with you.” (GP, private practice) 
 
In the private sector, most general practitioners did not have supporting staff such as 
diabetic educators and dieticians to provide patient education. One option was to enrol 
their patients for diabetes education in the government health clinics. 
“I mean the Government has a lot of budget for many mega-projects, … and I 
think there should be some kind of subsidy (patient education) program when 
GPs can participate. … It shouldn’t just be limited to the hospital. The 
participation should be open to the GPs.” (GP, private practice) 
 
Greater involvement of pharmaceutical industry, media and non-government 
organisations  
Pharmaceutical industry 
Pharmaceutical companies could play an important role in continuing medical education 
by organising training and workshops on insulin initiation for HCPs. 
“So, that is actually with the help of some educational grant, there’s been a lot 
of help from the pharma industry.....they have also given a grant to run the 
workshops ...” (Endocrinologist, government hospital) 
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Pharmaceutical representatives may act as a resource person to support the doctors in 
starting their patients on insulin. Unlike medical colleagues, the pharmaceutical 
representatives spent time with the GPs and guided them through the insulin initiation 
process step-by-step.  
“The pharma companies, they have been very good, so the guy will come with 
every literature to me, he will train me up, and then I will say, oh, so many units, 
what if the patient goes into hypo (hypoglycaemia), and then they will have to 
convince me, doctor, they are not going to go into hypo. We believe in that 
because we are going to start with a very low dose, these drugs are very 
different from the old insulin. So they are holding my hand, and they have 
guided me to use insulin......so I have learnt my insulin not through any 
endocrinologist, not through any doctor, but these guys… they walk the talk, 
walk the talk with me.” (GP, private practice) 
In the government sector, pharmaceutical companies were involved in providing patient 
educational and decision support material, which healthcare providers used when 
helping a patient to make decisions about initiating insulin. Most of the patient health 
education materials on insulin were developed and provided by the pharmaceutical 
companies.  
“Decision maps like those provided by Pharmaceutical Company A, that kind of 
thing. Some clinics have started doing that, erm... it is something which we 
supported, but I’m not sure how many clinics are motivated enough to move, to 
want to organise. …I see it as a good tool. I see it as a different approach to 
health education.” (Government policy maker) 
221 
 
“That's not the 'in' thing in Malaysia. Pharma. A lot people are not comfortable. 
For me, as long as it’s not biased. You know. This one (guide book) for example, 
this is supported... printing supported by Pharmaceutical Company B...(I) have 
to source for the fund. The ministry don’t want to pay. I think, that it's a bit 
ridiculous. I asked Pharmaceutical Company B, I asked around, I asked 
Pharmaceutical Company C , Company C don't want.” (Government policy 
maker) 
“So, that is actually with the help of some educational grant, there’s been a lot 
of help from the pharma industry, so even to develop this guide, it is actually 
with the help of pharma…” (Endocrinologist, government hospital) 
The pharmaceutical industry also helped to supply insulin pens to patients free of 
charge. In addition, in the private sector, where there was a lack of resources, some 
pharmaceutical companies employed diabetes educators to assist the doctors in 
educating patients about insulin therapy. 
“For me I would talk to the company and tell them, you make sure if you want 
me to use your insulin, you had better supply enough pens for me.” (Family 
Medicine Specialist, Government health clinic)  
“You can get them (pharmaceutical companies)…you can just give them a call, 
and you have a certain patient you think has to be on insulin, and that patient 
refuses to take the insulin in spite you have informed him, and you find 
resistance. And you can get these people, these people who market you this 
insulin, they will do the marketing for you. They will go to the house; they’ll talk 
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to the patient. I had one patient who had a problem, but after about 5 months the 
patient finally accepted to take insulin. (GP, private practice) 
Media 
Some HCPs felt that the media played an important role in educating the public about 
diabetes and the benefits of insulin.  
“I feel the media should play a part. An important role. Like, you know, a TV 
channel... Just every day, two, three times say, 5 minutes, what is diabetes, how 
important it is, how insulin is important… Because every day we all see the TV, 
in Tamil, or Malay, or Chinese, or English… if they put every day 5 minutes of 
time out, three times a day, I think people will think, you know, these are the 
psychological feelings, every day goes to the mind and they come to think of it.” 
(GP, private practice) 
Non-government organisations 
NGOs could be involved in organisation of conferences for training of HCPs in 
education and counselling of patients with diabetes. 
“…health counselling or health education delivery. Erm... Prof Prochaska’s, 
transtheoretical model, he came to Malaysia last year. So, there was a diabetes 
conference, erm... held by the erm, the Diabetes Education arm of, educators 
arm, of Persatuan Diabetes Malaysia (Malaysia Diabetes Association) ….” 
(Government policy maker) 
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When facing time constraints and lack of expertise, some doctors from the private sector 
felt that NGOs could help by providing a dietetic service and by engaging diabetes 
educators to counsel patients about insulin therapy. 
“...behind (my clinic) there’s diabetic centre of Malaysia... The diabetes centre 
is just behind. So if they actually need some further explanation, just go round 
the corner …that’s for my area. And then there’s also the nutrition specialist, 
they have full diet (full dietary advice) and everything they will…can be 
referred. So in our locality, quite easy.” (GP, private practice) 
Other important roles of NGOs included organising peer support group sessions, health 
screening and road shows; and subsidising glucometers, strips and needles for patients 
with diabetes. 
“We have two big NGOs for diabetes, which is um…the PDM, Malaysian 
Diabetes Association and then NADI, the National Diabetes Institute. So in 
terms of patient support, um…you know I mean…PDM is good in the sense that 
it gives patients the facilities to get uh…you know…I mean, at cost price all the 
equipment, test strips, meters and…and they have very good network, branches 
all over the country. So, they’re actually helping patients. …they are developing 
patient support material and then they go for road shows for screening, public 
screening, the usual thing.” (Endocrinologist, government hospital) 
Multidisciplinary team 
The HCPs suggested that setting up multidisciplinary teams, consisting of doctors, 
assistant medical officers, diabetic educators, nurses, pharmacists and dieticians, would 
greatly facilitate insulin initiation. However, information provision should be consistent 
224 
 
to avoid giving contradictory advice. The involvement of other healthcare team 
members could overcome the time constraints of doctors to counsel patients. 
“...ermm, forming a multidisciplinary team. Although probably not a complete 
team like they have in the hospital, but at least you should have a nurse, a 
medical officer, a specialist will not be available in our clinic. And then the 
pharmacist actually can be involved in the team so that everybody should be 
having a role and then of course you have to make sure that these people 
understand each other’s roles and are giving similar information.” (Family 
Medicine Specialist, government health clinic)  
 
“Uh, in the way there’s short of time, the patient lack of counselling, so I have to 
get somebody, the counselling nurse, to do the counselling. So those are 
uncontrolled they will send to the nurse, the nurse will try to talk to the patient 
and talk about diet, exercise, all those stuff. And then uh they will go back and 
take their medicine and go. So, with the counselling nurse on and then 
subsequently the pharmacists, uh, it can improve a bit. I think for the doctor it’s 
very difficult for the MOs (medical officers) to do the talking. They have no time 
to talk, basically.” (Family Medicine Specialist, government health clinic)  
To overcome the problem of short consultation time and fast turnover of doctors in the 
government clinics, policy makers advocated the empowerment of paramedical staff to 
counsel patients with diabetes who needed insulin. The proposed strategies included a 
reference guide and training programmes targeted at the allied health workers.  
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“Policy level, I feel, although the paramedics can’t prescribe, I feel that they 
actually can play a big role in influencing patient's decision, whether they want 
it or not, how empowered are they to... to... self-titrate, or to monitor. Erm, at 
the primary care level, because they are the constant figure in that particular 
clinic, the doctors come and go. So, I’m keen actually, for this, for example, for 
the insulin to come out with the quick reference to teach the paramedics as well. 
These are the things that can be done.” (Government policy maker) 
The HCPs emphasised the importance of teamwork in helping patients to control their 
diabetes and to advise them on insulin initiation. 
“Hmm… so that’s why our arrangement there… before the doctor sometimes 
sees us first, then we educate them…ha… so we explain to them what they 
should do, should increase which medicine, why sugar levels are high, why 
sugar levels are low, what…hmm… things like that… so teamwork is always 
better.” (Diabetic educator, government university hospital) 
 
“It should be…there must be a diabetic educator, dietician. It should be a 
combined work, not only a doctor who does this. There must be team play. A 
team work to do this.” (GP, private practice)  
Some doctors noted that having team members from different ethnic backgrounds 
helped to overcome the language barriers they face during consultations. 
“…that uh language, I feel, is a very important barrier you have to overcome. 
But anyhow with the help of my MOH (Medical officer of Health) I manage to 
get, uh, lots of Indian staff to be in the clinic. Even I got the sister who’s Indian, 
226 
 
I got the attendant who is Indian. So, basically it when we improve the 
communication, the patient can accept it (the treatment) better.” (Family 
Medicine Specialist, government health clinic)  
Discussion 
The finding from the study highlighted three main strategies to improve insulin 
initiation in a dual-sector health system: (1) collaboration between the public and 
private sector; (2) greater involvement of pharmaceutical industry, media and non-
government organisations (NGOs); and (3) establishment of multidisciplinary teams.  
The participants highlighted the uneven distribution of resources for the management of 
chronic diseases such as diabetes within the dual-sector healthcare system. The 
government health clinics are facing a shortage of doctors (Family Health Development 
Division, 2009; Planning and Development Division Ministry of Health, 2010; National 
Institute of Health, 2010), and the rising incidence of type 2 diabetes will aggravate the 
situation as the majority of patients with diabetes are managed in the public health 
sector. On the other hand, most of the private GPs in Malaysia run solo practices and 
they lack resources and support to initiate insulin. The lack of integration and 
collaboration of the dual-sector health system is a major barrier for insulin initiation in 
patients with diabetes. However, this dual-sector healthcare system may provide a good 
opportunity to improve the care of diabetes by utilising the strength of each sector to 
integrate diabetic care. Studies by the World Health Organisation and others have found 
that an integrated health system can be effective in improving quality of care (Bazzoli et 
al., 1997; WHO, 2008). Recently, a new national healthcare financing mechanism has 
been proposed to integrate the public and private healthcare systems under the 9
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Malaysia Plan 2006–2010, and this includes the primary care services (Economic 
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Planning Unit, 2006; Safurah, 2011; WHO, 2010). This would help to reduce the 
existing discrepancy in the distribution of resources and manpower between the public 
and private sectors for diabetes care, as emphasised by the HCPs in this study.  
In this study, the HCPs also highlighted the role of the pharmaceutical industry in 
providing HCP training and diabetes educators to counsel patients. In recent years, 
pharmaceutical companies have faced criticism (Angell, 2004; Carre, 2001; Moynihan 
& Cassells, 2005) and there are rising concerns about their influence on the HCPs’ 
prescribing decisions (Chren, 1999; Wazana, 2000). Restricting contacts between the 
pharmaceutical industry and HCPs could limit open dialogue, hamper innovation and 
create a gap in educational support for HCPs, at least in developing countries like 
Malaysia (Shipp & Mallarkey, 2009). Moreover, collaboration may result in mutual 
benefit for all parties, including health professionals, the pharmaceutical industry and 
patients (White, 2008). In the care of diabetes and insulin initiation, the collaboration 
between HCPs and the pharmaceutical industry in educational programmes and 
counselling for patients will eventually benefit all parties. However, some regulations 
are needed to prevent undue influence from the pharmaceutical companies. Some 
countries have put in place processes, such as the review and management of research, 
industry codes of conduct, community responses and guidelines by practitioner 
associations, to protect the interests of individual patients and community interests 
(BickestaffeI et al.; Komesaroff, Carney, La Brooy, Tattersall, & Greenberg, 2006; 
Komesaroff, 2007; Komesaroff et al., 2004). This may also help to foster research and 
the development of new products, maintain public confidence in pharmaceuticals and 
medicine, and facilitate ethical decision making among various stakeholders (Green, 
2008; Haines & Olver, 2008; Komesaroff, 2007). The Malaysian Government and local 
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professional bodies in the country may need to develop more comprehensive regulations 
in relation to the involvement of pharmaceutical companies in supporting health 
promotion programmes.  
Non-profit, non-government health organisations play an important role in providing 
counselling services and support in terms of health education, peer group programmes 
and financial assistance to patients with diabetes who need insulin initiation. Danika et 
al. reported that non-profit organisation-sponsored programmes promoting awareness 
about a disease or health condition are more effective than those sponsored by a 
pharmaceutical company (Danika, Jones., & Iverson., 2011). Some consumer groups 
have stressed the importance of active collaborations between health consumer 
organisations and the pharmaceutical industry (Consumers Health Forum of Australia & 
Medicines Australia, 2008).  
The multidisciplinary team approach to diabetes care, such as insulin initiation, is 
considered an essential step towards improvement of patient care (Del Prato et al., 
2005; Kahn & Anderson, 2009). Besides improving the efficiency of the diabetes 
service by reducing the doctor’s consultation time, a multidisciplinary team has been 
shown to improve glycaemic control, lower the risk of diabetes complications, decrease 
health care costs and improve patients’ quality of life (Codispoti, Douglas, McCallister, 
& Zuniga, 2004; Gagliardino & Etchegoyen, 2001). As highlighted by the HCPs in this 
study, a multidisciplinary team from different ethnic backgrounds is crucial to overcome 
the problem of language and cultural barriers, particularly in a multi-ethnic country like 
Malaysia. In a review by Caballero, increased cultural awareness and use of diabetes 
educators speaking the same language as the patients improved acceptance of insulin 
therapy in patients with type 2 diabetes (Caballero, 2006). Currently, in Malaysia, the 
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diabetes care teams are located mainly in the government health care clinics or 
university primary care clinics in urban areas. In the rural settings, many patients with 
diabetes are managed by medical assistants, whose role is mainly to prescribe, provide 
basic health education and identify complications. In view of the benefits of a 
multidisciplinary team approach, Malaysia’s healthcare system should empower the 
allied health workers, such as the medical assistants, by continuously training and 
enhancing their knowledge and skills on diabetes care, including insulin initiation. This 
will reduce the healthcare burden and cost without compromising patient care. 
The strength of this study lies in the fact that the sample encompassed all healthcare 
sectors and stakeholders who were involved in insulin initiation. We were thus able to 
gather data from all levels of HCPs involved in diabetes care. . This study also allows 
comparison of views from the private and government HCPs in a dual-sector health 
system, which may be applicable to other developing countries with a similar health 
system. 
The limitation of this study was that only HCPs’ perspectives were included and 
patients’ views were not captured. The researchers are planning to conduct interviews 
with patients with type 2 diabetes who are considering insulin as part of a larger study. 
Besides that, as the study was conducted in urban and semi-rural areas, therefore the 
findings cannot be generalisable to rural settings. Finally, two of the researchers are 
primary care physicians (PYL and CJN) and this may influence the interpretation of the 
data. These potential biases are reduced by constant reflection by the two researchers 
about their roles and by involving an independent non-clinician (YKL) in the analysis 
process. 
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 Future research should look into how pharmaceutical industry may be involved in 
educating the HCPs in the use of insulin especially in resource-limited countries. 
Secondly, the policy makers should develop strategies to facilitate collaborations 
between public and private health sectors especially in terms of how resources can be 
shared more effectively.  
Conclusions 
The importance of integration and collaboration between the public and private sectors, 
multidisciplinary teamwork and active involvement of NGOs was considered as crucial 
to improve service delivery for insulin initiation and diabetes care in Malaysia. The 
involvement of pharmaceutical industry and NGOs may be important in the resource-
limited private sector. However, some regulations need to put in place to prevent undue 
influence from the pharmaceutical industries on physicians’ clinical decisions. 
Therefore, a proposed integration of the public and private healthcare systems may help 
to make diabetes care, including insulin initiation delivery, more effective and efficient. 
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Research Letter 
51% of patients with type 2 diabetes in Malaysia are reluctant to take insulin (Nur 
Azmiah Z, Zulkarnain AK, & A, 2011). Patient education plays an important role in 
facilitating insulin initiation. In Malaysia, patient education material on insulin is 
lacking and patient education delivery relies on individual healthcare professionals 
(HCPs). Our study aimed to explore HCPs’ views on the content and delivery of patient 
education on insulin initiation. This study was part of a larger three-year study aimed at 
developing a decision support tool for insulin therapy. 
Purposive sampling was used to identify the range of HCPs involved in insulin 
initiation. Between October 2010 and May 2011, fourteen individual interviews (30-40 
minute) and four one-hour-long focus group discussions were conducted (n=41) (Table 
5.3.1). Sample size was determined by data saturation whereby data collection was 
stopped when no new themes emerged. Interviews were audio-recorded and transcribed 
verbatim.  
We employed a qualitative thematic approach to data analysis by coding the transcripts 
according to themes found in the data. Ethics approval was obtained from the Medical 
Research and Ethics Committee, Malaysian Ministry of Health. 
Our analysis showed that patient education content included three issues: the 
progressive nature of diabetes and eventual need for insulin; short- and long-term 
benefits of insulin for diabetes control; and the risk of diabetes complications associated 
with uncontrolled hyperglycaemia. When discussing insulin, HCPs concentrated on 
addressing insulin-related misperceptions and addressing injection-related issues.  
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Table 5.3.1 Demographic profile of participants 
Characteristics Number 
(n= 41) 
% Mean + SD 
(Range) 
Age   46.6 + 9.8 years  
(30-66 years) 
Sex    
Female 31 75.6  
Male 10 24.4  
Ethnicity    
Malays 15 36.6  
Chinese 10 24.4  
Indians 13 31.7  
Others 3 7.3  
Professional background    
General practitioner/ 
Medical Officer 
20 48.8  
Family medicine specialist 10 24.4  
Government policy maker 5 12.2  
Diabetes nurse educators 3 7.3  
Endocrinologists 2 4.9  
Pharmacist 1 2.4  
Healthcare sector    
Public 26 63.4  
Private 15 36.6  
 
HCPs described four approaches to educate patients on insulin initiation: simplifying 
the insulin initiation process; downplaying side effects; giving worst case scenarios; and 
using analogies to describe the need for insulin. Although some HCPs realised that 
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downplaying the side-effects and risks could be misleading, they would only explain the 
risks once the patient agreed to start insulin. Most, however, felt that it was important to 
educate the patient about hypoglycaemia.  
“You cannot tell them the bad points. Bad points will only be, tell them if you 
have hypoglycaemia, be prepared to watch out for yourselves. That’s 
all…everything else is benefits.” 
     General practitioner, private practice 
As a result of a lack of patient education material, HCPs used a variety of gadgets and 
handwritten information to counsel patients during insulin initiation, including: 
demonstrating to patients how to use an insulin pen; using HbA1c records as evidence 
of poor diabetes control; and using aids such as models of the pancreas to help explain 
the pathophysiology of diabetes. HCPs also provide written patient-specific information 
as they felt that verbal information alone was not enough for patient education. 
This study found that insulin counselling approaches used by HCPs often involve 
providing comprehensive information on benefits (rather than the risks) of insulin and 
ensuring patient understanding with the intention of persuading patients to start insulin. 
One concern is that, although a persuasive communication style may help to convert 
patients to insulin therapy, it may negatively affect future adherence to treatment. Non-
adherent patients frequently feel that their HCP had not properly explained the risks and 
benefits of insulin to them (Karter et al., 2010).  
In conclusion, Malaysian HCPs counselled patients who are considering insulin 
treatment; however, the information provided was biased towards the benefits of 
insulin. Therefore, patient education would benefit from a more structured and balanced 
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approach. This may involve training HCPs to support patients in decision making 
(Legare et al., 2012). In view of recent evidence that intensive glycaemic control with 
insulin may cause harm (Skyler et al., 2009), it is prudent that HCPs discuss the risks 
and benefits of insulin treatment with patients and help them make an informed 
decision.   
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Abstract 
Objectives 
This study aimed to explore patients’ views on their decision-making (DM) role 
preference and factors influencing this during insulin initiation. 
Methods 
We conducted individual in-depth interviews with people with type 2 diabetes who were 
making decisions about insulin treatment. Participants were selected purposively to 
achieve maximum variation. A semi-structured topic guide was used to guide the 
interviews which were audio-recorded and analysed using a thematic approach. We 
interviewed 22 participants between January 2011 and March 2012. The age range of 
participants was 28-67 years old. Our sample comprised 9 women and 13 men. 
Results 
The majority of patients preferred an active role in decision making (n=10). Six patients 
preferred a passive role where the doctor should make the decision. Lastly, only one 
patient expressed a preference for a collaborative role (patient prefers to share the 
decision with the doctor). In five participants, we were unable to determine their 
decision making preference. The following themes emerged as factors influencing 
patient’s DM role preference: trust in HCPs, responsibility for diabetes care, level of 
knowledge and awareness, involvement of family and personal characteristics.  
Conclusion 
Patient DM role preferences are influenced by views of the doctor-patient relationship, 
societal roles amongst family and peers, and their knowledge of the disease. Most 
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patients in Malaysia have a pre-existing DM role preference. However, few patients in 
Malaysia view the doctor-patient relationship as a collaborative partnership and more 
research needs to be done on encouraging shared decision making in Malaysian 
healthcare practice.  
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Introduction  
Encouraging patient participation in the clinical decision making encounter is advocated 
in healthcare policies (Institute of Medicine, 2012), research initiatives (Selby, Beal, & 
Frank, 2012) and medical practice models (Charles, Gafni, & Whelan, 1997; Elwyn et 
al., 2012). One aspect of patient involvement is decision making (DM) role preference. 
A patient’s DM role preference can be defined as "the degree of control an individual 
wants to assume when decisions are being made about medical treatment." (Degner, 
Sloan, et al., 1997b). Patients desire different levels of participation; this may range 
from desiring an active role (patient prefers to have full control of the decision), 
collaborative/ shared role (patient and doctor share control of the decision) to a passive 
role (patient prefers doctors to make the decision)(Caress, Luker, Woodcock, & Beaver, 
2002; Degner, Sloan, et al., 1997b; Heesen, Kasper, Segal, Kopke, & Muhlhauser, 
2004; Kraetschmer, Sharpe, Urowitz, & Deber, 2004). 
Studies have shown that a discord often exists between patients’ DM role preferences 
and actual roles in decision making. In a review of 22 studies, Tariman et al reported 
that across all cancer types, patients wanted more participation than what actually 
occurred (Tariman, Berry, Cochrane, Doorenbos, & Schepp, 2010). Some socio-
demographic groups experience more discord than others; in another review, less 
women than men (60% vs 66%, P = .001) and less Canadian patients than US patients 
(54% vs 84%, P <.001) reported concordance between their preferred versus actual 
roles (Singh et al., 2010).Accurate elicitation of DM role preference is important in 
order to address preference-specific barriers to patient participation (Caress, et al., 
2002). Strategies for elicitation include the use of vignettes and card sorts. Such 
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strategies however are limited by a short consultation and poor relationship between 
patient and doctor (Caress, et al., 2002). 
A variety of factors have been significantly associated with patients’ DM role 
preference, including: type of disease (Beaver, Bogg, & Luker, 1999),information-
seeking preference (Loeffert et al., 2010), trust in doctor (Kraetschmer, et al., 2004; 
Loeffert, et al., 2010), doctors' participatory decision-making style (Loeffert, et al., 
2010), educational level (Levinson, Kao, Kuby, & Thisted, 2005; Loeffert, et al., 2010), 
age (Loeffert, et al., 2010), gender (Levinson, et al., 2005), level of health (Levinson, et 
al., 2005) and race (Levinson, et al., 2005). However, little research has been conducted 
on exploring the motivation behind patients’ DM role preference. One qualitative study 
of adult asthma patients (n=32) revealed how patients desire for participation was 
different from their desire for control. The study concluded that although most patients 
wished to contribute or feel involved in decision making, this would not necessarily 
mean they wanted to control it (Caress, et al., 2002). 
Decision-making may also involve significant others, especially family members. 
Despite this, instruments used to assess DM role preference usually only focus on the 
patient-doctor dyad (Degner, Sloan, et al., 1997b). For example, the widely-used 
Control Preferences Scale was developed from grounded theory that initially included a 
family-controlled decision making preference (Degner & Russell, 1988). However 
subsequent versions of the scale only included options related to the patient-doctor dyad 
(Degner et al., 1997a; Degner, Sloan, et al., 1997b; Frank-Stromborg & Olsen, 2004).  
The study of patient’s DM role preference during insulin initiation in type 2 diabetes in 
Malaysia is useful in two ways. Firstly, exploring DM role preferences  may elicit some 
barriers to patient participation which may hinder informed decision making about 
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insulin. Study had shown that patients with diabetes who feel that their autonomy has 
been supported are more satisfied and have a better mental health-related quality of life 
(Y. Y. Lee & Lin, 2010). Hence, understanding the patients’ DM role preferences may 
improve the approaches in discussion of insulin initiation. This is important as insulin 
uptake in Malaysia remains poor (Letchuman et al., 2010) despite a high prevalence of 
poor glycemic control (Mafauzy, 2005). The Malaysian clinical practice guideline also 
recommends insulin initiation in patients with type 2 diabetes mellitus who are poorly 
controlled despite taking optimal oral glucose-lowering drugs (Ministry of Health, 
2009).  
Secondly, the study would shed light on discrepancies between preferred and actual DM 
role preference in Malaysia where medical paternalism (Mazlina & Julia, 2011; Zalilah, 
Mazanah, & Ahmad Zamri, 2008) and a lack of patient information (Yousuf, Fauzi, 
How, Akter, & Shah, 2009) are common. Malaysia has a dual-sector healthcare system 
comprising public government-subsidized healthcare and private fee-for-service sectors. 
One previous study has noted that a consumerist DM role preference mentality is 
common even in UK’s exclusively public-funded health system, signifying a 
consumerist shift away from paternalism in healthcare (Caress, et al., 2002).  This study 
would help to assess if patients from both private and public sectors in an Asian country 
like Malaysia, desire to be involved within the context of chronic disease treatment 
decisions.  
Studies on patient preferences for participation in clinical decision making are mostly 
population-based survey data. Little research has been conducted on exploring patients’ 
DM role preference regarding significant others. This study aimed to explore patients’ 
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views on their decision-making role preference and factors influencing this during 
insulin initiation.  
This study is part of a larger 3-year study that aims to produce a patient decision aid for 
use in a local primary care setting with patients with type 2 diabetes who are making a 
decision about insulin initiation.  
Methods 
Methodological approach 
As few studies have been reported on the rationale for patient’s DM role preferences, 
and in view of the exploratory nature of the research question, a qualitative study design 
was chosen. We decided on using semi-structured in-depth individual interviews as this 
would allow us to explore in depth each patient’s preferences within their experience of 
insulin initiation.  
Conceptual framework 
We used the shared decision making model as our conceptual framework, which aims to 
help clinicians and patients collaborate on making a decision together based on the 
integration of clinician’s knowledge and patient preferences (Barratt, 2008; Makoul & 
Clayman, 2006). Drawing on the Ottawa Decision Support Framework (O'Connor, 
2006), we developed an interview topic guide exploring patients’ DM role preferences 
and barriers and facilitators to making a shared and informed decision.  
Setting 
This study was conducted in Malaysia, a multi-cultural country comprising three main 
ethnicities (Malay, Chinese and Indian) and numerous other smaller ethnic groups. 
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Malay is the official and most common language, but each ethnicity usually also speaks 
their mother tongue. The country has a dual healthcare system:  public (government 
subsidized hospitals and health centres serving majority of the population) and private 
(fee-for-service hospitals and clinics) sectors. Patients are free to choose where they 
receive treatment. 
Sampling  
Patients with type 2 diabetes who were making or had made a decision about insulin 
within the past 1 year were included in this study. Healthcare professionals from the 
various healthcare settings helped to recruit participants for our study. We did this by 
explaining the study to the clinicians and distributing brochures detailing the inclusion 
criteria for our study and our contact information. As much as possible, we tried to 
conduct the interviews soon after doctors had advised patients to start insulin in order to 
capture patients’ initial experience and values in regards to insulin initiation. 
Purposive sampling was used in order to achieve maximal variation based on three 
factors: healthcare setting, patients’ decision about insulin, and ethnicity of patients. To 
achieve a broad socio-demographic range, we recruited patients from both public and 
private settings as well as from both rural and urban settings. We sought patients who 
were both open to insulin as well as averse to it. We also included patients who had 
prior experience with insulin use but had now stopped using it if they had initiated 
insulin within the past one year.  
Data collection 
An interview topic guide was developed based on literature review, conceptual 
framework and expert opinion (Table 5.4.1). The topic guide was pilot-tested and 
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iteratively modified based on themes that emerged during both pilot and subsequent 
interviews. Both participant information sheet and topic guide were translated into 
Malay and Chinese by researchers who were fluent in these languages. 
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Table 5.4.1 Interview topic guide 
Introduction 
1. Have you been asked to start insulin? 
2. What has been going through your mind since you were advised to start insulin?  
Actual decision making role  
3. Who else is involved in making this decision? What are their roles? 
a. doctors,  
b. family and  
c. friends 
Preferred decision making role 
4. Who do you think should make the decision about you starting insulin? 
a. Yourself 
b. Doctors 
c. Family 
d. Others 
 
Semi-structured in-depth interviews were conducted with patients in their preferred 
language (English, Malay or Chinese). Interviews were conducted by three researchers 
trained in qualitative research methods (YK, CJ, and PY) and each lasted 30-45 
minutes. Researchers arranged to interview patients at a time and location of their 
convenience, including their homes or workplaces if patients were unable to travel due 
to work commitments or infirmities. Participants were reimbursed for their time and 
travel.  
All participants gave written consent to participate in the research and for their 
interviews to be audio-recorded. In cases where the participant was illiterate, the 
information sheet was read out to the patient and patients indicated their consent by 
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initialling the consent form. However, most illiterate participants were accompanied by 
a literate family member who was able to explain the information sheet to them. 
Patients were told that the data would be confidential and anonymous.  
We chose to explore DM role preference verbally with the question “Who should make 
the decision about insulin?” with prompts for self, doctor and family. In cases where the 
family accompanied the patient for the interview (n=2) we observed and recorded 
interactions between the family and patient in the field notes and sought information 
from the family regarding the family’s participation in the decision making process. 
Data analysis 
Interview transcribing was the first step in analysis. English and Malay interviews were 
transcribed verbatim whilst Chinese interviews were translated into English for analysis. 
Malay interviews were not translated as all researchers have good command of the 
language. Thematic analysis was used to analyse the data where by connected themes 
were coded into larger nodes. Three researchers (YK, WY, and CJ) coded two 
interviews line by line to develop an initial list of nodes. A process of constant 
comparison was employed whereby subsequent interviews were coded using this list 
and new themes which emerged from new interviews were added to the list upon 
consultation with the research team.  
Nodes were collated into broader categories based on thematic similarities between 
nodes in monthly face-to-face discussion meetings. Finally selective coding was 
conducted to generate central or core categories based on connecting and consolidating 
axial codes. All codes were checked by two researchers (YK, CJ) to ensure consistency 
of coding and consensus on the list of nodes.   
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After thematic analysis, a framework analysis was applied to the categories of data to 
categorize patients according to their expressed DM role preference based on patients’ 
responses to the DM role preference prompt in the interview.  
Data collection was stopped when thematic data saturation was reached. Evidence of 
data saturation was obtained when no new free nodes emerged from the data, showing 
that the core categories had already been captured. A secondary saturation criterion was 
based on the saturation of free nodes, as there was evidence of repeated coding within 
the same codes.  
Data analysis was facilitated by the use of Nvivo9 software (Nvivo9, 2010) to manage 
transcripts, themes and quotes, whilst keeping in mind the context of the quotes within 
the individual interviews. 
Ethics 
Ethics approval was obtained from the Medical Research and Ethics Committee, 
Ministry of Health, Malaysia and the Medical Ethics Committee, University of Malaya 
Medical Centre. 
Results 
Sampling characteristics  
A total of 22 patients were interviewed between January 2011 and February 2012. 
These patients came from 5 different healthcare locations (1 public hospital based 
primary care clinic, 3 public health centres, 1 private clinic). Patient demographic 
information can be found in Table 5.4.2. Although most patients were from an urban 
setting, even within the urban sample patients were very diverse as they came from 
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different socio-economic levels. Although patients were informed that they would be 
participating in an individual interview, four patients were accompanied by family 
members. In such instances, care was taken to avoid having the family members 
dominate the discussion by consciously focusing questions on the patient. 
The majority of patients preferred an active role in decision making (n=10). Six patients 
preferred a passive role where the doctor should make the decision. Lastly, only one 
patient expressed a preference for a collaborative role (patient prefers to share the 
decision with the doctor). In five participants, we were unable to determine their 
decision making preference. They were unable to respond to the question when asked 
about their DM role preference despite repeated prompts and most (n=4) had minimal 
formal education (primary school or no formal education).  
The following themes emerged as factors influencing patient’s DM role preference: 
trust in HCPs, responsibility for diabetes care, level of knowledge and awareness, 
involvement of family and personal characteristics. 
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Table 5.4.2 Characteristics of participants. Values are numbers unless stated 
otherwise 
Characteristic Participants (n=22) 
Male 13 
Mean (SD) age (years) 54.68 (9.29) 
Age range 28-67 
Healthcare setting 
- Public university hospital based primary care 
clinic 
- Public healthcare clinics 
- Private specialist clinic 
 
8 
7 
7 
Location 
- Urban 
- Semi-urban/ Rural 
 
19 
3 
Language interview was mainly conducted in 
- Malay 
- English 
- Chinese 
 
11 
8 
3 
Ethnicity 
- Malay 
- Chinese 
- Indian  
 
6 
5 
11 
Highest level of education 
- No formal education 
- Primary 
- Secondary  
- Tertiary 
 
3 
7 
6 
6 
Decision-making role preference 
- Active role (patient prefers to make the decision) 
- Collaborative role (patient prefers to share the 
decision with the doctor) 
- Passive role (patient prefers the doctor to make the 
decision) 
- Unsure/ researcher unable to determine 
 
10 
1 
 
6 
 
5 
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1) Patient’s trust in HCP 
Levels of trust in the HCP were an influence on patients preferring either active or 
passive roles. Patients who preferred passive roles did so because they trusted the 
professional training of the doctor and left the decision to the doctor. The doctor was 
viewed as an authority on the disease who knew the best course of treatment.  
I don’t think much about it (the decision); I leave it to the doctors. They are the- 
that’s why I told Dr. S that she’s, on disease, an authority, let her decide. 
Patient F4, Female, 61 years old, public university hospital diabetic clinic. 
Conversely, patients preferred an active DM ROLE PREFERENCE if they had a low 
level of trust in doctors. One patient said he mistrusted the doctor, and felt that the 
diagnosis was vague and inaccurate. He only went to doctors as it was necessary for 
obtaining prescriptions. 
I make (the decisions) myself…doctors, I don’t take so much interest (in) 
doctors, because they’re not telling me the right thing. If you (the doctor) telling 
right, what sickness I’m suffering from, or what’s the problems with me, then I 
don’t mind. But to me, I feel they’re very vague and don’t want to tell me. So I 
don’t really follow their words and… I’m just going doctor for the sake of 
getting medicine, that’s all. 
Patient M10, Male, 55 years old, public hospital based clinic. 
 
 
 
252 
 
2) Responsibility for diabetes care 
The roles and responsibilities played by various parties during insulin initiation 
influenced patients’ DM role preferences. Patients considered their own role as well as 
the roles of their families and doctors.  
An active role was preferred if patients felt that the responsibility of decision making 
and injection administration was their own. Firstly, patients preferred an active role if 
they felt that the final say in the decision was theirs and not the doctors. Although the 
doctor provided professional opinion and monitored the patient’s treatment, the patient 
would have to agree to insulin as the next course of treatment. 
(I prefer to make the decisions) myself…the doctor just gives his opinion. If I 
accept, the reality is that I have to do it myself. That’s all. 
Patient M2, Male, 61 years old, public health clinic. 
(The decision is) mine. Even if the doctor decides to give the insulin he must 
have my approval. That means I must agree before it happens. He can suggest, 
then I’ll see if I accept or not. His (the doctor’s) responsibility is to follow 
through with the treatment, or advise us to do this, which medicine is important 
to eat or even to take insulin, like that lo. 
Patient M8, Male, 60 years old, private clinic. 
Patients who knew that they would be self-administering insulin made the decision 
themselves as they knew that the administration of insulin would be their own 
responsibility. Although there was potential help from family members, they preferred 
to inject the insulin on their own.  
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I made decision myself, they said I have to do it; ok I’ll do it, no problem. I 
didn’t like my wife jabbing me you know because I’d rather do it myself you 
know that some people they prefer to have other people jab them you know.  
Patient M1, Male, 47 years old, public hospital-based clinic. 
Only one patient expressed a preference for a collaborative role. The patient realized 
that both doctor and patient had roles to play in insulin initiation; the doctor provided 
medical advice while the patient was responsible for self-monitoring of her diabetes.  
Err… I think (the decision on who should start insulin is) 50:50, the doctor will 
also advise me isn’t it, you see? I think is 50:50.I also feedback to the 
doctor.Ahh… because I monitor my diet, I monitor my reading, you see. So like 
every morning ahh… I take one piece of wholemeal and ahh… Nescafe without 
sugar, the reading also that high, you see. What you (doctor) want me to do, you 
see? 
Patient F8, Female, 57 years old, private clinic. 
3) Level of knowledge and awareness 
Some patients admitted feeling not that they did not know anything about medicine and 
accepted the doctor’s recommendations.  
Because I know nothing about medicine field. Of course the doctor told me 
about insulin mahh… He proposed to me, then I just accept lohh.  
Patient M13, Male, 43 years old, private clinic. 
For some patients, collaboration was aided by the patient’s knowledge about the 
disease. One patient requested her doctor to initiate insulin when oral medication failed 
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to control her diabetes: “My (blood sugar) reading didn’t come down, then I told Dr H 
maybe should start on insulin, you see. He said yes… because I heard so many stories 
ahh, if the drugs cannot work then you have to take insulin, you see.”(Patient F8, 
Female, 57 years old, private clinic). 
4) Involvement of family 
Some patients would discuss the doctor’s advice with their spouse before deciding on 
whether to start insulin.  
No uh…doctor was telling to me (about insulin), then I went and tell my wife… 
My wife said, just uh what the doctor say is good means, just carry on follow the 
suggestion lah. Then I have to follow the doctor what he said after her... I have 
to follow lah. 
Patient M3, male, 63-year old, public health clinic 
When it came to actual decision-making, patient’s families played an active role in 
making the decision by gathering health information, sitting in with the consultations, 
and voicing their opinion on insulin.  
If she (the patient) decides then, she should consult, because we (the family), we 
usually take her, to visit the doctor, so we seek the doctor’s advice, he’s also 
involved so we ask him whether whatever action, can we do this, we let her 
know. Because we also read the papers, magazines, surf the net, so from there 
we get all sorts of information then we just share with her.  
Patient’s daughter (Patient F7, female, 63-year old, private clinic) 
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However, some patients preferred not to involve the family or peers when make 
decisions for their health. Patients did not involve others because they felt that health is 
a personal topic that should not be discussed with others. Although the patient below 
discussed the decision about insulin with his wife, he said that he would not discuss the 
topic with his friends due to a code of social conduct, whereby health issues were 
considered private and it was important to maintain his image of masculine normality. 
Never say anything (to others)…because my people, friends, friends all their 
personal thing…they for keeping personally… they secret never leak out. I also 
don’t want…I got sick lah, I got all this all, I don’t want to say. I want to just 
like normal, man lah… I want uh just like normal lah man lah…I just take the 
medicine, I control the sugar. I’m a man lah..normal man.  
Patient M3, male, 63-year old, public health clinic 
Family dynamics were found to influence DM role preferences. Patients pointed out that 
they needed opportunities to discuss decisions and their role in the family. One patient’s 
role as the ‘head of the family’ dictated his freedom to make his own health-related 
decisions.  
Our family is only together once in a while…As the head of the family I would 
want my own liberty to do things ma. If, if it’s about my own thing then I must 
do it myself, make decisions. 
Patient M8, male, 60-year old, private clinic 
Another patient noted that she did not want to involve her husband as he was busy with 
his work. 
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…he (patient’s husband) doesn’t know anything. He’s busy with his work, you 
see. There’s no point discuss, he’s not doctor, he’s not medical person, you see, 
he won’t know anything. 
Patient F8, female, 57-year old, private clinic 
Patient views on the treatment played a part in deciding whether or not to include others 
in their decision. Patients did not include others if insulin was viewed as a routine part 
of diabetes treatment, which was not a major decision. 
Interviewer: Who else did you involve in the decision? 
Patient: Me and me myself. Nothing lah…I don’t see it’s anything so big la. It’s 
just like today you’re saying you must take Metformin, tomorrow you’re saying 
you have to add Diamicron, so what? 
Patient F1, female, 58-year old, public university hospital primary care clinic 
5) Personal characteristics 
Individual traits such as socio-economic background and personality type influenced 
patients DM role preference. Patients with low education levels often had difficulty 
understanding and articulating their preferred DM role preference. In terms of 
personality type, one patient noted that taking an active decision making role was a 
consistent trait across other types of decision making scenarios.  
All my life, I make the decision. Even with my husband the final say will be 
mine, I’m a very, what do you call it, very strong will- like a man all my life. 
Even when I was a (high school) student, I’ll be the school captain those days 
even with my health, that time also. 
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Patient F4, Female, 61 years old, public hospital based clinic. 
In general, patients who were more educated were better able to articulate their DM role 
preference whilst patients who were less educated had difficulty responding to questions 
about preferences. In the following example, the patient did not reply to the 
interviewer’s question about decisional making preference but instead described how 
the insulin initiation process was conducted. 
Interviewer: Who should make the decision, for injection? The doctor makes 
the decision, you make the decision, or your family makes the decision? 
Patient: Oh, my family is not like this. Ah…I am taking the injection. But my 
mom has diabetes as well. But my mom doesn’t take injections.  
Interviewer: No injections…so the decision to take injections, who should 
make that decision? You or the doctor? 
Patient: The doctor gave me (the injections).  
Patient F3, Female, 48 years old, public health clinic. 
Discussion 
This study gives insight into patient’s views on their preference for an active, 
collaborative or passive role during insulin initiation. Our study identified five 
categories of factors that influenced patient DM role preferences: trust in HCPs, 
perceived responsibility, level of knowledge, perceived family involvement and 
personal characteristics. Caress et al’s study on patients with chronic asthma reported 
similar themes, whereby respondents cited level of knowledge; trust; duration of 
condition; severity of condition at the decisional juncture; lifelong nature of asthma; a 
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perception that “it is my body”; characteristics of the individual and their response to 
health professionals as influencing role preference (Caress, et al., 2002).   
In terms of preferences between active and passive roles, the majority of the patients in 
both private as well as public sectors preferred an active role. Thus, it is not only 
‘paying customers’ that want to have a say in treatment options. Previous studies report 
that even in an entirely public-funded healthcare system, patients still exercised a 
‘consumerist’ mentality and desire active participation in decision making (Caress, et 
al., 2002). This raises the question of how best to assess patient’s DM role preferences 
in a consultation as it is hard to differentiate active, collaborative and shared patient DM 
role preferences based on consultation behaviour alone (Kumar et al., 2010). Engaging 
patients in open discussion about decision-making preferences is more effective than 
relying on interpreting communication behaviour (Kumar, et al., 2010). This may prove 
challenging in Malaysia where barriers to insulin initiation include the lack of time in 
consultations, low manpower resources and substantial language barriers (Y. K. Lee, 
Lee, & Ng, 2012). 
Other studies have reported that in general, patients who prefer a passive role have 
above-average trust in their doctor (Kraetschmer, et al., 2004; Loeffert, et al., 2010). 
Levels of trust increase in response to a positive perception of doctor’s decision making 
style and the establishment of the doctor-patient relationship over time (Loeffert, et al., 
2010). Our study shows that the converse is also true; patients who have low levels of 
trust in doctors prefer a more active role. In such instances, patients may view doctors 
as gatekeepers (providing access to medication) rather than caregivers. Counselling 
during the consultation may be needed to establish a more therapeutic doctor-patient 
relationship. Level of trust may also be related to patient knowledge; patients with low 
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levels of knowledge feel that they should adopt a passive role and concede decision 
making control to the more expert doctor (Caress, et al., 2002).   
Perceived responsibility was related to self-administration of insulin. An active role was 
preferred if patients perceived that they would be responsible for administering 
injections and managing the treatment regime. Compared to acute health conditions, 
chronic conditions involve a higher degree of self-management and patients are more 
aware of how future consequences would affect them. Similarly, asthma patients also 
preferred an active role if they perceived that it was “’their body’ into which treatment 
would be ingested” (Caress, et al., 2002). Potential conflict arises as chronic disease 
management can be routine and doctors may lapse into an automatic step-up regime for 
their patients without taking the effort to involve patients in the treatment decisions. 
Under the theme of perceived family involvement, most patients did not wish to involve 
significant others in their decision to take insulin. Male patients especially were 
influenced by masculine roles (e.g. toughness and family headship) in preferring 
individualistic decision making. In contrast, 100% of eighty men with prostate cancer 
reported preferring a collaborative role with their partners (Davison, et al.; 2002). Two 
possible explanations can be given for this. Firstly, the characteristics of the disease and 
subsequent choices are different. Cancer carries a greater urgency, and is uses up more 
resources, whilst insulin can be delayed and is a part of long-term chronic care. 
Secondly, the cultural notion of family headship could influence Asian men to make the 
decision alone, despite the emphasis in Asian culture on communal caregiving (e.g. 
familial obligation, extended family support) (Kong, 2007). 
In this study, verbal communication about decisional preferences elicited little more 
than descriptions about the consultation experience. Strategies to aid patients in 
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expressing DM role preference such as providing card sorts and computer aids may be 
helpful (Neufeld, Degner, & Dick, 1993). However, modifications such as graphical 
representations of DM role preference will be needed for patients with low literacy 
levels. Besides the use of aids, doctors should aim to practice a more participative 
communication style to facilitate patient’s expression of DM role preference. Healthcare 
professionals can help alleviate barriers to service-user participation by assessing if a 
preference for autonomy is due to a lack of trust (Kraetschmer, et al., 2004), ensuring 
patients are not disempowered by a lack of knowledge (Caress, et al., 2002; 
Kraetschmer, et al., 2004) and supporting patients who feel ‘abandoned’ or worried 
about participating (Elwyn, et al., 2012). 
Only one patient was able to state that she preferred a collaborative role. One reason for 
this could be because we did not include a ‘shared’ role item prompt in the DM role 
preference  interview guide as we were unaware of the spectrum of DM role preference 
at the time of guide development (refer to Table 2). However, the fact that most patients 
(16 out of 22) were able to express a DM role preference for either active or passive 
roles shows that the DM role preferences in Malaysia may still be heavily skewed 
towards either doctor or patient control, with little conceptualization of the patient-
doctor encounter as being a collaborative partnership. Thus, even if shared decision 
making were to be advocated as an ideal option, patients may find expressing their 
preferences surprising, unsettling and hard to comprehend (Elwyn, Frosch, & Rollnick, 
2009a). 
Limitations 
The study had a number of limitations. Firstly, allocation of patient’s DM role 
preferencewas done through verbal elicitation. A clearer preference would have been 
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obtained by asking patients to choose using a range of vignettes or preferences. 
However, this does not affect validity as this was a qualitative study and no statistical 
analyses were performed on the correlation between DM role preference and factors. 
Furthermore, verbal elicitation of DM role preference was useful in uncovering 
potential communication barriers in consultations and these barriers are reported.  
Secondly, the study has low generalizability as it focuses specifically on insulin 
initiation. As discussed above, decisional context may influence preferences for DM 
role preference and partner involvement.  
Thirdly, the study results are skewed to either patient- or doctor-only decision making 
preferences as a collaborative role option was not offered to participants. The impact of 
this in the research methodology is discussed in the last paragraph of the discussion 
section above.  
Strengths 
The studies strengths are that we explored DM role preferences within a diverse sample 
involving different ethnicities, languages and healthcare systems. Previous qualitative 
studies have been conducted in western, largely mono-cultural, single healthcare system 
contexts. Our study reports a range of DM role preference in both public and private 
healthcare systems and inference is made that patient decision making roles are skewed 
to either doctor or patient with little conceptualization of a collaborative partnership.  
Conclusions 
Patient DM role preferences are influenced by views of the doctor-patient relationship, 
societal roles amongst family and peers, and their knowledge of the disease. Most 
patients in Malaysia have a pre-existing decision making role preference. However, few 
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patients in Malaysia view the doctor-patient relationship as a collaborative partnership 
and more research needs to be done on encouraging shared decision making in 
Malaysian healthcare practice.  
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Chapter 5.5: Exploring patient values in medical decision making: A 
qualitative study 
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Abstract 
Background 
Patient decisions are influenced by their personal values. However, there is a lack of 
clarity and attention on the concept of patient values in the clinical context despite clear 
emphasis on patient values in evidence-based medicine and shared decision making. 
The aim of the study was to explore the concept of patient values in the context of 
making decisions about insulin initiation among people with type 2 diabetes. 
Methods and Findings 
We conducted individual in-depth interviews with people with type 2 diabetes who were 
making decisions about insulin treatment. Participants were selected purposively to 
achieve maximum variation. A semi-structured topic guide was used to guide the 
interviews which were audio-recorded and analysed using a thematic approach. We 
interviewed 21 participants between January 2011 and March 2012. The age range of 
participants was 28-67 years old. Our sample comprised 9 women and 12 men.  
Three main themes, ‘treatment-specific values’, ‘life goals and philosophies’, and 
‘personal and social background’, emerged from the analysis. The patients reported a 
variety of insulin-specific values, which were negative and/or positive beliefs about 
insulin. They framed insulin according to their priorities and philosophies in life. 
Patients’ decisions were influenced by sociocultural (e.g. religious background) and 
personal backgrounds (e.g. family situations). 
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Conclusions 
This study highlighted the need for expanding the current concept of patient values in 
medical decision making. Clinicians should address more than just values related to 
treatment options. Patient values should include patients’ priorities, life philosophy and 
their background. Current decision support tools, such as patient decision aids, should 
consider these new dimensions when clarifying patient values.  
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Introduction 
Patient decisions are influenced by their personal values; however, there is a lack of 
clarity and attention on the concept of patient values in the clinical context. This is 
despite clear emphasis on patient values in evidence-based medicine (EBM) and shared 
decision making (SDM) (Elwyn et al., 2012; Makoul & Clayman, 2006; O'connor, 
2001; Sackett, Straus, Richardson, Rosenberg, & Haynes, 2000). EBM advocates that 
patients and clinicians make a choice together after considering the best available 
evidence, the clinician’s experience and the patient’s values (Barratt, 2008; Makoul & 
Clayman, 2006). 
Current definitions of patient values are often vague (e.g. patient values are “the 
features that matter most to patients (International Patient Decision Aids Collaboration, 
2006)”, “the unique preferences, concerns and expectations each patient brings to a 
clinical encounter and which must be integrated into clinical decisions if they are to 
serve the patient” (Sackett, et al., 2000)) or too narrow. For instance, international 
standards for patient decision aids narrow the scope of value clarification methods to 
patient views on physical, psychological and social effects, and the positive and 
negative features that matter most to patients (Elwyn et al., 2009b).  
To date, most studies on the patient role in shared decision making have focused on 
measurable patient outcomes, such as more accurate risk assessment (Carling et al., 
2009) or increased patient involvement during consultations (Couet et al., 2013). Little 
research has been conducted on how patients actually choose between options and the 
patient voice is missing from the conversation (The PLoS Medicine Editors, 2007; 
2009).  
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Previous studies have reported that values function as a filter through which patients 
interpret clinical evidence (Charles, Gafni, & Whelan, 1997; Lockwood, 2004; Reyna, 
2008) and make treatment choices (Karel, 2000; Lockwood, 2004). Understanding how 
values influence patient decision making is particularly relevant to preference-sensitive 
decisions where there are trade-offs or when there is no one best option. Insulin 
initiation is one such example of a ‘difficult’ decision which is influenced heavily by 
patient values (Lee, Lee, & Ng, 2012; Polonsky, Fisher, Guzman, Villa-Caballero, & 
Edelman, 2005). This is particularly important in the context of diabetes which is 
reaching epidemic proportion and has significant morbidity and mortality (Whiting, 
Guariguata, Weil, & Shaw, 2011).  
This study used insulin initiation as an exemplar to explore patient values and proposed 
to create a new model to explain patient values in the context of decision making. It 
aimed to explore and define patient values because this may help clinicians to 
understand and address patient concerns and expectations when making decisions. 
Methods 
Ethics Statement 
This study received ethics approval from the Medical Research and Ethics Committee, 
Ministry of Health, Malaysia (Ref No: NMRR-10-1233-7299) and the Medical Ethics 
Committee, University of Malaya Medical Centre, Kuala Lumpur (MEC Ref No: 
841.6).  
Methodological approach 
Due to the lack of literature on values from patients’ perspective, and the exploratory 
nature of the study, a qualitative study design was chosen (The PLoS Medicine Editors, 
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2007). We conducted individual semi-structured in-depth interviews to explore each 
patient’s values within their experience of insulin initiation. This study formed part of a 
larger three-year project to develop a decision support tool for clinicians and patients 
who are making decisions about insulin therapy. 
Conceptual framework 
Our study was developed from the perspective of a SDM model. We used the Ottawa 
Decision Support Framework (ODSF), an SDM implementation framework, as the 
conceptual framework within which patient values are nested (A. M. O'Connor, 2006; 
A. M. O'Connor et al., 1999). The ODSF identifies the decisional needs of patients as 
values, decisional conflict, knowledge and expectations, support and resources, decision 
characteristics, and, personal characteristics. Patient values are defined in the ODSF as 
the “desirability or personal importance of outcomes of options” (A. M. O'Connor, 
2006). We developed a topic guide with 16 questions exploring two main decisional 
attributes: barriers and facilitators to insulin initiation and barriers and facilitators to 
decision making; the former focused on patient’s perceptions about insulin itself, while 
the latter explored the patient’s experience of the decision making process. In order to 
explore in-depth the topic of values, we then incorporated Schwartz’s theory of values, 
which is a psychological theory relating to the priority and function of human values (S. 
H. Schwartz, 2006). In this theory, the five key attributes of values are: “(1) values are 
concepts or beliefs; (2) values pertain to desirable end states or behaviors; (3) values 
transcend specific situations; (4) values guide selection or evaluation of behavior and 
event; and (5) values are ordered by relative importance” (S. H. Schwartz & Bilsky, 
1987). Table 5.5.1 shows the seven questions in our topic guide which explored these 
five attributes in the context of insulin initiation. 
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Setting 
This study was conducted in Malaysia, which is an upper-middle-income, multi-cultural 
country comprising three main ethnicities (Malay, Chinese and Indian) (The World 
Bank, 2012). Malay is the official language but English is widely spoken in urban areas. 
Malaysia has a dual healthcare system. The public sector consists of government-
subsidized hospitals and health clinics, which serve the majority of the population; the 
private sector comprises fee-for-service hospitals and clinics. Patients are free to choose 
where they prefer to receive treatment.  
Malaysia has the tenth-highest prevalence rate of diabetes in the world (International 
Diabetes Federation, 2009a; Letchuman et al., 2010) and 70-80% of the Malaysian 
patients in the primary care setting fail to achieve target HbA1c levels of < 7.0% (Ismail 
et al., 2011; Mafauzy, 2005).  The Malaysian clinical practice guideline recommends 
insulin initiation in patients with type 2 diabetes mellitus who are poorly controlled 
despite taking optimal oral glucose-lowering drugs (Ministry of Health, 2009). 
However, insulin uptake remains poor (Letchuman, et al., 2010). 
Sampling  
Our sample included a range of patients at various stages of decision making. Patients 
with type 2 diabetes who were still considering insulin or had made a decision about 
insulin within the past 1 year were included in this study. We decided on this range 
considering the range of patients’ decision making times is varied for insulin initiation. 
Unlike one-off medical decisions (such as screening tests or surgery), insulin initiation 
is a decision that may be considered over a prolonged period of time; patients may 
change their views about insulin before, during, and after initiation (Goodall, Sarpong, 
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Hayes, & Valentine, 2009). Clinicians recruited patients whom they had recently 
advised to start insulin.  
Purposive sampling was used whereby we recruited non-randomized participants with 
specific characteristics in order to achieve maximal variation based on three factors: 
healthcare setting, patients’ decision about starting insulin, and their ethnicity. To 
achieve a broad socio-demographic spectrum in the sample, we recruited patients from 
public and private, as well as rural and urban settings. We sought patients who were 
open to insulin as well as averse to it. We included patients who were reluctant to 
initiating insulin therapy as well as patients who were motivated to initiate insulin 
therapy. As the interviews progressed, we constantly reviewed the sample 
characteristics and updated the clinicians on the types of patients we were interested in. 
Data collection 
An interview topic guide was developed based on literature review, conceptual 
framework and expert opinion (Table 5.5.1). The topic guide was pilot-tested and 
iteratively modified based on themes that emerged during both pilot and subsequent 
interviews. Both the participant information sheet and topic guide were translated into 
Malay and Chinese by researchers who were fluent in these languages. Before each 
interview, participants were given an information sheet and written consent was 
obtained to participate in the study.  
Semi-structured in-depth interviews were conducted with patients in their preferred 
language (English, Malay or Chinese). Interviews were conducted by three researchers 
trained in qualitative research methods (YK, CJ, and PY) and each lasted 30-45 
minutes. Researchers arranged to interview patients at a time and location of their 
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convenience, including their homes or workplaces if patients were unable to travel due 
to work commitments or infirmities. Participants were reimbursed for their time and 
travel. Although the patients were informed that they would be participating in an 
individual interview, four were accompanied by family members. In such instances, 
care was taken to avoid having the family members dominate the discussion by 
consciously focusing questions on the patient.  
Table 5.5.1 Semi-structured interview topic guide and corresponding value 
attribute in Schwartz’s Theory of Values  
Table 5.5.1, continued 
Interview questions Corresponding value attribute in 
Schwartz’s Theory of Values (if any) 
Part 1: Introduction and rapport building 
Q1. Can you tell me about your history 
of diabetes  
 
Part 2: Focusing on beliefs about insulin and values 
Q2. Have you been asked to start 
insulin? By whom? 
 
Q3. What has been going through your 
mind since you were advised to start 
insulin?  
 
Values are concepts or beliefs. We probed 
the patient’s beliefs about insulin such as 
negative or positive perceptions, and sources 
of beliefs. 
Q4. Where do you get your ideas/ 
beliefs about insulin from? 
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Table 5.5.1, continued 
 
Q5. Is starting insulin a difficult 
decision for you? Why or why not?   
Values guide selection or evaluation of 
behaviour and events. We explored if 
patients were motivated to start or avoid 
insulin and their reasons for doing so. 
 
Q6. Are you motivated to start insulin? 
Why or why not? 
Q7. Have you received any 
information about starting insulin?  
Q8. What are important priorities to 
you at this stage of life?  
Values pertain to desirable end states or 
behaviours. We explored patients’ life 
priorities as an operational definition of 
desirable end states. 
Values are ordered by relative importance. 
We probed if patients valued some priorities 
over others, and if priorities had changed over 
time with different stages in life. 
 
Values transcend specific situations. We 
explored if non-health related priorities 
influenced patients’ decisions about insulin. 
Q9. Do these influence your decision 
to start insulin?  
If yes, how so? If no, why not? 
 
 
Data analysis 
English and Malay interviews were transcribed verbatim while Chinese interviews were 
translated into English for analysis. Malay interviews were not translated as all 
researchers were familiar with the language. A thematic analysis approach was used for 
data analysis, based on Strauss and Corbin’s method of open, axial and selective codes 
(Strauss & Corbin, 1990). Three researchers (YK, WY, and CJ) independently coded 
two interviews line by line to develop an initial list of codes (open coding). A process of 
constant comparison was employed whereby subsequent interviews were coded using 
this list and new themes which emerged from new interviews were added to the list 
upon consultation with the research team. Any discrepancies in the coding process were 
resolved by discussion during monthly research meetings. 
Codes were organised and re-organised into broader categories based on thematic 
similarities between codes (axial coding). Selective coding was conducted to generate 
central or core categories based on connecting and consolidating axial codes. All codes 
were checked by two researchers (YK, CJ) to ensure consistency of coding and 
consensus on axial and selective codes. 
Data collection was stopped when data saturation was reached. Evidence of data 
saturation was obtained when no new axial or selective codes emerged from the data, 
showing that the core categories had already been captured. A secondary saturation 
criterion was based on the saturation of open codes, as there was evidence of repeated 
coding within the same codes.  
Data analysis was facilitated by the use of Nvivo9 software to manage transcripts, 
themes and quotes, while keeping in mind the context of the quotes within individual 
interviews. 
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Results 
Sample characteristics  
A total of 21 patients were interviewed between January 2011 and February 2012 from 
five different healthcare locations (one public hospital-based primary care clinic, three 
public health clinics, and one private clinic). Table 5.5.2 details the range of patients 
interviewed. Although most patients were from an urban setting, they came from 
diverse socio-economic background. We achieved good variation in our sample in terms 
of healthcare setting, patients’ decision about starting insulin, and ethnicity. Three core 
categories of themes emerged: 1) Insulin-specific values, 2) Life goals and philosophies 
and 3) Socio-cultural values and personal background.  
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Table 5.5.2 Characteristics of participants. Values are numbers unless stated 
otherwise. 
Characteristic Participants (n=21) 
Male 12 
Mean (SD) age (years)  55.24 (9.14) 
Age range (years) 28-67 
Status of insulin use  
Not currently on insulin 13 
Already using insulin 8 
Healthcare setting 
University hospital based primary care clinic 7 
Public healthcare clinics 8 
Private clinic 6 
Language used during interview  
Malay 9 
English 10 
Chinese 2 
Ethnicity 
Malay 6 
Chinese 5 
Indian  10 
Decision about insulin 
Keen to start insulin 10 
Not keen to start insulin 8 
Undecided 1 
Not applicable (previous insulin users- gestational 
diabetes (n=1) and short-term insulin use(n=1)) 
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TREATMENT-SPECIFIC VALUES 
When making decisions whether or not to start insulin, patients had specific beliefs and 
feelings about insulin (treatment-specific values). Examples of participants’ perceived 
advantages and disadvantages of insulin are reported in Table 5.5.3.  
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Table 5.5.3 Beliefs and feelings about insulin 
Table 5.5.3, continued 
Themes Participant quotes 
BELIEFS ABOUT INSULIN 
Positive beliefs about insulin 
Improve control of diabetes 
 
“To me, I feel that maybe the (oral) drug does 
not help, then have to use the insulin. I was 
prepared because I see that my reading, ah, 
never come down”  
F8, female, 57 y.o., private general practice  
 
Prevent diabetes-related 
complications 
 
So I’m thinking, if I’m sixty years old, how 
long more can I live? Can I put ten more years, 
can I put twenty years? So why wait till, you 
know, when my diabetes is very bad and then 
put full dose of insulin. Try it now and see. 
F4, female, 61 y.o., public hospital-based 
primary care clinic. 
 
Minimal side-effects 
 
“Insulin is what our body is producing, you see, 
rather than all these chemicals going into the 
body. So it’s just that we take the insulin, it’s 
easy, direct, no…side effects. I mean, there 
should be minimal side effects.” 
F4, female, 61 y.o., public hospital-based 
primary care clinic. 
 
Enable the patient to lead normal 
lifestyle 
 
“[The doctor] said we give you insulin, means 
you can eat, no need to control (your diet). You 
don’t want to eat, or you want to eat, this 
(insulin) is better. That’s why I said, 
straightaway said I want it” 
M3, male, 63 y.o., public health clinic.  
 
Convenience of once-daily injections 
 
“[Insulin] is convenient. If you’ve injected in 
the morning then at night you don’t have to 
inject” 
M12, 61 y.o., private general practice 
 
Medication adherence is improved 
 
“But if you take insulin every day, you won’t 
forget. Tablets sometimes you forget. Insulin 
you know that when you wake up in the 
morning, you have to inject. Oh, it’s time to eat, 
it’s time to inject. For tablets, you’re working, 
working, working and then you have this tablet 
and that tablet, take half hour after meal, you 
forget. You go to a restaurant, at that time, you 
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Table 5.5.3, continued 
take your tablets, and you need water, right? 
Ah, you have to look for water. For him 
(insulin-users) you don’t have to, no need to 
look for water, just inject insulin.” 
F6, female, 58 y.o., public hospital-based clinic 
 
Negative beliefs about insulin 
Injection-specific beliefs 
Scarring 
 
“I don’t want to start the insulin. My main 
concern is the injection and the scar. Everyday 
injecting, you know, I’m worried it will leave a 
scar. Because, diabetic people, when you have 
small injuries, you’ll get black scars, I think my 
legs have got some.” 
M10, male, 55 y.o., public hospital-based clinic 
 
Risk of infections 
 
 
“I’m afraid of, if I start injections tomorrow, 
will I get any side-effects? Usually, for people 
with diabetes, when they get a wound, it gets 
infected, right? Ah, I’ve seen a friend, his leg 
got cut by a wire, infected and pus-filled.” 
M7, male, 67 y.o., public hospital-based clinic 
 
Easier to forget to take injections 
 
“And then, if they (people who take insulin) 
missed one day, also it’s a problem. So that’s 
the reason why I don’t want to take insulin, I’ve 
been taking medicine for all this while. 
Medicine is a habit to me, every day I take, I’m 
reminded to take. Insulin, no, I mean, you might 
forget.” 
M10, male, 55 y.o., public hospital-based clinic 
 
Interference with current lifestyle 
 
“The way the nurses, the dieticians and the 
diabeticians and the doctors told me look you 
must align yourself so they have here 4 meals 
or 3 meals or whatever and the insulin jabs 
would correspond to meals. I never take regular 
meals and the thing is like um... when we have 
problem with diabetes it's simply because we 
cannot cope with that huge amount of glucose 
in our body so human beings physiologically 
shouldn’t eat big meals you see we only 
supposed to have small parts throughout the 
day. But that was what I was trying to do and 
then the way that they told me is just that...is 
contrary to what I’ve been doing.” 
M1, male, 47 y.o., public hospital-based clinic 
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Table 5.5.3, continued 
Injection- and needle-phobia 
 
“It’s just that the jabs bothered me at that time. 
The thing is I don’t like poking myself... that’s 
normal and the thing is you know like uh... 
you... doing it 4 times a day you know it's not 
easy and I mean it was like you have to do it 
really... I mean sort of like I don’t know you 
have to have a very good angle to it and then 
you won’t feel anything and there are some 
parts that you, there are some places where you 
cannot just push it through.” 
M1, male, 47 y.o., public hospital-based clinic 
 
“I’m really afraid of needles. And my daughter 
told me, how about the needles, right. It’s tiny, 
you better be careful, if it breaks.” 
F3, female, 48 y.o., public health clinic 
 
Preference for oral tablets or lifestyle 
intervention 
 
“I feel that I can control my own body. That’s 
all I think about. When I can’t control (my 
diabetes), my body doesn’t have enough 
exercise, that’s the time that I will take insulin. 
So, now, I have enough exercise, I can control. 
That’s all.” 
M6, male, 56 y.o., public health clinic.  
 
Social stigma attached to injections “Will I look like a drug addict? That’s the 
reason I don’t want to take insulin. It’s just like 
a drug addict, you know, on the road. They 
inject themselves, you know, to make them 
high. This insulin also you have to inject 
yourself. So you look like a drug addict. I’m not 
a drug addict, because I only smoke, that’s the 
only thing I do. So I don’t want to go into the 
stage where injection, injection, injection.” 
M10, male, 55 y.o., public hospital-based clinic 
Insulin-specific beliefs 
Unsure about the origin 
 
“I think, quite a number of my friends were not, 
maybe SPM (high-school) level ah, don’t know 
that insulin is a natural body made product. 
They think it’s a very strong medicine, that kind 
of attitude.” 
F4, female, 61 y.o., public hospital-based clinic 
 
Damaged organs 
 
“I told (my friends) I got to take injections and 
all that. They err, they said, you inject here, the 
behind gets spoilt. (Interviewer: Behind? 
Kidneys?). Yeah, sooner or later its spoilt. My 
aunties use it, injections. They said kidneys 
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Table 5.5.3, continued 
have a lot of problem. That’s why they say, just 
take oral tablets. Don’t take injections, just eat 
medication, let go of bad habits, reduce your 
food and all that.” 
M4, male, 53 y.o., public health clinic 
 
Fear of hypoglycemic events 
 
 
[Interviewer: So previously, was it your work 
that caused you to stop insulin?] No, it was the 
sweat, I have the sweat. So every night, I have 
to…shivering and wake up. So I was panic, you 
know. So I stopped it.” 
M11, male, 57 y.o., private general practice 
FEELINGS ABOUT INSULIN 
Positive feelings about insulin 
Normalization 
 
“Insulin is better, I think so, means, I’ll 
recommend insulin. Because now I see all the 
people taking insulin, later on, I also take, it’s 
better.” 
M3, male, 63 y.o., public health clinic 
 
Acceptance 
 
“So I have no choice in that (insulin)…and it’s 
just that when they found that the levels were 
not good, that’s when they said it would be 
better to start on the insulin. Because they gave 
this very good analogy saying that it is like 
throwing salt into the sea. You see… when you 
throw salt into the sea there’s no effect. So 
that’s the kind of analogy…so I have to 
change.” 
F1, female, 58 y.o., public hospital-based clinic 
Negative feelings about insulin 
Severity of diabetes 
 
“My response (to starting insulin) was that my 
diabetes was not that serious ah. As I said, I will 
not take it for the time being, I want to observe 
for a while and see how it goes. [Interviewer: 
You feel, that if other people take insulin, under 
what conditions do you think it is important to 
take insulin?] It is very serious already, when 
no cure from medicine, then only take this 
insulin, isn’t it?” 
M8, male, 60 y.o., private general practice 
 
Denial (patient had been advised by 
doctor to start insulin) 
 
“Interviewer: So, it was Dr. H who asked you to 
start insulin, right? 
Pt M11: No, he didn’t, he didn’t. 
Interviewer: Oh…sorry.” 
M11, male, 57 y.o., private general practice 
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Frustration or failure 
 
“I think it’s basically attitude change but it’s 
rather a difficult step lah, that transition (to 
insulin) was difficult. For me, it’s like failing an 
exam. I tried with so many medications as each 
time she increases the medications I get 
depressed. Very sad, ah, it’s getting bad, it’s 
getting bad.” 
F4, female, 61 y.o., public hospital-based clinic 
 
Feeling punished or threatened 
 
“She (the doctor) say...she scare, she want to 
scare me. She said, “So high your reading! 10 
point something, just now it was like that. 10 
point something, you so high, I must put you on 
insulin all that”. I said, please don’t do that, I 
say.” 
F5, female, 66 y.o., public hospital-based clinic 
 
 
Beliefs about insulin 
The most commonly mentioned advantage was that insulin would help control diabetes 
and thus prevent diabetes complications. Some thought that insulin would replace oral 
glucose-lowering tablets (fewer medications) while others believed that insulin had 
fewer side-effect than tablets. Furthermore, some were reluctant to increase their daily 
number of oral tablets. One participant had the misperception that insulin was only 
injected once a week. 
However, the majority of participants had negative perceptions about insulin. They 
expressed doubt over the origin of insulin; concern over insulin side-effects (e.g. 
hypos); believed that insulin might cause kidney failure and impair pancreatic function. 
Cost of insulin was also a concern for patients from poor socio-economic backgrounds 
and private patients whose insulin was subsidised by their employers. 
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When I am working, the cost (of insulin) can probably be covered. But, when 
I'm not working? Who wants to cover? Like I say, insulin isn't bad, it's good. 
But, it's the cost. Cost and for me, how long you want to stick to that kind of 
medicine. It's expensive, I know, and that one (insulin) is indeed expensive.   
F9, female, 43 years old (y.o.), private general practice. 
Moreover, patients had injection-related concerns including: pain, fear of needle, 
scarring from injections, lifestyle interference, infection at injection sites, forgetting to 
inject and insulin storage. Some participants were not aware that finer, less-painful 
needles were available. Two participants were afraid that the needle would break during 
injections.  
Feelings about insulin 
Participants also reported positive and negative affection about starting insulin. When 
advised to start insulin, some patients felt that their diabetes was worsening while others 
denied the need for insulin. They were not confident to self-inject; there was a sense of 
frustration or personal failure and felt that they were being punished for not controlling 
their diabetes. Conversely, some had a more positive affection about insulin initiation. 
They considered insulin initiation as a natural disease progression. They also gained 
confidence in insulin therapy by discussing with peers who used insulin.  
LIFE PRIORITIES AND PHILOSOPHIES 
When asked what was important in life that might influence their decision making, the 
participants’ responses could be coded into two categories: life priorities and general 
philosophies.  
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Life priorities 
Life priorities were specific goals in life. Three types of life priorities emerged from the 
interviews: health, finance and career.  
Health  
Health was a major priority for four participants. Two participants said that health was 
more important than finance. They said, “It’s OK, we can spend a lot of money. Waste 
money even, if it’s to look for medicine. We want to look after our body.” (M4, male, 
53 y.o., public health clinic) and “Even if I have a lot of money, if we are not healthy, 
it’s unacceptable” (M7, male, 67 y.o., public hospital-based clinic). One patient said that 
awareness of risk of diabetes complications “puts you at fear, [you could be that close 
to] death” (M9, male, 28 y.o., public hospital-based clinic).  
Career/ Employment 
Interviews with patients who put priority on career or employment served to illustrate 
how different patients expressing a similar priority could frame insulin either positively 
or negatively. For example, one patient viewed insulin positively as he believed it 
helped him to control blood glucose spikes that had hindered his concentration during 
work. The other patient viewed insulin negatively as it would interfere with his work 
schedule.  
“Establishing myself in terms of career …my sugar is under control and then I 
can still hope for the future in terms of careers prospects because I don’t get the 
sugar spikes anymore, you know” (positive view of insulin) 
M9, Male, 28 y.o., public hospital-based clinic  
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 “I feel good if I go to work…it’s difficult for me to take insulin in the morning, 
because I have to leave for work at 5 am. We have to think about this as well.” 
(negative view of insulin) 
M6, Male, 57 y.o., public health clinic  
Finance 
Finance was a priority mentioned by three patients. Insulin-related costs were a concern 
for them. The need for a self-monitoring blood glucose (SMBG) meter caused one 
patient to say, “My priority is surely (pause) finance. Doctor A told me to buy the 
diabetes monitor; she said it’s sold here. The problem is…I can’t afford it. It’s hard 
being a taxi driver, because taxi rental is fifty ringgit (GBP 10) everyday” (M5, male, 44 
y.o., public health clinic).  
Hierarchy of Life Priorities 
A hierarchy of priorities existed for participants. For example, health was more 
important than finance. However, priorities were sometimes co-related; one participant 
reasoned that health was important because it helped to achieve her financial goals.  
“I was thinking, like, if I want to save my money, I must take care of my health. 
Hah, that’s why I go for exercise, you see. Exercise is important. And diet. 
That’s my concerns.” 
F9, female, 43 y.o., private general practice 
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Life Philosophies 
Some patients framed insulin according to their life philosophy. In contrast to life 
priorities, which are concrete goals that are important to the patient, life philosophies 
are related to patients’ worldviews and ethical beliefs about what are morally desirable.  
Avoiding Suffering 
Avoiding suffering was a recurring theme. One participant stated that his view on life 
was to “die happy” and that he would consider taking insulin because he didn’t want to 
“suffer and die” (M3, male, 63 y.o., public health clinic).  
Another said that “If  my suffer(ing)s are very major, I’m going to be dependent on 
anybody, I might as well go kill myself, instead of living with all the suffering and 
whatever nonsense that’s going on.” (M10, male, 55 y.o., public hospital-based clinic). 
Another participant associated suffering with death by saying she prayed that “Please 
help me, I don’t want to suffer pain. If I live, just let me live normally. When I die, 
don’t let me suffer pain or anything, don’t let me die that way” (F6, female, 56 y.o., 
public hospital-based clinic). 
Fatalism 
Some participants refused insulin treatment as they felt that everyone was fated to die 
one way or another.  
“About dying, I’m not worried about it because these things they come naturally. 
Die means you die, no helping it. You inject until he dies, also die in the end, it’s 
like that. So there is nothing to worry about.” 
M8, male, 60 y.o., private general practice 
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Not Being a Burden 
Not burdening others was the most important philosophy for one lady. She explained 
that “I don’t want to be a burden to anybody and as well as to myself. I want to be 
independent, and a helpful person. That’s the thing that’s making me agree to insulin” 
(F4, 61 y.o., public hospital-based clinic).  
SOCIO-CULTURAL VALUES AND PERSONAL BACKGROUND 
Patients’ decision to start insulin was also shaped by their larger social environment, 
belief system (e.g. religion), and personal background (e.g. family context).  
Religion 
Religious values were a factor that influenced patients’ views about insulin. Four 
participants were concerned that the use of insulin might conflict with their religious 
beliefs. A Muslim patient was concerned about the purity (‘halal’) of insulin and needed 
assurance from a Muslim clinician. A Hindu patient illustrated how insulin injections 
could potentially desecrate holy sites as religious rules forbade blood being spilled 
inside temples. 
I wouldn’t like to be in a (Hindu) temple, take out my needle and jab, I don’t 
think it’s nice. Because that’s supposed to be a spiritual, clean place. So my son-
in-law was, like, arguing with me that day and said the blood doesn’t come out. 
In a spiritual place, blood shouldn’t come out as if it will fall on the floor of the 
temple, it’s a very big (pause) sin. 
F4, female, 61 y.o., public hospital-based primary care clinic. 
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Personal and family background 
The following example illustrates how a 66 year-old woman’s family context influenced 
her decision to avoid insulin. For this patient, her insulin-specific belief was the 
perception that insulin was expensive. 
“I feel I want to save money. Insulin is expensive; I don’t want to take it.” 
F5, female, 66 y.o., public hospital-based clinic 
When asked what was important to her in life, she said that her life priority was on 
work. This was related to her view that her children were unable to support her.  
“I am mostly thinking about work. My son in law, children…how much money 
can they give? My daughter has her own family, my son also has his own 
family.” 
Finally, when probed why work was prioritised, it emerged that this was due to her tight 
financial situation. She had to work to support her family and provide for her children’s 
studies after her husband became ill. 
“I suffer a lot. My husband retired at fifty-five. Because the doctor asked him to 
stop working, that time he has a heart problem. That’s why every cent I earned, I 
give it to my son and daughter to study.” 
Discussion 
This study aimed to explore patient values and what role it plays when making a health 
decision. The study identified a range of patients’ positive and negative perceptions of 
insulin as well as life priorities and philosophies that influenced patients’ decision 
making. Through analysis of patient narratives, we illustrate how patients’ personal 
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background also influenced their decision about insulin. The study expands the current 
definition of patient values as treatment preferences to cover a broader dimension 
including personal life goals and philosophies. 
The strength of this study is that the theoretical framework was drawn from a social 
science theory of human values. By broadening our scope of values to those outside of 
healthcare, we illustrate how priorities such as career achievement and ethical 
convictions are influential in patient decision making. Thus, the complex interactions 
between treatment-specific beliefs, goals and contextual background that emerged from 
the data are more holistic and, we believe, provide a more accurate representation of 
actual patient values.  
The limitations of our study are that the specific themes from this study may not be 
transferable to other conditions. Patient values are shaped by local culture and norms.  
Therefore, priorities and philosophies identified in this sample of patients may not be 
similar to patients elsewhere.   
The first category of values comprised of beliefs and feelings about insulin. These 
influenced patients’ view of insulin as being either positive or negative. Firstly, patients 
have a set of cognitive beliefs about the perceived advantages and disadvantages of 
insulin (refer to Table 5.5.3). Not all of these beliefs are correct; patients also reported 
misperceptions about insulin. Besides cognitive concepts of insulin, patients also 
expressed an affective concept of insulin i.e. how insulin made them feel. Denial, 
punishment or lack of self-efficacy would influence patients to view insulin negatively. 
Our study reports that patients in Asia share similar beliefs about insulin as those in the 
west, such as the fear of injections (Goderis et al., 2009; Karter et al., 2010), 
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inconvenience when using insulin (Hunt, Valenzuela, & Pugh, 1997; Polonsky, et al., 
2005), fear that insulin will cause organ damage (Karter, et al., 2010; Larkin et al., 
2008), and feeling a sense of failure or punishment (Hayes, Fitzgerald, & Jacober, 2008; 
Karter, et al., 2010). However, while most studies only highlight medically-related 
barriers concerning the efficacy and side-effects of insulin (Khan, Lasker, & 
Chowdhury, 2008), our study underlines the importance of exploring non-medical 
beliefs as potential barriers during insulin initiation. Some examples in our study 
include religious beliefs about blood, and patients’ fear of social stigma from 
associating drug use with injection scars. Such socio-cultural and religious concerns 
may be factors for higher insulin refusal rates in Asian populations (42-52%) (Ahmed et 
al., 2010; Khan, et al., 2008; Nur Azmiah Z, Zulkarnain AK, & A, 2011) compared to 
the west. 
Besides insulin-specific beliefs, other non-health beliefs also influenced patients’ 
decisions. Patients would consider if insulin agreed with their system of life goals and 
philosophies. In other words, the choice about insulin was interpreted according to the 
patient’s worldview. Previous literature has highlighted different types of patient values 
that should be considered when making a healthcare decision (Petrova, Dale, & Fulford, 
2006). Schwartz et al have reported that from a list of seven ‘life goals’ (family, wealth, 
job, education, health/fitness, travel, and personal fulfilment), participants were 
significantly more willing to trade off achieving family goals for health or life years 
compared to other goals (A. Schwartz, Hazen, Leifer, & Heckerling, 2008). Such value 
typologies however face the limitation of being either conceptual or hypothetical. Our 
study adds to the literature by reporting on patients actually used values when 
considering insulin. Besides weighing the pros and cons of insulin from a medical 
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perspective, patients also viewed if insulin would be congruent with their worldview, 
which includes their life goals and philosophies.  
Implications for practice 
Currently, patient education remains the cornerstone of counselling patients who are 
resistant to insulin (Brod, Kongso, Lessard, & Christensen, 2009; Davis & Renda, 2006; 
Fu, Qiu, & Radican, 2009). The majority of the interventions focus on motivating 
patients to start insulin by changing their perceptions about insulin (e.g. normalization 
of insulin) and challenging negative perceptions about insulin use. There is little 
discussion about decision support and whether the treatment agrees with patients’ 
values. One reason for this is the assumption that both HCPs and patients share similar 
values (Petrova, et al., 2006). This study shows that patient values may not be congruent 
with health-seeking goals. Thus, besides addressing patients’ negative perceptions, 
HCPs must also explore patients’ underlying value motivations (Mulley, Trimble, & 
Elwyn, 2012).  
From our analysis, patient values comprise three key categories: treatment-specific 
values; life priorities and philosophies; and socio-cultural and personal background. In 
Figure 5.5.1 we propose a conceptual model whereby these components form the 
content of the model and are arranged in three layers. The need to elicit patient values in 
medical decision making arises within the context of a specific medical decision. As 
such, the arrangement of the layers in the model was based on how closely related the 
value categories were to the medical decision being discussed. Whereas the first layer 
(treatment-specific values) are beliefs that are specific to the treatment (e.g. “I am afraid 
of insulin injections because they are painful.”), the second (life priorities and 
philosophies) and third (socio-cultural and personal background ) layers are trans-
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situational, meaning that they are applied to other areas besides health. The second layer 
is the patient’s personal, individual beliefs (which may also include health as a priority) 
while the third layer comprises of cultural and contextual influences. This model 
expands on the current scope of patient values in EBM (Lockwood, 2004; Sackett, et 
al., 2000) and SDM (Barratt, 2008) to also include life priorities and philosophies (or a 
patient’s worldview). In the centre are treatment-specific beliefs which depend on the 
medical context, while layers further from the centre are more deep-seated and trans-
situational, and more importantly, also influence the treatment choice.  
 
Figure 5.5.1 A conceptual model of patient values 
Recent literature has expressed the need to consider the broader communicative and 
relational contexts when practicing SDM (Matthias, Salyers, & Frankel, 2013). When 
supporting patients in making decisions, clinicians need to address more than just 
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beliefs and feelings about the treatment options. A deeper understanding of patients’ life 
priorities and background are essential, particularly when making decisions about 
treatments. From our study, we suggest that assessing these values involves 
competencies in eliciting and analysing patient narratives (Charon & Wyer, 2008; 
Greenhalgh, 1999; Meisel & Karlawish, 2011; Nunn, 2011). Understanding patient 
narratives is especially important for long-term care of chronic diseases which are 
heavily influenced by factors such as prior and current life experiences, resources, and 
explanatory models of illness (Ban, 2003).  
Further research needs to be done on a number of aspects. Firstly, how generalizable is 
the proposed conceptual model of patient values? More studies should be conducted in 
different healthcare decisions, locations and cultures. Secondly, would an intervention 
targeting goals and philosophies be more effective than management programmes 
focusing on improving patient perceptions about insulin? One example would be value 
self-confrontation, (S. H. Schwartz & Inbar-Saban, 1988) where a patient with poor 
glycaemic control could be shown how their set of values differs from that of patients 
with good glycaemic control.  
Conclusion 
In this paper, we introduce a comprehensive model of patient values based on actual 
patient perspectives. This model fits well with the practice of EBM and SDM by 
helping clinicians to understand how patients also consider other non-health values 
when making a treatment decision. Further study needs to be done to explore the 
applicability of this model in other contexts.   
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Chapter 6: General discussion and conclusion 
This thesis has aimed to explore a simple, yet unanswered, question: What are patient 
values in medical decision making? The research has spanned three systematic/ 
situational reviews, five research publications and numerous conference presentations. 
Chronologically, the research roughly progressed as such:  
1) systematic reviews identified current views and research gaps on three areas: 
patient involvement in medical decision making in Malaysia; definitions of 
patient values in medical decision making; and barriers and facilitators to insulin 
initiation in type 2 diabetes;  
2) interviews with HCPS identified the range of patient, HCP and system factors 
influencing insulin initiation in Malaysia;  
3) interviews with patients identified the various types of values which influenced 
their decision to initiate insulin;  
4) grounded theory analysis of patient values resulted in a conceptual model of 
patient values. 
The final chapter of this thesis serves as summary and discussion of the body of 
research reported in the five chapters of this thesis. This chapter is not so much a 
reiteration of the results that have already been presented or repetition of the discussion 
sections of each individual paper, but rather a critical summary of the main themes in 
the investigation of patient values in SDM.  
In discussing the common themes in the various papers the following points are 
pertinent: What do the results say about the challenges to insulin initiation in Malaysia 
and what strategies can help to address these issues? How can the patient values model 
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benefit SDM practice and how does the model of patient values fit in with current 
developments in SDM? 
6.1 The challenge of timely insulin initiation in Malaysia 
Using three sources (a systematic review, HCPs in Malaysia, patients with type 2 
diabetes) this thesis identified a range of patient, HCP and system barriers to insulin 
initiation (Table 6.1). Healthcare in Malaysia operates within a complex multicultural, 
dual-sector context and a wide range of barriers to insulin initiation emerged from the 
study. In Malaysia, patients’ barriers include culture-specific barriers such as the 
religious purity of insulin, preferred use of complementary medication and perceived 
lethality of insulin therapy (Chapter 5.1, Chapter 5.5). Malaysian HCPs cited negative 
attitudes towards insulin therapy and the ‘legacy effect’ of old insulin guidelines 
(previously, insulin was only initiated in a hospital setting); while system barriers 
highlighted the lack of resources (e.g. a lack of diabetes nurse educators), language and 
communication challenges, and lack of access to resources, especially for the  private 
health sector (Chapter 5.1, Chapter 5.2). 
These barriers are already being addressed by measures being undertaken by 
policymakers and HCPs. Policy initiatives aimed at addressing these barriers included 
an insulin-specific practice guideline and plans to subsidize SMBG costs (Chapter 
1.6.3). HCPs who operate in the private healthcare sector utilized the help of NGOs and 
pharmaceutical companies to train patients (Chapter 5.2) and HCPs utilized various 
strategies to guide patients to start insulin if they were hesitant to do so (Chapter 5.3).   
In the clinical consultation, it is important to differentiate between issues which 
influence the decision making process and barriers to implementing the chosen option. 
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For the former, barriers to making an informed shared decision are reported in this 
thesis. These include patient misconceptions about insulin, negative HCP attitudes 
about insulin, and communication barriers between the HCP and patient. On the other 
hand, assuming a patient has decided to start insulin, they may encounter barriers to 
implementing their choice. For example, they may not be able to afford the cost of 
SMBG monitoring, or they may require daily assistance as they are unable to self-
administer insulin. In the Ottawa Decision Support Framework (O’Connor, 2006), 
HCPs need to consider how to support both the decision making process (through 
shared decision making) as well as the implementation of the choice (e.g. through 
referral to the appropriate health services). 
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Table 6.1 Comparison of barriers to insulin initiation from HCP interviews, patient interviews and systematic review 
Table 6.1, continued 
Source HCP-reported barriers (Lee, Lee 
& Ng, 2012a;  Lee, Lee, & Ng, 
2012b) 
Patient-reported barriers (Chapter 5.5) Barriers in the systematic review 
(Chapter 3.1) 
Patient 
barriers 
 Negative beliefs about insulin 
1. Fear of side effects and pain 
2. Misconceptions about insulin 
o Insulin is lethal 
o Insulin is a punishment 
o Insulin is a stigma 
o Insulin is a medication for old 
people 
o Insulin causes sexual 
dysfunction 
 
 Prefers alternative treatment 
 
 Lack of knowledge  
 
 Lack of self-efficacy 
 
 Socio-cultural factors 
1. Negative influence from family 
members 
2. Insulin is unlawful for Muslims 
 Negative beliefs and feelings about 
insulin 
1) Injection-specific beliefs 
o Scarring 
o Risk of infections 
o Easier to forget to take injections 
o Interference with current lifestyle 
o Injection- and needle-phobia 
o Preference for oral tablets or lifestyle 
intervention 
o Social stigma attached to injections 
 
2) Insulin-specific beliefs 
o Unsure about the origin 
o Damaged organs 
o Fear of hypoglycaemic events 
 
3) Negative feelings about insulin 
o Severity of diabetes 
o Denial (patient had been advised by 
doctor to start insulin) 
 Negative beliefs and attitudes 
about insulin 
1. Negative perception of insulin 
2. Negative attitudes 
3. Fear of needle and pain 
4. Side effects of insulin 
5. Emotional barrier 
 
 Barriers in administering 
1. Barriers in administering 
2. Hassle of home glucose monitoring 
3. Lack of self-efficacy/skills 
 
 Lack of knowledge/Misconception 
about insulin side effects 
 
 Socio-cultural factors 
1. Social factors 
2. Inconvenience 
3. Interference with social and work 
activities 
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Table 6.1, continued 
o Frustration or failure 
o Feeling punished or threatened 
 
 Socio-cultural factors 
1. Religious values 
2. Personal and family background 
4. Stigma and discrimination 
5. Lack of social support 
6. Socio-demographic factor 
 
HCP 
barriers 
1) Negative attitudes towards 
insulin 
2) Lack of motivation and 
confidence 
3) Training-related barriers 
4) Conflicting advice from the 
HCPs 
- 1) Negative attitudes  
2) Lack of doctor-patient relationship 
3) Communication barriers  
4) Not involving patients in decision 
making 
System 
barriers 
1) Lack of continuity of care 
2) Lack of manpower 
3) Lack of resources 
4) Language barriers 
5) Lack of collaboration between 
the private and public sectors 
- 1) Lack of diabetes services 
2) Lack of education resource 
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6.2 The patient values model: Contributing to larger patient-centred conversations 
The results show that SDM is still a novel concept, both in individual consultations and 
at policy level. In HCP-patient consultations, Chapter 5.3 highlights that HCPs often use 
a paternalistic approach when initiating insulin while Chapter 5.4 reveals examples of 
how insulin consultations are skewed to either doctor- or patient-only decision making. 
A situational review of SDM in Malaysia (Chapter 2.0) showed that SDM was poorly 
researched and implemented in policy, research and practice. There is potential for 
growth in SDM implementation in all these areas within the Malaysian context (Table 
2.1).  
Besides efforts to promote awareness of SDM in Malaysia, another important effort is to 
integrate SDM as a component of the larger patient-centred care paradigm. This can be 
done as SDM shares components with other patient-centred practice models, 
specifically EBM (Barratt, 2008). For example, both SDM and EBM recognize that 
incorporating both evidence and preferences into practice is challenging (Barratt, 2008). 
Rather than an ‘either/or’ mentality, a ‘both/and’ approach should be encouraged 
whereby SDM and other models identify common areas and gaps to be investigated, 
thereby progressing the larger patient-centred care agenda.  
One such area is patient values, for which a systematic review showed that there is a 
lack of clear definition (Chapter 3.2). The first model of patient values derived from the 
systematic review (Figure 3.2.2) provides an overview of how values have been defined 
in the literature. However, it has limitations as it seeks to combine various sources and 
themes into a single framework and is thus largely based on HCP perspectives of what 
patient values mean. Certainly, a truly patient-centred model should be one that is based 
on patient-derived data, and focused on an actual exemplar. Thus, the second model in 
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Chapter 5.5 (Figure 5.5.1) is derived from actual patient data in the context of insulin 
initiation in type 2 diabetes. 
The second model of patient values (Chapter 5.5) is especially relevant as patient values 
are a key concept in both SDM (Chapter 1.2) as well as EBM (Sackett, 2000). The 
model identifies three categories of values that influence a medical decision. Two points 
can be noted about the model. The first is that the model and its components fit well 
with existing models of patient-centred models. For instance, the three layered 
components of the patient values model (treatment-related values; life goals and 
philosophies; socio-cultural values) bear similarities with the model of illness and 
disease proposed in the bio-psychosocial model, which also takes into account not just 
health beliefs, but also emotions and the larger social context (Engel, 1980). The bio-
psychosocial model however is a general model from which doctors can empathise with 
the whole patient illness experience. The patient values model adds specific clarity to 
patient-centeredness by focusing on the role of values during preference-sensitive 
decision making, thus being useful for doctors who have reached a stage of deliberation 
of options in their consultations with patients. Research wise, by documenting the 
developmental process of the model along with the actual patient quotes, readers are 
able to understand for themselves how the model was developed from patient 
perspectives using insulin initiation as the exemplar (Chapter 5.5.).  
Within the field of SDM, the model of patient values contributes to current discussion 
on the little-understood, yet influential, role of intuitive processes in patient decision 
making (Fagerlin et al., 2012), a research gap which was highlighted in Chapter 1.2. 
Early SDM literature noted that values function as an interpretive filter (emphasis in 
bold added): 
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“Patients interpret information on average treatment outcomes in order to make 
them personally meaningful within the decision-making context they are in. In so 
doing, their own values and beliefs act as filters in processing what information 
is allowed in and how it is understood” (Charles, Gafni, & Whelan, 1999).  
The proposed model of patient values informs this statement by showing how patients 
perceived insulin initiation through three types of filters, or lenses. The model sheds 
light on the complex perspective that patients have on a medical decision. Existing 
models of patient values in literature have been criticised for being based on HCP or 
researcher perspectives only (Karel, 2000). In consultations, patient views are often 
confined to a narrow scope (e.g. health-related categories), and without a definition of 
patient values, there is the risk that patients and doctors have different assumptions of 
what it means to incorporate values into decision making. This can lead to differing 
expectations and poor patient-doctor partnerships. Indeed, in this study, only one patient 
expressed a desire for a collaborative decisional role, which may indicate that the 
concept of the patient-practitioner relationship as a partnership is lacking in Malaysian 
society (Chapter 5.4). The model and the quotes are one example of the oft-missing 
patient voice that needs to be included in the consultation. 
6.3 Methodological considerations 
Exploration of barriers faced by HCPs when initiating insulin was done using a 
qualitative methodology. The choice of a qualitative methodology was to explore the 
area of insulin initiation as no results of previous studies (at the time of study design 
conception) were available in Malaysia. 
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Criticisms of qualitative methods are the subjectivity of data interpretation and the lack 
of generalizability of results. In order to reduce the risk of biased interpretation, three 
researchers come to consensus on the codes for both patient and HCP data. 
Discrepancies in interpretation of transcripts and code names were discussed between 
researchers and any changes made to the coding structure were done with agreement. 
The strength of this study lies in the use of multiple conceptual frameworks to develop 
the HCP and patient interview topic guides. As the results were later used to develop a 
complex intervention (the DMIT insulin PDA), a solid literature and theory base was 
needed to minimise the risk of the intervention leaving out important factors. The 
conceptual framework involved two systematic reviews, one SDM implementation 
model and a psychological theory of values. Researchers were able to define the depth 
(e.g. exploring the five key attributes of patient values) as well as the breadth (e.g. 
exploring the patient, HCP and system barriers to insulin initiation) required for in-
depth interviews and focus group discussions.  
6.4 Implications for practice and research 
The implications of the patient values model for practice are in PDA development as 
well as clinical practice. In terms of PDA development, developers should check if all 
three types of values are elicited in the values clarification sections of PDAs.  
Findings from the study were used to inform the development of the “Making Choices: 
Should I Start Insulin?” PDA (DMIT Group, 2012). Treatment-specific beliefs are the 
first category of values that need to be addressed and real-life patient quotes were used 
to develop the “What are your concerns?” introduction pages to the PDA (Appendix L). 
These quotes were also used to illustrate the ‘Patient FAQs’ section in the HCP Training 
303 
 
Guide where sample responses to these concerns were provided for HCPs (Appendix 
M).  
Secondly, patient’s personal and socio-cultural values were elicited in the “What is 
Important to You?” values clarification section of the PDA. These concerns included 
concerns “about the cost of insulin treatment”, “how other people will think of me using 
insulin” and “that my family may not agree with me starting insulin”. However, the 
model of patient values was not explicitly used to design the values clarification section 
of the PDA as the analysis of the patient data had not been completed when the PDA 
design was being finalised.  
Future research should focus on the transferability of the patient values model to other 
healthcare contexts. Transferability is defined as “the range and limitations for 
application of the study findings, beyond the context in which the study was done” 
(Malterud, 2001), which in this study is the application of the patient values model in 
other healthcare contexts besides insulin initiation. The key to transferability of 
qualitative research is how much the result of the study advances theoretical 
understandings which can be applied to multiple situations (Kuper, Lingard & 
Levinson, 2008).  As an initial assessment, because the model was developed from 
grounded theory practice, the patient values model contains general categories of values 
which can potentially be applied to other medical decisions besides insulin initiation. 
Given that patient values are an integral, yet undefined, component of SDM and EBM, 
the patient values model helps to inform both these practice models by providing a 
simple and systematic model of the types of beliefs that influence patients’ decisions.  
One way in which the model can inform general medical practice is that HCPs can use 
the model of patient values to explore values during consultations, especially in 
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situations where HCPs do not have prior knowledge of a patient (such as first time 
consults). For example, HCPs could sequentially explore patient's negative and positive 
perceptions of the options, and then move on to how the option may affect their life 
priorities and finally discuss the patient's socio-cultural environment.  This general 
model of patient values is flexible enough to be adapted for use in various medical 
decisions and should prove useful as a tool as part of patient-centred care or 
communication skills training in medical curricula. 
The results underscore the role of culture and society on values in medical decision 
making, especially within a multicultural Asian context. The plurality of socio-cultural 
beliefs, languages and healthcare systems (including alternative medicine) make 
practicing SDM challenging in these contexts. This study highlighted the need for 
expanding the current concept of patient values in medical decision making. Clinicians 
should address more than just values related to treatment options and definitions of 
values should include patients’ priorities, life philosophy and their background.  
One other area of potential research is to investigate how and why values may change 
over time. Two models of patient values were produced in this thesis: the first based on 
the systematic review of patient values (Chapter 3.2); and the second based on the 
patient interviews (Chapter 5.5). The lists of values for both models are quite similar; 
however the list from the patient interviews is broader than the model from the 
systematic review as it also includes more abstract non-health related priorities (such as 
life goals). One difference between the models was that the dimension of longitudinal 
stability in the systematic review was not present in the patient interviews as patients 
were only interviewed once in the study and the study was unable to capture how values 
changed and the reasons for this change. Future research can investigate the longitudinal 
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stability of the value structures of actual patients and identify factors which predicate 
value changes.  
Another area of research is evaluating the validity of the model of patient values. 
Studies can try to measure the effect of each category of values on patient decisions on 
different types of decisions in various health decisions. For example, a questionnaire 
could be developed to measure the importance that patients place on each category of 
values using a Likert scale. These scores could then be correlated with patient 
willingness to initiate insulin to find out which categories are most strongly correlated 
with the behaviour. The same measures can be repeated with other health behaviours 
and regression analyses can be performed to find out which of the three value categories 
is the strongest predictor in various health decisions. Validation studies of the patient 
values model on other areas of healthcare decision making such as acute illness or 
surgery choice should be carried out to explore the transferability of the model to other 
decision making areas.  
Adapting the patient values model to clinical practice would be another potential area of 
research. Such adaptation would help facilitate the practice of SDM as perceptions that 
SDM will positively impact the clinical process and improve patient outcomes are the 
second and third most common facilitators after personal HCP motivation to practice 
SDM (Gravel, 2006). Indeed, using the patient values model within a SDM framework 
to explore patient concerns will help achieve many of the perceived benefits of SDM 
such as: helping patients address all their concerns, providing HCPs with more 
background information to better judge patients’ needs and preferences, and improving 
patient satisfaction by reducing their worries and increasing their understanding of the 
disease (Gravel, 2006).  Possible innovations include adapting the model into a patient 
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questionnaire to be filled by the patient while waiting to see the doctor or a web-based 
smartphone app that allows patients to highlight their values and concerns to the doctor 
when making an appointment.  
The patient values model also fits well with current ideas on health literacy and can be 
taught to patients to improve their communication with HCPs. The concept of health 
literacy has moved beyond the original definition which only included patient ability to 
perform health-related reading and computational skills (Simonds, 1974). Health 
literacy is now seen as going beyond just cognitive skills, to also include the patients 
social skills (e.g. communication, negotiation, organization) and Nutbeam 
conceptualizes health literacy as an action oriented concept, rather than just an 
intellectual one (Nutbeam, 2000). Indeed improving health literacy is seen as a form of 
patient empowerment. For example, Kwan et al (2006) define health literacy as 
“People's ability to find, understand, appraise and communicate information to engage 
with the demands of different health contexts to promote health across the life-course”. 
The patient values model fits well into the current view of health literacy as it helps 
patients to interpret information and choose options according to what is important to 
them. One goal of health literacy is active involvement of patients in consultations 
(Edwards et al, 2012). Using the patient values model as a framework for patients to 
think about and communicate their personal values will help patients to more accurately 
communicate their needs and concerns to HCPs. 
6.5 Limitations 
Although the patient values model describes general categories of values which likely 
are also influential in other disease conditions, without further study, the transferability 
of the model to other disease conditions remains the main limitation of this study. Some 
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factors which may limit the transferability of the model are treatment reversibility, acute 
vs. chronic conditions, and socio-cultural values. Treatments which are non-reversible 
(e.g. surgery) may involve other types of values (e.g. decisional regret) which were not 
elicited in this study. Another dimension is the length of treatment: type 2 diabetes is a 
chronic condition which prompts patients to consider long-term effects of the treatment 
(e.g. lifelong costs, impact on career) while more acute conditions may involve different 
concerns. Finally, the socio-cultural values in the study are from a Malaysian context 
and culture will differ in other settings.  
6.6 Conclusion 
The “patient revolution” of patients being actively involved in many, if not all, facets of 
healthcare is gaining strong support in policy and research (Richards, Montori, Godlee, 
Lapsley & Paul, 2013). Patient participation in healthcare is driven by two currents; 
evidence that increased patient participation improves health system efficacy (e.g. 
reducing overmedication), and secondly, concern that the doctor-patient relationship 
needs to more closely resemble a partnership rather than a paternalism (Barratt, 2008; 
Richards, Montori, Godlee, Lapsley & Paul, 2013).  
Putting patients at the centre of healthcare benefits from practice models that help 
patients and HCPs understand, and negotiate together, the roles that each plays in the 
medical encounter. These models identify the components (e.g. information, training, 
needs, preferences, values, identities, roles) that each party brings to the encounter, and 
how these should be incorporated to form a patient-doctor partnership. This thesis has 
developed a model of patient values that identifies the three main categories of values 
from a grounded theory of patient values in insulin initiation. 
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Interest in SDM has only just begun in Malaysia. Most patients are not yet able to make 
informed choices due to the prevalence of misconceptions, the lack of patient education 
resources and the problems of cross-cultural communication (Chapter 5.1). Some HCPs 
still prefer a paternalistic style and as in the case of insulin are hesitant to recommend 
some treatments (Chapter 5.3). Patients in Malaysia’s multicultural setting hold to a 
plethora of values and beliefs and current definitions of patient values do not include 
these larger worldviews. The patient values model represents my contribution to the 
efforts of a small group of Malaysian practitioners and researchers who are committed 
to understanding and resolving the challenges and barriers to implementing SDM in a 
resource-limited, multi-cultural setting.  
In SDM, the patient values model identifies the categories of values which should be 
considered in value clarification methods, and may be useful for guiding practice (a 
‘rough guide’ to eliciting patient values in various types of medical decisions) and 
improving SDM training (illustrating what are patient values in medical curricula).  
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APPENDIX A: The Decision Making in Insulin Therapy (DMIT) Project 
A.1 Introduction to DMIT (http://www.dmit.edu.my) 
Malaysia has the highest prevalence rate of type 2 diabetes (11.7%) in the Western 
Pacific region and this figure is projected to rise to 13.3% by 2030 (International 
Diabetes Federation, 2011). The majority of patients in Malaysia have poor glycaemic 
control; only about 20% of them have HbA1c levels of less than 7% (Chan, Ghazali et 
al., 2005; Mafauzy, 2005; Ismail, Chew et al., 2011). This leads to an increase of micro 
and macro vascular complications which impose heavy burden on Malaysia’s stretched 
healthcare system (Ibrahim, Aljunid et al. 2010; Zhang, Zhang, et al. 2010), where 
cardiovascular disease already accounts for the highest number of hospital deaths in the 
country (Ministry of Health 2010).  
Despite the availability of many treatment options (Ministry of Health 2009), blood 
glucose control remains poor (Chan, Ghazali et al., 2005; Mafauzy, 2005; Ismail, Chew 
et al., 2011).  One reason is the delay in stepping up treatment regimen such as insulin 
therapy (Donnon PT, Steinke DT et al., 2002). There are many barriers in starting 
insulin treatment (Polonsky and Jackon 2004; Polonsky, Fisher et al., 2005) and few 
interventions have been developed to help patients and clinicians overcome these 
barriers. 
A.2 Overview of the DMIT project 
Thus, the project aimed to develop a decision support tool to help HCPs and patients 
participate in SDM during insulin initiation. This complex intervention was developed 
based on the needs of stakeholders (patients, clinicians and policy makers), current best 
evidence and decision support theories (UKMRC, 2008). This practical decision-
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making tool would be evaluated for implementation in the primary care setting across 
Malaysia.  
 Development and pilot-testing of the tool took place over three phases between 
September 2010 and August 2013 (Figure A.1). Overall project development was 
based on the conceptual frameworks of the Ottawa Decision Support Framework 
(ODSF) (O'Connor, Tugwell et al., 1998) and the UKMRC complex intervention 
framework (UKMRC, 2008). A decision-making tool was developed by the research 
team using the needs of the clinicians and patients (findings from Phase 1); evidence 
from the systematic review; and decision support theories. This tool was in the form 
of a 16-page PDA booklet entitled “Making Choices: Should I Start Insulin?” 
(Figure A.2) (DMIT Group, 2012). 
 
Figure A.1: Exploratory, Development and Pilot phases of the DMIT Project 
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Figure A.2: ‘Making Choices: Should I Start Insulin’ PDA 
Source: DMIT Group, 2012 
A.3 Role in DMIT and publications 
My role in the project was an evolving one. Although I initially joined as a research 
assistant in September 2010, I received a scholarship from the University of Malaya in 
October 2010 which converted me to a full time PhD student. Thus another research 
assistant was recruited and I functioned as a co-researcher and overall project co-
ordinator for Phase 1 (Exploratory Phase) of the project. As my PhD focused on patient 
decision making values, I conducted almost all the 21 patient interviews and analysed 
the data. During Phase 2 (Development Phase), I focused on the publication of data 
from Phase 1 as part of my PhD scholarship requirements. Papers published in my PhD 
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are from the Phase 1 data collection period. More papers were written up for Phase 2 
and 3 but these will only be published after the period of my PhD.  
Although less involved in overall co-ordination for Phase 3 (Pilot testing Phase), I was 
still very much involved in developing the assessment tools for evaluating the PDA, 
facilitating the training workshops (involving one-hundred and one HCPs) and 
interviewing patients (n=18) and HCPs (n=13) about their experience with using the 
PDA in clinical consultation.  
A.4 Funding and Research Team 
DMIT was funded by a University of Malaya Research Grant (Reference number 
UMRG236/10HTM) and the principal investigator Prof Dr Ng Chirk Jenn is from the 
Department of Primary Care Medicine, University of Malaya. Besides Dr Ng, the 
research team comprised seven co-researchers from university, government primary 
care and private practice settings and one research assistant.  
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APPENDIX B: Interview Topic Guide – Healthcare Professionals 
Part 1 – Needs Assessment for Decision Making 
General – Starting Insulin 
1. Can you tell me on average how many diabetic patients you see in one week?  
2. What decisions do these patients have to make about their diabetes? 
Let’s focus on: whether to start insulin.  
Patient’s Decision Making 
3. Is starting insulin a difficult decision for your patients? 
a. If yes, why is it difficult for them? What difficulties do patients face when 
deciding whether to start insulin? 
b. If no, why not? 
4. How do they feel when they are making this decision? 
5. What are the things that patients consider before they decide whether or not to start 
insulin?  
a. Information, what information,  
b. Values,  
c. Influence from others: how others do it, support from others, handling 
pressure 
 
6. What kind of help do they need to make this decision?  
a. information, support 
7. Who else, besides your patient, are involved in making this decision?  
a. family, friends 
b. how are they involved in the decision making 
HCP’s Support 
8. Who are the patients whom you would advise to start insulin? 
9. If a patient refuses to start insulin, what other options do they have?  
a. What are the advantages and disadvantages of these options? 
10. How do you help patients to start insulin?  
11. What role do you play in the decision making process? 
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12. How do you explain the risks and benefits of insulin to your patients?  
13. What barriers do you face when advising them to start insulin?  
a. Talking about risks and benefits,  
b. Exploring values, ideas, concerns and expectations 
c. Coaching them how to make decisions 
d. Motivating them 
14. What kind of help do you need to overcome these barriers? 
15. Could you share an example of successfully advising your patient/s to start insulin? 
a. How did you do it? (For insulin prescribing doctors) 
Decision Support 
16. There are different ways of helping patients to make decisions about starting insulin. 
I would like to hear your opinion whether they will work with your patients.  
 Counselling with healthcare professionals (doctors, nurses, others healthcare 
professionals) 
 Discussion group of people facing the same problem 
 Information materials – content, format and who should prepare these 
information 
 Patient decision aid (show them the decision aid and ask for their comments) 
 
End of Interview 
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APPENDIX C: Interview Topic Guide – Patients 
General – Diabetic treatment 
1. How long have you had diabetes?  
2. How do you feel about having diabetes? 
3. What have you done to try and control your diabetes? 
Let’s focus on: the decision whether to start insulin.  
Patient’s Decision Making 
4. Have you been asked to start insulin? 
a. Who has advised you to start insulin? 
b. When was that? 
c. What stage are you at now in starting insulin? 
Already started, Agreed but not started, Still considering, Refuse to start.  
5. What do you know about insulin? 
6. What has been going through your mind since you were advised to start insulin?  
7. Where do you get your ideas/ beliefs about insulin from? 
a. Friends 
b. Family 
c. Direct experience 
d. Cultural beliefs 
8. Is starting insulin a difficult decision for you?  
a. If yes, why is it difficult? 
b. If no, why not? 
Probe emotional barriers related to insulin: 
negative feelings and phobias(e.g. depression, anxiety and embarrassment, feelings 
of failure, lack of confidence, needle phobia) 
 * If patient is unable to identify barriers to starting insulin, then ask: 
Are these barriers (halangan) to starting insulin for you? 
Probe with list of barriers from HP: 
a. Prefer Complimentary and Traditional medicine 
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b. Conflicting information 
c. Fear of needles and pain 
d. Fear of side effects (hypo, weight gain) 
e. Lack of knowledge 
f. Self-efficacy 
g. Visual impairment 
9. Have you received any information about starting insulin? 
a. What information would you like to have? 
b. Who should discuss with you about starting insulin? 
c. Are you satisfied with the information provided so far? Why or why not? 
10. Do you have other options besides insulin? 
a. If yes, what are they? 
b. How do you choose between options? 
11. Are you motivated to start insulin?/ Adakah anda rasa bersemangat untuk 
memulakan insulin? 
a. If yes, what motivates you to start insulin? 
b. If no, why not? 
Probe motivating beliefs about insulin: 
Effectively managing diabetes, concern over worsening blood glucose, know of 
others who manage their diabetes well with insulin  
12. What are the things would help you to make a decision whether or not to start 
insulin? 
 More information - what information 
 Support from others – healthcare professionals, family, friends, people who have 
used insulin 
Prompts: side effects, risks and benefits 
13. What are important priorities (keutamaan) to you at this stage of life?  
Examples: Health, money, family 
a. Does this influence your decision to start insulin?  
b. If yes, how so? 
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c. If no, why not? 
14. Who else is involved in making this decision? What are their roles? 
a. doctors,  
b. family and  
c. friends 
15. Who do you think should make the decision about you starting insulin? 
a. Yourself 
b. Doctors 
c. Family 
d. Others 
Decision Support 
16. Here are some ways to help patients make decisions – what do you think? 
 Counselling by healthcare professionals 
 Discussion group of people facing the same problem 
 Information materials – content, format and who should prepare these 
information 
 
End of Interview 
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APPENDIX D: Coding Tree (HCPs) 
D.1 Codes describing the barriers to insulin initiation
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D.2 Codes describing policies related to diabetes and insulin 
 
D.3 Codes describing problems faced by patients who are using insulin therapy
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D.4 Codes related to HCP strategies to initiate insulin in patients with type 2 
diabetes 
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APPENDIX E: Coding Tree (Patients) 
E.1 Codes describing the values of patients during insulin initiation 
E.1.1 Life Philosophies and Priorities 
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E.1.2 Insulin-specific perceptions 
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E.1.2 Insulin-specific perceptions, continued 
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E.1.2 Personal and socio-cultural background 
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E.2 Codes describing the decision-making context of insulin initiation 
 
E.3 Codes describing the decision-making process of patients 
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APPENDIX F: Ethics Approval 
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APPENDIX G: Participant Information Sheet (Healthcare Professional) 
Please read the following information carefully, do not hesitate to discuss any 
questions you may have with the researcher. 
Study Title  
Developing and pilot-testing an intervention for patients with type 2 diabetes who are 
making decisions about starting insulin therapy 
Introduction 
We would like to invite you to take part in a research study. This study will find out the 
problems faced by healthcare professionals and their patients with type 2 diabetes who 
need to make decisions about starting insulin therapy. 
Before you decide whether to participate, you need to understand why the research is 
being done and what it would involve. Please take time to read the following 
information carefully and talk to the researcher if you wish.  
Ask us if there is anything that is not clear or if you would like more information. Take 
time to decide whether or not you wish to take part.  
What is the purpose of this study? 
When patients are advised to begin insulin therapy by their healthcare providers, they 
often find the decision difficult as there are many factors to be considered. Healthcare 
professionals help patients make informed decisions by advising them on the risks and 
benefits of the treatment, and also helping them to evaluate how they feel and think 
about the treatment.  
Therefore, the purpose of this study is to find out the barriers, motivators and needs of 
patients that you have encountered in the course of advising a patient to start insulin 
therapy.  
This information will then be used to help create a practical decision-making tool which 
doctors and nurses can use to help patients make informed choices about insulin 
therapy.  
A total of 30 healthcare professionals will be interviewed for this study.  
What are the procedures to be followed? 
If you agree to take part in this study, you will be invited for a session in which a 
researcher will conduct an in depth interview. During the session, the researcher will go 
through the Participant Information Sheet with you. If you agree to participate, the 
researcher will ask you to sign a consent form, followed by a simple questionnaire about 
your background (10 minutes).  
You will participate in a one-to-one interview. The researcher will ask questions about 
topics related to making decisions about insulin therapy. He/ she will record the 
conversation using an audio voice recorder. The purpose of the recording is to allow the 
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researcher to collect information discussed during the interview, which is important for 
them to analyse later. The one-to-one interview will take about 30 minutes. 
All information collected during the course of the research will be kept strictly 
confidential. Any information that contains your name, telephone and address will be 
removed so that you cannot be identified.  
Who should participate in the study? 
Healthcare professionals working in the primary care setting (private or public sectors) 
who have discussed insulin initiation with their type 2 diabetes patients in the past six 
months. 
Who should not participate in the study? 
You should not participate in this study if: 
1. you are not practicing in a primary care setting 
2. you have not advised patients with type 2 diabetes regarding starting insulin 
treatment in the past six months  
What will be benefits of the study: 
(a) to you as the participant? 
You will be able to contribute significantly to the development of a practical tool that 
will help doctors and patients manage diabetes better by making informed decisions 
about insulin therapy.  
You will be given RM 100.00 to compensate for your travel and time to attend the 
interview.  
(b)          to the researcher? 
The researcher will be able to develop a decision-making tool that will be used by 
healthcare professionals and patients in making informed-choices about insulin therapy. 
With better control of diabetes, many patients can live normal lives without the 
complications associated with diabetes. 
The researcher will also be able to contribute to the larger body of medical knowledge 
in the field of diabetes, healthcare professional-patient communication, and 
development and implementation of decision-making tools.  
What are the possible drawbacks? 
During the interview, sometimes, you may be asked questions about your patients that 
you feel are sensitive or which you are uncomfortable to disclose. You can refuse to 
answer any questions which you feel uncomfortable with, or you can stop the interview 
anytime. 
 
Can I refuse to take part in the study? 
Yes. This study is voluntary and you can refuse to take part at any stage of the study. 
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Who should I contact if I have additional questions during the course of the study? 
Doctor’s Name:     Dr Ng Chirk Jenn         Tel: 03-7949 2621 
Research assistant’s Name:   Mr Lee Yew Kong  Tel:  012-609 2018 
  
359 
 
APPENDIX H: Participant Information Sheet (Patient) 
PATIENT INFORMATION SHEET 
Please read the following information carefully, do not hesitate to discuss any 
questions you may have with your Doctor. 
Study Title  
Developing and pilot-testing an intervention for patients with type 2 diabetes who are 
making decisions about starting insulin therapy 
Introduction 
We would like to invite you to take part in a research study. This study will find out the 
problems faced by people with type 2 diabetes who need to make decisions about 
starting insulin therapy. 
Before you decide whether to participate, you need to understand why the research is 
being done and what it would involve. Please take time to read the following 
information carefully; talk to others about the study if you wish. 
Ask us if there is anything that is not clear or if you would like more information. Take 
time to decide whether or not you wish to take part.  
What is the purpose of this study? 
When patients are advised to begin insulin therapy by their doctor, they often find the 
decision difficult as there are many factors to be considered. Informed decision-making 
on insulin therapy not only requires you to know the risks and benefits of the treatment, 
it also depends on how you feel and think about the treatment. Sometimes, you may not 
have had opportunity to discuss this information in detail with your doctor or nurse. 
Therefore, the purpose of this study is to find out the problems you have encountered 
when you are making a decision about insulin therapy.  
This information will then be used to help create a practical decision-making tool which 
doctors and nurses can use to help patients make informed choices about insulin 
therapy.  
A total of 30 patients will be interviewed for this study.  
What are the procedures to be followed? 
If you agree to take part in this study, you will be invited for a session in which a 
researcher will conduct an in depth interview. During the session, the researcher will go 
through the Participant Information Sheet with you. If you agree to participate, the 
researcher will ask you to sign a consent form, followed by a simple questionnaire about 
your background (10 minutes).  
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You will participate in a one-to-one interview. The researcher will ask questions about 
topics related to making decisions about insulin therapy. He/ she will record the 
conversation using an audio voice recorder. The purpose of the recording is to allow the 
researcher to collect information discussed during the interview, which is important for 
them to analyse later. The one-to-one interview will take about 30 minutes. 
All information collected during the course of the research will be kept strictly 
confidential. Any information that contains your name, telephone and address will be 
removed so that you cannot be identified.  
Who should enter the study? 
People with type 2 diabetes who are advised to start insulin treatment. 
Who should not enter the study? 
You should not participate in this study if: 
• You do not have type 2 diabetes 
• You have not been advised by your doctor to start insulin 
• You are already taking insulin 
What will be the benefits of the study: 
(a) to you as a participant? 
You will be able to contribute to the development of a practical tool that will help 
doctors and patients manage diabetes better by making informed decisions about insulin 
therapy.  
You will be given RM 50.00 to compensate for your travel and time to attend the 
interview.  
(b)          to the researcher? 
The researchers will be able to develop a decision-making tool that will be used by 
doctors and patients in making informed-choices about insulin therapy. With proper 
management of diabetes, many patients can live normal lives without the complications 
associated with diabetes. 
The researchers will also be able to contribute to the larger body of medical knowledge 
in the field of diabetes, doctor-patient communication, and development and 
implementation of decision-making tools.  
What are the possible drawbacks? 
During the interview, sometimes, you may be asked questions about certain topics 
which are sensitive or may upset you. You can refuse to answer any questions which 
you feel uncomfortable with, or you can stop the interview anytime. 
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Can I refuse to take part in the study? 
Yes. This study is voluntary and you can refuse to take part at any stage of the study. 
Your treatment and follow-up at the clinic will not be affected if you refuse to take part 
in this study. 
Who should I contact if I have additional questions during the course of the study? 
Doctor’s Name:     Dr Ng Chirk Jenn         Tel: 03-7949 2621 
Research Coordinator’s Name:   Mr Lee Yew Kong  Tel: 012-609 2018 
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APPENDIX I: HCP & Patient Participant Consent Form 
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APPENDIX J: HCP demographic information form 
 Name 
 Age 
 Sex  
 Address  
 Email 
 Telephone number 
 Workplace 
(   ) Private sector     (   ) Government sector      
 Position 
 Years of practice since graduation 
 Postgraduate training 
(   ) Yes     (   ) No      
 How many patients with type 2 diabetes have you seen in the past one month? 
_____ 
 Do you initiate insulin with your patients? 
(   ) Yes     (   ) No      
o If yes, how many of your patients are on insulin? ____ 
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APPENDIX K: Patient demographic information form 
 Name 
 Age 
 Sex  
 Address  
 Occupation  
 Education 
(   ) None     (   ) Primary     (   ) Secondary    (   ) Diploma    (    )Tertiary     
(   )Postgraduate 
 When where you first diagnosed with diabetes? __________ 
 Are you currently on insulin?    Yes/ No 
If yes, how long have you been on insulin? _____________ 
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APPENDIX L: ‘What are your concerns?’ section of the DMIT Insulin PDA 
The section “What are your concerns?” on pages 3 and 4 of the PDA (DMIT Group, 
2012) provides a list of concerns is based on actual patient concerns from interviews 
with patients and HCPs. This section entitled is the first page of content in the PDA. 
The section addresses patients’ possible concerns in order to engage patients on a 
personal level and to encourage them to read the PDA for themselves by directing them 
to content in the PDA which addresses their concerns.  
 
Figure L.1 ‘What are your concerns?’ section of insulin PDA 
Source: DMIT Group, 2012  
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Figure L.1, Continued 
References 
DMIT Group. (2012). Making Choices: Should I Start Insulin? Kuala Lumpur: UM 
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APPENDIX M: ‘Patient scenarios and relevant responses from the insulin PDA’ 
section in the DMIT HCP’s Guide to the Patient Decision Aid 
Pages 12-14 of the HCP’s Guide provide a list of common issues faced during insulin 
initiation. These issues are based on actual patient quotes from the patient interviews. A 
sample response for HCPs as well as the section in the PDA which addresses these 
concerns is provided.  
 
Figure M.1 ‘Patient scenarios and relevant responses from the insulin PDA’ 
section 
Source: DMIT Group, 2012 
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Figure M.1, Continued 
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Figure M.1, Continued 
References 
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